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Abstract 
Optimizing a Scaffoldless Approach for Cartilage Tissue Engineering 
By Benjamin D. Elder 
Articular cartilage has a poor intrinsic healing response, so tissue engineering 
provides a promising approach for cartilage regeneration. The major objective of 
this proposal was to enhance the self-assembling process, used in articular 
cartilage tissue engineering, by investigating the effects of construct confinement, 
hydrostatic pressure application, and growth factor addition. First, the effects of 
construct confinement in different directions and at different times were 
investigated. It was demonstrated that construct confinement resulted in 
enhanced biomechanical properties in the direction orthogonal to the 
confinement surface, either by enhancing collagen organization or by increasing 
collagen production. Next, the effects of hydrostatic pressure at different 
timepoints, magnitudes, and frequencies on the biomechanical and biochemical 
properties of self-assembled constructs were determined. It was demonstrated 
that the application of static hydrostatic pressure, at 10 MPa, for 1 h/day, from 
days 10-14 days led to significant increases in compressive and tensile 
properties, accompanied by significant increases in GAG and collagen content, 
respectively. To our knowledge, this was the first study to demonstrate increases 
in the biomechanical properties of tissue from pure HP application. Furthermore, 
the effects of exogenous application of growth factors, at varying concentrations, 
dosages, and combinations, with and without hydrostatic pressure, were 
assessed on the biochemical and biomechanical properties of engineered 
constructs. A systematic approach was used to determine the effects of BMP-2, 
IGF-I, and TGF-pi, alone and in combination, on the functional properties of 
engineered constructs. This was the first study to demonstrate significant 
increases in both compressive and tensile biomechanical properties as a result of 
growth factor treatment. Also, for the first time, synergistic and additive effects 
on construct biomechanical and biochemical properties were found when 
combining growth factor treatment with hydrostatic pressure application. Finally, 
the effects of various decellularization treatments were examined, and it was 
determined that it was possible to remove cells while maintaining construct 
functional properties. The results presented in this thesis are exciting, as they 
have allowed for a better understanding of the self-assembling process, and 
have allowed the self-assembled constructs to mature into functional articular 
cartilage, as evidenced by biomechanical and biochemical properties spanning 
native tissue values. 
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Introduction 
The overall objective of this thesis is to enhance the self-assembling process for 
in vitro tissue engineering of articular cartilage. The self-assembling process has 
been developed by our group and applied to engineer articular cartilage 
constructs. Motivated by this objective, it is hypothesized that 1) the self-
assembling process can be enhanced by identifying suitable growth factors and 
mechanical forces; and 2) the effects of these exogenous factors individually or 
in combination will allow the formation of constructs in vitro resembling native 
tissue. To test these global hypotheses, three specific aims were employed: 
1) To determine the effects of radial and vertical confinement on the 
self-assembling process of articular cartilage. This approach involves 
determining the effects of construct confinement in different directions and 
at different times on the self-assembling process. First, self-assembled 
constructs are radially confined in agarose wells for four different 
timepoints. Next, the constructs are confined for two weeks, and then 
transferred to incrementally larger wells for the third and fourth weeks of 
culture. Finally, the effects of vertical confinement, in the form of passive 
axial compression are examined. The engineered constructs are 
assessed histologically for collagen and glycosaminoglycan (GAG), and 
immunohistochemically for collagen types I and II. Additionally, the 
constructs are assessed biochemically to quantify DNA, total collagen, 
and GAG content. Finally, biomechanical evaluation of the constructs is 
performed using creep indentation and uniaxial tensile testing. It is 
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hypothesized that the application of confinement will enhance the 
mechanical properties of the constructs, and that confinement at different 
timepoints in construct development will have a significant effect on 
construct properties. 
2) To determine the effects of hydrostatic pressure on the self-
assembling process of articular cartilage. This approach involves the 
determination of hydrostatic pressure (HP) effects on the self-assembling 
process. Initially, an appropriate control for HP is selected at one 
application time. Next, the self-assembled constructs are placed under 
static physiologic-magnitude HP to determine the temporal effects of HP 
application. Additionally, the immediate and long-term effects of HP 
application are assessed. Finally, a full-factorial experimental design is 
used with two factors (magnitude, frequency) at three levels each. These 
factors are optimized, with "optimal" defined as the set of conditions 
producing properties closest to native tissue in terms of extracellular 
matrix (ECM) composition and biomechanical properties. The best two 
HP conditions are subsequently used in specific aim 3. The hypotheses of 
this aim are that 1) there exist optimal conditions (magnitude, frequency, 
application time) for HP that improve the quality of self-assembled 
constructs and 2) these optimal conditions fall within the physiologic range 
of pressure magnitudes. 
3) To determine: 
a. The effects of growth factors alone and in combination 
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b. The combined effects of growth factors and HP on the self-
assembling process of articular cartilage. 
The first step of this approach involves the determination of growth factor 
effects on the self-assembling process. The self-assembled constructs are 
treated temporally with three individual growth factors at two concentrations, 
each delivered in the media continuously or intermittently. The best treatment 
for each growth factor, that produces construct properties closest to native 
tissue in terms of ECM composition and biomechanical properties, is carried 
forward and studied in combinations of two and three at a time to quantify 
growth factor interactions. The optimized growth factor combinations are then 
combined with the optimized HP conditions from specific aim 2 to examine 
their combined effects. The specific hypotheses of this aim are that 1) there 
exist growth factor conditions that are most beneficial in the self-assembling 
process and 2) combining growth factor treatment with HP will result in 
additive and synergistic effects. 
Chapter 1 delivers an overview of the field of articular cartilage tissue 
engineering, while chapter 2 describes the prior use of HP in articular cartilage 
tissue engineering strategies. Chapters 3 through 6 focus on studies to enhance 
the functional properties of tissue engineered constructs such that they approach 
native tissue. Finally, Chapter 7 describes a method for the decellularization of 
scaffoldless tissue engineered constructs. Chapter 1 reviews the field of articular 
cartilage tissue engineering, with a specific focus on the design criteria for a 
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tissue engineered constructs, as well as highlighting the various parameters that 
must be addressed in cartilage tissue engineering studies, including scaffolds, 
growth factor and cytokine application, and the use of exogenous mechanical 
stimulation. This chapter motivates the use of the selected growth factors and 
mechanical stimulation strategies used in this thesis. 
Chapter 2 reviews the prior work involving the application of HP to articular 
cartilage chondrocytes. This chapter focuses on prior HP studies in several 
areas, including HP bioreactor design and the use of HP in tissue engineering 
strategies, with a particular emphasis on examining the differences between HP 
application to chondrocytes in monolayer, in 3-D tissue engineered constructs, as 
well as explants. Furthermore, a comparison between the different effects of 
intermittent and static HP is made. Additionally, the chondroprotective effects of 
HP, the use of HP as a differentiation agent, the use of high magnitude HP, as 
well as the mechanotransduction pathways of HP application are examined. This 
chapter identifies four criteria, namely magnitude, frequency, duration of 
application, and application time in construct development, as parameters that 
may be altered in studies involving the effects of HP. These parameters are all 
examined in chapters 4 and 6. 
Chapters 3-6 address work performed toward the completion of the Specific Aims 
of this thesis. Chapter 3 addresses Specific Aim 1, and describes the beneficial 
effects of radial and vertical confinement on construct properties. Chapter 4 
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addresses Specific Aim 2 and demonstrates the effects of temporal HP 
application by identifying a suitable control for HP application, determining the 
effects of HP application at different timepoints in construct development, and 
examining both the immediate and long-term effects of HP application. Specific 
Aim 3 is addressed in chapter 5, which determines the effects of multiple 
individual growth factors, including TGF-pi, IGF-I, and BMP-2, at different 
concentrations and different application times, on construct functional properties; 
additionally, this chapter demonstrates the effects of treatment with growth factor 
combinations. Chapter 6 addresses Specific Aims 2 and 3, and identifies the 
optimal magnitude and frequency for HP application. Additionally, this chapter 
examines the effects of combined treatment with HP and growth factors, and 
demonstrates synergistic and additive effects when combining TGF-p1 treatment 
with HP application. 
Finally, chapter 7 describes a preliminary study to identify a method for construct 
decellularization, with the objective of eliminating the cells and DNA content of 
the tissue while preserving the biochemical and biomechanical properties of the 
tissue, particularly the GAG content and compressive stiffness. 
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Chapter 1: Paradigms of Tissue Engineering with 
Applications to Cartilage Regeneration 
Benjamin D. Elder and Kyriacos A. Athanasiou 
Chapter published as: Elder, BD and Athanasiou, KA. Paradigms of Tissue 
Engineering with Applications to Cartilage Regeneration. In: Musculoskeletal 
Tissue Regeneration: Biological Materials and Methods, Pietrzak, WS, Ed. 
Totowa, NJ: Humana Press 2008:593-615. 
ABSTRACT 
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Tissue engineering has been widely explored as an option for regeneration of 
various musculoskeletal tissues. This chapter examines the tissue engineering 
paradigm, or approach, with a focus on its application to cartilage tissue 
engineering. Since understanding the tissue engineering approach will require 
an understanding of cartilage physiology, a brief review of cartilage structure and 
function is provided. A discussion of current studies of the four parameters of the 
paradigm, namely scaffolds, cell sources, bioactive agents, and bioreactors is 
presented, along with the latest technologies that incorporate manipulation of 
several parameters in a single approach. 
8 
INTRODUCTION 
Tissue engineering approaches currently are studied in order to repair many 
musculoskeletal tissues, including bone, vertebrae, knee meniscus, tendon, 
ligament, temporomandibular joint (TMJ) cartilage, and articular cartilage. This 
approach aims for functional tissue restoration and involves the use of cells, 
scaffolds, bioactive agents, and mechanical forces. The goal of tissue 
engineering is to create tissue with biomechanical and biochemical properties 
that match those of the native tissue. 
Cartilage degeneration from injury or from osteoarthritis is one of the greatest 
problems currently faced in orthopedics, and is the second most common chronic 
condition reported in the United States.1 According to the website 
www.arthritis.org.2 approximately 21 million people in the US are affected with 
osteoarthritis, resulting in total annual costs of approximately $5700 per person 
living with osteoarthritis. Due to the prevalence of articular cartilage pathologies 
and the need for more effective methods for cartilage repair, tissue engineering 
has emerged as a promising approach for cartilage regeneration. This chapter 
will provide an overview of the paradigms of tissue engineering, predominantly 
exemplified by exploring the strategies currently used to engineer articular 
cartilage. To gain a better understanding of how tissue engineering approaches 
are applied to articular cartilage regeneration, a brief discussion of articular 
cartilage structure and function is provided. 
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BACKGROUND 
Structure and Function of Articular Cartilage 
Articular cartilage is a specialized form of hyaline cartilage that is essential for the 
proper function of diarthrodial joints. The main function of articular cartilage is to 
distribute forces between the subchondral bones. Also, along with synovial fluid, 
articular cartilage provides lubrication, friction reduction, and wear resistance for 
the joint. 
Articular cartilage is avascular, aneural, and alymphatic, and is sparsely 
populated by cells called chondrocytes. Articular cartilage is considered to 
consist primarily of a solid phase and a fluid phase.3 Water is the primary 
component of the fluid phase and accounts for 75-80% of the wet weight of the 
tissue. Additionally, electrolytes such as Na+, Ca2+, and CI" are found in the fluid 
phase. The solid phase is characterized by the extracellular matrix (ECM), 
consisting predominantly of collagen and proteoglycans, which surrounds the 
chondrocytes and provides structural support to the tissue. The ECM is 
composed of approximately 50%-75% collagen, and 30-35% proteoglycans.4,5 
Collagen is the primary constituent of the ECM of articular cartilage. As reviewed 
elsewhere,5 collagen II accounts for 90-95% of the collagen in the matrix and is 
often used as a marker for chondrogenic differentiation in tissue engineering 
studies. The collagen II fibrils are largely responsible for the tensile strength of 
the tissue. Other types of collagen are present in the matrix in much smaller 
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amounts and serve varying roles. Collagen XI contributes to fiber formation with 
collagen II, while collagen VI, IX, and X contribute to the ECM structure. 
Proteoglycans are glycoproteins that are characterized by long, unbranched, and 
highly charged glycosaminoglycan (GAG) chains.6 Aggrecan, the most common 
proteoglycan in articular cartilage, is responsible for the compressive strength of 
the tissue. In addition to collagen II, the expressions of GAG and aggrecan are 
also used as specific markers for chondrogenic differentiation. 
Mature articular cartilage has a distinct zonal arrangement in vertical sections 
(Fig. 1). Beginning with the articulating surface, it consists of the superficial, 
middle, deep, and calcified zones. These zones exhibit great differences in their 
properties.7 The superficial zone comprises the first 10-20% of the thickness of 
the tissue, and is characterized by densely packed collagen II fibrils oriented in 
the direction of shear stress, along with flattened chondrocytes. The middle zone 
comprises the next 40-60% of the tissue thickness, and consists of randomly 
arranged collagen fibers and chondrocytes with a more rounded morphology. It 
also serves as a transition between the superficial and deep zones. The deep 
zone contains collagen fibers that extend into the calcified zone in order to 
reinforce the bond between cartilage and bone. The cells of the deep zone 
appear more ellipsoid in shape, and are aligned with the collagen fibers. A 
distinct tidemark separates the deep zone from the calcified zone. This tidemark 
is usually considered to be the boundary between cartilage and bone. The 
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calcified zone is composed of chondrocytes that are trapped in a calcified matrix. 
Chondrocytes sparsely populate cartilage, comprising less than 10% of the 
volume of the tissue.8 Chondrocytes differentiate from mesenchymal stem cells 
(MSCs) and are responsible for the maintenance and regulation of the ECM 
through the enzymatic degradation of existing ECM, the synthesis of new ECM, 
and the production of various bioactive agents such as growth factors. In healthy 
articular cartilage, chondrocytes do not proliferate. Since the tissue is relatively 
avascular, the chondrocytes exist in a low oxygen tension environment and must 
obtain oxygen and nutrients from the synovial fluid through diffusion. 
Biomechanics of Articular Cartilage 
As mentioned above, the aggrecan content of cartilage is largely responsible for 
its compressive properties. Aggrecan is negatively charged, leading to osmotic 
swelling and hydration of the tissue from the Donnan osmotic pressure.9 When 
cartilage is compressed, the interstitial fluid pressure initially supports most of the 
applied load. The water is then pushed out of the matrix and into the synovial 
cavity; therefore, it moves from a loaded region to an unloaded region. The 
frictional force between the leaving water and the matrix leads to dissipation of 
the applied force, and the load eventually equilibrates. Upon removal of the load, 
fluid comes back into the aggrecan network. This process allows for the 
cushioning of an applied load without damage to the chondrocytes or ECM. The 
interaction between the matrix and the interstitial fluid of cartilage is modeled by 
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Mow et al.'s3 biphasic theory. Applying the biphasic theory to articular cartilage 
in studies of creep indentation yields three material properties: the aggregate 
modulus, the Poisson's ratio, and the permeability of the porous solid phase, 
which measure the stiffness, the apparent compressibility, and the resistance to 
fluid flow respectively.3 The mechanical properties of articular cartilage vary with 
the anatomic location of the joint. A review by Hu et al.5 indicated that the 
aggregate modulus ranges from 0.53 M.Palo 1.34 MPa, the Poisson's ratio from 
0.00-0.14, and the permeability from 0.90 x 10~15 m4/Ns to 4.56 x 10"15 m4/Ns. 
Articular cartilage is exposed to a wide variety of forces including hydrostatic 
pressure, compression, and shear forces. As reviewed elsewhere,10 the force 
exerted on the knee has been found to be approximately 3.5 times body weight, 
while the ankle and shoulder experience loads of 2.5 times body weight and 1.5 
times body weight respectively. In addition, contact pressures between 3-18 
MPa have been observed in the human hip joint.11 During loading of articular 
joints, synovial fluid inside the joint capsule generates hydrostatic pressure by 
transmitting force throughout the tissue. Compressive forces are generated in 
articular cartilage as a result of direct contact between the articulating surfaces. 
Likewise with compressive forces, shear forces are generated in the knee joint 
during loading as a result of direct contact between the articulating cartilage 
surfaces, as the two surfaces attempt to move past each other. 
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Repair of Articular Cartilage 
As reviewed elsewhere,12 injuries of articular cartilage can be classified as 1) 
chondral damage without visible tissue disruption, 2) cartilage damage alone 
such as chondral flaps and tears, and 3) cartilage damage accompanied by 
underlying bone damage (osteochondral fracture). As a result of the relatively 
nonexistent vascular supply, scarcity of chondrocytes in the tissue, and the lack 
of chondrocyte proliferation, the ability of articular cartilage to repair itself is 
intrinsically limited. As reviewed elsewhere,13 in a chondral injury, the 
chondrocytes surrounding the defect show a limited ability to proliferate in order 
to repair the damaged site. In an osteochondral injury, MSCs from the bone 
marrow can migrate to the site for tissue repair. However, in both cases, the 
defect is repaired with fibrocartilage formation, which is predominantly collagen I 
and lacks the mechanical integrity of articular cartilage, thus leading to its 
relatively rapid degradation with normal loading of the joint.14 
The current clinical options for treatment of patients with damaged articular 
cartilage are relatively limited. According to a recent review,15 the most 
successful treatment options for restoring native hyaline cartilage have involved 
tissue grafting, where cartilage is removed from a less load-bearing region and is 
grafted to the defect site. However, this approach involves significant donor site 
morbidity and the result is often short-lived, as fibrocartilage fills the donor site 
and the area surrounding the graft. Autologous chondrocyte implantation is 
another treatment strategy that entails harvesting a limited supply of cartilage 
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cells from the individual, expanding the cells in culture, and injecting them in the 
defect site. The area is then covered with a periosteal flap. As reviewed 
elsewhere,15 this procedure was intended to treat focal defects of the knee in the 
United States; however, it has also been used to treat focal defects in the ankle, 
shoulder, elbow, hip, and wrist. Although this procedure has yielded promising 
results,16 25% of the patients experienced graft failure, 22% experienced 
delamination, and 18% experienced tissue hypertrophy.17 In addition to the 
reported clinical complications, a major drawback to this procedure and any other 
currently available is that it has only been used to treat focal defects and has not 
been used to treat entire osteoarthritic joints. 
Tissue Engineering 
Due to the poor ability of articular cartilage to heal itself, and the limited clinical 
treatment options, tissue engineering may provide the most promising approach 
to articular cartilage regeneration, potentially providing engineered tissue that is 
indistinguishable from native cartilage. As reviewed elsewhere,18' 19 the 
biomechanical characteristics of engineered constructs are the most important 
quantitative indicators of the approximation of the regenerated tissue to native 
tissue, but biochemical analyses of the collagen and GAG content also yield 
important information. Tissue engineering aims to accomplish the regeneration 
of articular cartilage by manipulating four parameters: scaffold material, cell 
sources, bioactive agents (growth factors/cytokines), and mechanical forces (Fig. 
2). Although significant steps have been made in the study of each parameter, 
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complete tissue regeneration likely will require the complex task of optimizing 
these parameters in combination. 
TISSUE ENGINEERING PARADIGMS 
Scaffolds 
The main function of a scaffold in tissue engineering is to provide support and a 
temporary structure to cells as they begin to secrete and form an ECM. The 
engineered construct will eventually replace the scaffold as it slowly degrades 
over time. There are two approaches to employing a scaffold: immediate 
implantation of the cell-seeded scaffold or in vitro culture of the scaffold before 
implantation, and each of these approaches has different design concerns. A 
scaffold used in vivo for cartilage tissue engineering should contain internal 
channels that allow for the diffusion of nutrients and room for tissue growth.20 
Also, it should have adequate biocompatibility to prevent the release of toxic 
byproducts and a large immune response, and should exhibit biodegradation 
kinetics that match the rate of new tissue formation. In addition, a scaffold 
should have sufficient mechanical properties to allow for its immediate use in 
vivo, as the cells will not have had enough time to synthesize an ECM that will 
eventually replace the scaffold. Finally, the scaffold should allow for the 
attachment, proliferation, and differentiation of cells seeded on its surface.20 
However, if a scaffold will be cultured in vitro rather than implanted immediately, 
the inherent mechanical properties of the scaffold are not nearly as important, as 
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the degrading scaffold will be replaced by an engineered construct with its own 
mechanical properties before implantation. 
In general, scaffold materials can be divided into two groups: natural and 
synthetic materials. Also, composite scaffolds, which are composed of multiple 
materials, have been used in tissue engineering. The use of these scaffold 
materials will be discussed further with a particular emphasis on successful 
approaches in cartilage tissue engineering. 
Natural Polymers 
Natural polymers have several properties making them advantageous for use as 
scaffolds. They often have excellent adhesion properties, adequate 
biocompatibility, and decreased toxicity during scaffold degradation.21 Collagen, 
fibrin, chitosan, hyaluronan, alginate, and agarose have all been investigated 
with varying degrees of success in cartilage tissue engineering. 
Collagen gels have been used extensively as a scaffold material, as collagen is a 
fundamental component of the ECM of cartilaginous tissues as well as various 
other connective tissues; therefore, collagen gels are expected to have low 
immunogenicity, although like all natural polymers, they must be purified before 
their use. In addition, as a widely abundant ECM component, collagen allows for 
excellent incorporation of both endogenous and exogenous cells from joint 
tissue, thus making it an excellent candidate for success in both in vitro cell-
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seeding and in vivo integration. Nehrer et al.22 compared type I and type II 
collagen gels, and found that chondrocyte-seeded type II collagen gels 
maintained the chondrocyte phenotype and had increased expression of GAGs. 
Although some success has been observed with collagen gels, as with all natural 
scaffolds, concerns regarding pathogen transfer have been expressed. 
Specifically, the increased incidence of prion diseases such as bovine 
spongiform encephalopathy has hindered the use of collagen from bovine 
sources. 
Fibrin has been used as both a delivery device and a stand-alone scaffold.23 
This material has the advantage of being injectable, which would allow for its 
non-invasive delivery. Passaretti et al.24 demonstrated that chondrocytes 
expanded through passage one and seeded in a fibrin polymer that was injected 
subcutaneously in nude mice made an ECM resembling that of native cartilage. 
However, fibrin has poor mechanical properties and may lead to a host immune 
response. 
Chitosan is a polymer derived from the N-deacetylation of chitin, which is 
abundant in the exoskeleton of arthropods. The properties of chitosan make it 
extremely useful as a scaffold material. It has excellent biocompatibility,25 is 
easily synthesized,26 and its mechanical properties and degradation rates can 
easily be manipulated. 
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Hyaluronan, alginate, agarose, as well as various synthetic polymers are all used 
to create hydrogels, which are highly water-soluble polymers that can be cross-
linked covalently or physically. They are highly swollen with water, usually 
containing >90% water. Often, hydrogels have excellent biocompatibility but 
weak mechanical properties. The main advantage of hydrogels is that as low 
viscosity, fluid-like solutions, they are injectable and can fill irregularly shaped 
defect sites. Once the defect site has been filled with a cell/polymer suspension, 
the hydrogel can be cross-linked, for example, by transdermal 
photopolymerization,27 thus causing a fluid-solid transition to occur. This 
procedure permits the researcher to avoid many of the problems involving cell-
seeding, and provides the clinician with a minimally invasive treatment for 
chondral defects that avoids surgical intervention. Another advantage of 
hydrogels is that they are excellent at maintaining the chondrogenic phenotype; 
this is probably because embedding the chondrocytes in the hydrogel preserves 
their round morphology. Furthermore, embedding the cells in a hydrogel is 
extremely useful when using mechanical stimulation, as it allows for uniform 
force transfer to the cells without the stress shielding that may be caused by 
other scaffold materials. 
Hyaluronan is a naturally occurring polysaccharide that is an important 
component of articular cartilage. Burdick et al.28 recently demonstrated that the 
mechanical properties and degradation rates of hyaluronan scaffolds could easily 
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be manipulated to encompass a wide range of desirable values, which could 
potentially allow for clinical use. 
Alginate is a polysaccharide derived from algae that has excellent 
biocompatibility. As a hydrogel, alginate can be delivered with an injection, which 
allows for minimally invasive treatment of chondral defects. Alginate has also 
proven effective for maintaining or even inducing the chondrogenic phenotype. 
This is probably because the chondrocytes are embedded in the alginate 
hydrogel, which enables them to maintain their round morphology. Another 
exciting attribute of alginate hydrogels is their ability to be formed into different 
shapes,29 which would allow for the production of a geometrically customized 
construct prior to implantation. However, the major downside of alginate 
hydrogels is the inability to modulate their long degradation time in vivo, which 
can hinder the growth of new tissue.20 
Agarose is a polysaccharide derived from seaweed that is very similar to alginate 
in its properties. Like alginate, agarose has excellent biocompatibility, and helps 
to maintain the chondrogenic phenotype by preserving chondrocytes' round 
morphology. Agarose has been used extensively in in vitro studies,23 although it 
shares the slow degradation kinetics of alginate. Another problem with agarose 
is that it may elicit a foreign body giant cell immune response in vivo.30 
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Synthetic Polymers 
Synthetic polymers are fabricated in a laboratory, and offer several advantages 
over natural polymers. Their physical and mechanical properties can easily be 
modulated, thus allowing for degradation kinetics and mechanical properties that 
are optimized for a specific application. In addition, since they are not derived 
from organisms, there is no concern regarding pathogen transmission, and they 
can easily be synthesized in large quantities. Also, synthetic polymer scaffolds 
can undergo surface modifications, with peptides or bioactive molecules, that can 
enhance their biocompatibility and integration in defects. However, unless they 
are sufficiently small or synthesized to form a hydrogel, they must be surgically 
implanted into the recipient. 
The most widely used materials are the poly(a-hydroxy esters), including 
polyglycolic acid (PGA), polylactic acid (PLA) and their copolymer poly(lactic-co-
glycolic acid) (PLGA).31"33 The biocompatibility of each polymer has been 
extensively studied, and allows for their use in various implantation applications. 
PLA and PGA are often extruded into long polymer strands, which are then used 
to form a highly porous nonwoven fibrous mesh. The porous nature of the 
scaffold allows for cell to cell communication and nutrient diffusion, but leads to 
poor mechanical properties until tissue formation occurs. Many studies have 
demonstrated the efficacy of these polymers in cartilage ECM synthesis and the 
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maintenance of the chondrocyte phenotype, as well as efficacy in in vivo 
studies.23 
Copolymers of PLA/PGA are advantageous, as they allow for more control over 
the degradation kinetics, by varying the ratios of monomers used. PLGA 
scaffolds have shown promising results in in vivo studies,23 but an exciting new 
approach has been to construct hydrogels out of the copolymer. Mercier et al.34 
created hydrogels out of PLGA microspheres that, when seeded with 
chondrocytes and injected in athymic mice, allowed for the production of 
cartilaginous ECM. 
A recent approach has been the creation of composite scaffolds, in which 
multiple scaffold materials are used together in an effort to harness the 
advantages of each component. For example, Caterson et al.35 demonstrated 
the efficacy of a PLA/alginate amalgam for the chondrogenic differentiation of 
MSCs. 
"Scaffold-less" Approaches 
Despite the promising results obtained using the various aforementioned scaffold 
materials, there are problems associated with using a scaffold. For example, 
scaffolds can hinder cell to cell communication, contribute to stress shielding, 
and alter the chondrogenic phenotype. Furthermore, they may be toxic or 
produce toxic byproducts during degradation, and their degradation rate must be 
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modulated to coordinate with new tissue formation.36 As a result of these 
inherent problems, novel approaches to tissue engineering have been developed 
that do not employ the use of a scaffold. These approaches include pellet 
culture,37 aggregate culture,38 and a more recent approach, the self-assembling 
process.36 
In the self-assembling process, calf articular chondrocytes were seeded at high 
density in 5mm diameter and 10mm deep agarose wells. After 24 hours of 
culture, the cells formed constructs that were not attached to the walls of the 
agarose wells. After 4 weeks of culture, the constructs were transferred to large 
wells, and following 12 weeks of culture, this process resulted in tissue 
engineered constructs of clinically relevant dimensions, at ~15mm in diameter 
and 1mm in thickness. The constructs resembled native articular cartilage 
morphologically, and had levels of collagen II and GAG approaching that of 
native tissue, with no collagen I production. Perhaps the most exciting result was 
that the self-assembled constructs reached over 1/3 the stiffness of native tissue. 
The self-assembling process has also been coupled with mechanical 
stimulation.39 Hydrostatic pressure application under a treatment of 1 Hz and 10 
MPa for 4 hours/day was shown to stimulate collagen production and aid in the 
retention of GAGs within constructs compared to static culture. Although more 
work still needs to be done in the characterization and optimization of the 
method, the self-assembling process is a promising approach towards functional 
tissue engineering of articular cartilage. 
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Cell Sources 
An ideal cell source must satisfy several criteria: be easily accessible or 
available, demonstrate self-renewal or the ability to be expanded extensively, 
have the capacity to differentiate into the cell lineage of interest upon induction or 
remain differentiated in the cell lineage of interest, and exhibit minimal 
immunogenicity or tumorigenicity.40 Progenitor cells such as MSCs and 
embryonic stem (ES) cells as well as fully differentiated chondrocytes have all 
been used as cell sources for engineered cartilage constructs. Certain 
advantages and disadvantages are inherent to approaches involving each cell 
type. 
Primary chondrocytes from native cartilage are the most obvious cell source for 
tissue engineering of cartilaginous tissues. Immature chondrocytes are often 
used for studies due to their higher metabolic activity.41 Chondrocytes can easily 
be isolated from freshly excised articular cartilage following an enzymatic 
digestion with collagenase. However, a large number of cells must be obtained 
to be seeded onto a three-dimensional scaffold. Since overharvesting 
chondrocytes can lead to further problems at the harvest site, serial passage of 
chondrocytes on monolayers is required to acquire the large cell density needed 
for seeding on a three-dimensional scaffold. Chondrocytes passaged in 
monolayer "dedifferentiate" and become more fibroblast-like in appearance and 
ECM production: they lose their round morphology and become more spindle-
shaped, switch their collagen production from primarily type II collagen to type I 
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collagen, and they regain their ability to divide.42"44 This loss of chondrogenic 
potential is associated with the suppressed activation of key signaling proteins in 
the Ras-mitogen-activated protein kinase pathway, which leads to apoptosis.45 
In a recent study, it was found that passaged articular chondrocytes in monolayer 
showed phenotype changes as early as one passage, and their chondrogenic 
phenotype could not be rescued even with 3-D culture in alginate beads.46 
Despite these limitations, primary chondrocytes continue to be used in clinical 
applications as several culture conditions, such as culture in agarose gels,47 
allow for the reexpression of the chondrocyte phenotype. 
The study of stem cells has gained prominence in cartilage tissue engineering, 
as new chondrocytes, originating from host MSCs,48 repair osteochondral 
defects. Adult MSCs are multipotent cells that can be induced to differentiate 
down multiple cell lineages such as chondrogenic, osteogenic, and adipogenic 
lineages. MSCs are advantageous as they are able to self-renew, and they can 
be obtained relatively non-invasively from tissues such as bone marrow 
aspirates,49"54 adipose tissue,55"60 synovial tissue,61 as well as several other 
tissues. The chondrogenic phenotype is often characterized by the expression 
and synthesis of collagen II and proteoglycans, as well as by the upregulation of 
genes such as sox-9 which are markers of cartilage ECM production. MSCs 
used in cartilage engineering have been differentiated through the application of 
members of the transforming growth factor-p (TGF-P) family as well as 
dexamethasone. MSCs used in research studies so far have primarily come 
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from bone marrow. Several studies have indicated that a 3-D culture 
environment is important for chondrogenic differentiation, as it may help to 
maintain a rounded cell shape. An exciting finding from a study by Yoo et al.51 
was that the addition of TGF-pi and dexamethasone maintained the 
chondrogenic potential of bone-marrow derived MSCs through 20 passages. 
This is an important finding as in vitro expansion through several passages often 
is required to generate sufficient cells for implantation. Human adipose-derived 
adult stem (hADAS) cells show great promise for cartilage tissue engineering as 
they can be isolated from various easily accessible sources such as from the 
inguinal fat pad62, infrapatellar fat pad63, and subcutaneous adipose tissue.52 
hADAS cells express markers characteristic of articular cartilage when cultured 
with TGF-01, dexamethasone, and ascorbate.57,58,60,62 Although adult stem 
cells represent a promising cell source for articular cartilage engineering, more 
work needs to be performed to understand the developmental processes 
involved in differentiation so that these processes may be further manipulated to 
optimize in vitro cell expansion while maintaining chondrogenic differentiation; 
then, it may be possible to develop in vivo approaches for construct delivery and 
host integration. 
As with the study of several other tissues, the use of embryonic stem cells is 
increasing in cartilage tissue engineering.64"67 ES cells are derived from the inner 
cell mass of the embryonic blastocyst and are pluripotent. Following aggregation 
into embryoid bodies in vitro, they can differentiate into tissue of all three germ 
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layers. ES cells are capable of virtually infinite proliferation while remaining in an 
undifferentiated state. Because of their pluripotency and their provision of an 
unlimited cell source, their use is promising for many tissue engineering 
applications. Although ES cells appear to be an extremely promising cell source, 
their differentiation pathways must be better elucidated to manipulate them 
further for cartilage tissue engineering. In addition, the ethical and legal 
concerns regarding the source and means of collection of ES cells significantly 
complicate their use. 
Finally, an exciting new cell source may derive from dermal fibroblasts which can 
be triggered to differentiate by culture on cartilage matrix proteoglycans.68"70 This 
cell source could be extremely useful as the cells are both easily accessible and 
widely available. 
Growth Factors 
Growth factors are used in tissue engineering to modulate cellular differentiation 
and proliferation, as well as to modulate ECM synthesis. Articular cartilage 
displays dramatic changes when exposed to growth factors that are naturally 
present in the native environment. The effects of many of these growth factors 
alone and in combination have been studied for cartilage tissue engineering, 
including the transforming growth factor beta (TGF-(3) family, insulin-like growth 
factor (IGF), fibroblast growth factors (FGFs), hepatocyte growth factor (HGF), 
and platelet-derived growth factor (PDGF). As reviewed elsewhere,71 growth 
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factor studies generally are conducted in vitro in which the growth factor is 
delivered as a soluble factor in the media; therefore, the concentration and 
frequency of delivery can easily be manipulated. Growth factor effects have also 
been studied in vivo, albeit with variable results as it is far more difficult to control 
the interactions within the body as well as the concentrations.71 However, as 
scaffold delivery vehicles and gene therapy approaches continue to improve, 
delivery of growth factors at more controlled doses and temporal increments may 
become a more achievable task. 
Members of the TGF-p family are probably the most widely used growth factors 
to date. For cartilage tissue engineering, the notable members of the TGF-p 
family include TGF-p1, TGF-P3, and bone morphogenetic proteins (BMPs). 
TGF-p151"53' 56 and TGF-P350, 72 are both widely used as chondrogenic 
differentiation factors for MSCs and embryonic stem cells. In addition to uses in 
chondrogenic differentiation, TGF-pi has been shown to upregulate ECM 
synthesis although there are conflicting reports on its effects. Several studies 
have shown that TGF-p1 increases collagen II expression in monolayer73 and in 
3-D scaffolds74, while other studies have shown no effects on the gene 
expression of ECM proteins.75 Possible explanations for the different observed 
effects of TGF-p1 include variable effects of TGF-pi on the zonal populations of 
chondrocytes, as well as variations in the temporal application of the growth 
factor. The main effect of BMPs in cartilage tissue engineering is chondrogenic 
differentiation or the maintenance of differentiation. They have also seen 
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extensive use in bone tissue engineering for osteogenic differentiation and 
increased matrix synthesis. As reviewed elsewhere,71 although other BMPs have 
been studied, BMP-2 has been the most commonly used BMP for studies 
involving cartilage. BMP-7 is another BMP that is beginning to be used in 
cartilage tissue engineering, and has also been used recently as a chondrogenic 
differentiation factor.76 
Several other growth factors show potential for use in cartilage tissue 
engineering. IGF-I has a profound anabolic effect on chondrocytes in vitro,77'79 
and has been shown to increase GAG production, as well as aggrecan and 
collagen II gene expression in articular chondrocytes grown on monolayer.80 
Perhaps the most exciting in vivo effect of IGF-I use is the autoinductive 
autocrine/paracrine transcriptional response, which could potentially be 
harnessed to extend and amplify the effects of IGF-I on cartilage repair.81 Basic 
fibroblast growth factor (bFGF) has been shown to stimulate chondrocyte 
proliferation and synthesis,82"84 although it has also been used for 
fibrochondrocyte studies involving the knee meniscus and the 
temporomandibular joint.33 FGF-18 has recently been shown to promote 
chondrogenic differentiation of limb bud mesenchymal cells.85 HGF has been 
minimally studied in cartilage tissue engineering, but preliminary studies indicate 
that it may enhance or modulate chondrocyte proliferation.86, 87 The effects of 
PDGF on proliferation and ECM synthesis have been minimally reported, but it 
has been shown to have an effect on chondrocyte proliferation.88 
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Although many growth factors show promising results when used alone, their use 
in combination has yielded exciting results, as synergism between many growth 
factors has been observed in several studies. BMP-2 and TGF-pi work in 
concert for the chondrogenesis of periosteal cells; it was suggested that BMP-2 
induces neochondrogenesis, while TGF-p1 modulates the terminal differentiation 
in BMP-2 induced chondrogenesis.89 Combined treatments with TGF-P3 and 
BMP-6 or TGF-P3 and IGF-I were shown to be the most effective combinations 
for chondrogenic induction of bone marrow MSCs.90 However, growth factor 
combinations do not always interact synergistically. For example, the addition of 
IGF-I and TGF-p in combination did not improve the histologic features or 
mechanical performance of tissue engineered cartilage constructs.91 
Perhaps the most exciting new results have come from studying the synergism 
between growth factor application and mechanical stimulation. Bonassar et al.92 
found that the combination of IGF-I and dynamic compression led to a 290% 
increase in proteoglycan synthesis, a degree greater than that achieved by either 
stimulus alone. Also, Mauck et al.93 showed that the combination of dynamic 
deformational loading with either TGF-pi or IGF-I increased the stiffness of 
engineered constructs by 277% or 245%, respectively, with respect to untreated 
free-swelling controls. 
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Growth factor treatment has been extremely useful for cartilage tissue 
engineering, as it has allowed and maintained chondrogenic differentiation,75,94, 
95
 and has also increased production of ECM proteins in studies of articular 
cartilage,80,92 knee meniscus,96,97 and the TMJ.33'98 However, there are still 
properties of the growth factors that need to be investigated. In addition to the 
need to better characterize the roles of each growth factor, their effects on 
different cell types, the correct dosage frequency, and concentrations must be 
elucidated to optimize their use in tissue engineering. 
Mechanical Loading 
To serve its function as a biomechanical structure, articular cartilage is exposed 
to a wide variety of forces including hydrostatic pressure, compression, and 
shear forces. Chondrocytes are directly connected to their microenvironment by 
focal adhesions which are discrete regions of the cell's plasma membrane that 
bind to extracellular material.21 In addition to their involvement in the structural 
integrity of the chondrocyte, focal adhesions are involved in the process of 
mechanotransduction, in which cells regulate transcriptional activities based on 
mechanical signals received at their surface. Although the exact mechanisms of 
mechanotransduction in the chondrocyte have not been completely elucidated, 
evidence suggests that elements of the cytoskeleton and integrins allow the 
coordination of mechanical forces and transcriptional changes. 
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Several studies have suggested that mechanical stimulation is necessary for 
maintaining and possibly improving the biomechanical function of articular 
cartilage. For example, during immobilization, articular cartilage undergoes 
changes characterized by a loss of function.99, 10° Also, in a canine study, 
articular cartilage in the knee became significantly stiffer following loading in 
physiologic ranges as a result of running on a treadmill.101 To investigate these 
issues further, many studies subjected cartilage explants to mechanical 
stimulation, and determined that mechanical stimulation served to maintain and 
even upregulate the production of ECM, and it was determined that in vitro 
loading conditions within the physiologic range of native hyaline cartilage were 
most beneficial.102 Several methods have been used to deliver mechanical 
stimulation to articular cartilage; these include hydrostatic pressure, direct 
compression, and shear, and are the predominant forces present in the knee. 
Hydrostatic Pressure 
During loading of diarthrodial joints, synovial fluid inside the joint capsule 
generates hydrostatic pressure that is transmitted to cartilage. Direct 
compression of cartilage also generates hydrostatic pressure, as the majority of 
the force is absorbed by the water in the cartilage matrix. As the fluid tries to 
leave the cartilage matrix, it experiences resistance to its flow and therefore 
cannot easily leave as a result of the relative impermeability of cartilage. Since 
the water is somewhat "trapped" in the tissue, a uniform normal load or 
hydrostatic pressure is applied to the individual chondrocytes in the tissue as a 
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result of the interstitial fluid pressure. However, since the cartilage matrix is not 
completely impermeable, the water is eventually forced out of the tissue and into 
the synovial cavity. The energy of the applied load is then dissipated as water 
leaves the tissue and encounters resistance as it moves through the cartilage 
matrix. In diarthrodial joints during normal activity, the magnitude of this 
interstitial pressure is usually between 7 and 10 MPa.103 Also, a normal adult 
cadence corresponds to frequencies of 0.6 to 1.1 Hz loading per leg during 
walking,104 and >1.5 Hz during running.105 
Two approaches have been used to combine the application of hydrostatic 
pressure with culturing techniques for tissue engineering.106 In the first 
approach, the application of hydrostatic pressure is separated from culturing. 
The cells are grown in static culture, and are moved to a specialized chamber 
(Fig. 3A) at certain times to apply hydrostatic pressure. Following application of 
hydrostatic pressure, the cells are returned to their static culture conditions, and 
this process is repeated per the desire of the researcher. This approach is 
beneficial because it allows for the application of hydrostatic pressure only at 
certain times and for certain durations, rather than applying a continuous load. 
However, the major drawback of this approach is that there is an increased risk 
of contamination while transferring the cells between the static culture and 
hydrostatic pressure chamber. The second approach uses a semicontinuous 
perfusion system; a single device allows for medium to be delivered to the cells 
while hydrostatic pressure is applied. This approach is advantageous because it 
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minimizes the possibility of contamination, and it can be automated; however, the 
downside of this approach is that fluid shear is also introduced into the system. 
When using hydrostatic pressure stimulation, the parameters that may be varied 
include the frequency of loading, the duration and magnitude of loading, as well 
as the time points at which the cells are subjected to loading. As reviewed 
elsewhere,106 loads near the physiological range, between 0.1 and 15 MPa, and 
frequencies between 0.05 and 1 Hz, have yielded the most favorable results, 
although the majority of the hydrostatic pressure studies conducted so far have 
tested explants or monolayers. Research involving the use of hydrostatic 
pressure in 3-D culture of chondrocytes, especially at longer time points, is 
lacking. However, a recent study using hydrostatic pressure at previously tested 
ranges was shown to have beneficial effects on 3-D constructs.39 In the study, 3-
D self-assembled articular chondrocyte constructs (as described previously) were 
subjected to 10 MPa hydrostatic pressure at 1 Hz for 4 hours per day and 5 days 
a week for up to 8 weeks, which led to a significant increase in collagen content 
while preventing a decrease in GAG content relative to the unstimulated control 
group. However, no significant difference in mechanical properties was observed 
between the treatment groups. 
Hydrostatic pressure does not always produce beneficial results. For example, 
several studies that investigated constant hydrostatic pressure found little or no 
improvement in ECM composition.107"109 Also, when hydrostatic pressure is 
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above the physiological range, it may actually harm the cells, as decreased ECM 
production and expression of inflammatory mediators have been observed with 
these higher pressures.108 
Although the results on using hydrostatic pressure stimulation seem promising at 
this point, far more work must be undertaken to elucidate the precise application 
conditions for optimizing biomechanics) and biochemical properties, particularly 
in 3-D engineered articular cartilage constructs. 
Direct Compression 
During normal joint loading in a healthy person, compressive forces are 
generated in articular cartilage as a result of direct contact between the 
articulating surfaces and once hydrostatic pressure in the interstitial fluid 
subsides, as water is forced out of the loaded cartilage matrix. If no pathologic 
processes are present, articular cartilage is able to withstand compression many 
times per day without injury. In general, cartilage experiences deformation or 
strain in the range of 2-10%, which was determined under a load of five times 
body weight in the human hip.110 
As with hydrostatic pressure, the application of direct compression is usually a 
two-step approach, in which the application of force is separated from culturing. 
The cells are grown in a static culture, and are moved to a specialized device 
(Fig. 3B) at certain times in order to apply direct compression. These devices 
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are generally designed so that a flat surface compresses the top of the construct 
at a specific load or displacement. Following application of the force, the cells 
are returned to their static culture conditions, and this process is repeated as 
desired. 
When using direct compression, the parameters that may be varied include strain 
or magnitude, frequency, and the time points at which the constructs are 
subjected to loading. As reviewed elsewhere,106 most studies have examined 
frequencies in the range of 0.0001 to 3 Hz, strains from 0.1 to 25%, loads from 
0.1 to 24 MPa, and durations lasting hours to weeks, although these parameters 
are often limited by the equipment used. 
As with constant hydrostatic pressure loading, cartilage responds negatively to 
static loading, most likely as a result of limited mass transport.106 Therefore, 
studies using dynamic compression have produced the most positive results. 
Mauck et al.111 found a 33% increase in GAG production and an aggregate 
modulus on the same order of magnitude as in native cartilage when subjecting 
cartilage constructs to 3% strain at 1 Hz and three times of 1 hour on, 1 hour off 
per day, 5 days per week, for 4 weeks. Also, in dynamic compression, the 
loading frequency is an extremely important parameter to be studied. Lee et 
al.112 subjected constructs to compression at frequencies from 0.3 to 3 Hz and 
15% strain, and found that GAG synthesis was significantly higher in the 
constructs subjected to 1 Hz compression. Interestingly, in addition to improved 
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biochemical properties, dynamic compression has recently been shown to 
enhance the chondrogenic differentiation of MSCs, again indicating that 
mechanical loading plays an important role in cartilage repair.113 
Bioreactors and Shear Forces 
The purpose of a bioreactor is to create an environment that will aid in the 
development of the desired tissue properties. In tissue engineering, the major 
uses of bioreactors have been in the application of shear forces or in examining 
the effects of media perfusion and gas exchange on constructs. 
As with compressive forces, shear forces are generated in the knee joint during 
loading as a result of direct contact between the articulating cartilage surfaces, 
as the two surfaces attempt to move past each other. Although a thin layer of 
synovial fluid provides lubrication between the cartilage surfaces, shear forces 
continue to occur as the surface-to-surface contact is not completely frictionless. 
Several studies, discussed in 106, have shown a benefit to applying shear to 
cartilage constructs. The most widely used bioreactors in cartilage tissue 
engineering have been spinner flasks, perfusion bioreactors, and rotating-wall 
bioreactors. 
Spinner flasks are perhaps the simplest bioreactors used, as a magnetic stir bar 
mixes oxygen and nutrients throughout the medium. Their primary use has been 
for cell-seeding of scaffolds, as mixing in spinner flasks has proven extremely 
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useful for uniformly seeding cells on scaffolds at high yields.114 This approach 
involves attaching scaffolds to needles suspended from a stopper at the top of 
the flask. Cells in the medium are mixed in the flask due to the stir bar, and 
eventually are seeded onto the scaffold. Bueno et al.115 recently used a modified 
spinner flask, called a wavy-walled bioreactor, which is designed to enhance the 
mixing of the medium while minimizing the shear. They found that the kinetics of 
chondrocyte aggregation were significantly improved over a spinner flask when 
using a wavy-walled bioreactor. 
In a direct perfusion bioreactor, a scaffold is surrounded tightly by a medium 
chamber consisting of a hollow tube, and medium is forced through the fixed 
scaffold, from one end of the tube to the other. This design allows for a more 
uniform shear force and a more uniform concentration of nutrients to be delivered 
to the construct, as the cells located in the entire scaffold thickness are exposed 
both to convective solute transport and to a flow-induced mechanical stimulus.116 
Also, as used in some of the hydrostatic pressure systems, these bioreactors 
prevent the need to change the medium and therefore reduce the risk of 
contamination. Janssen et al.117 recently used a direct perfusion bioreactor in the 
production of engineered bone constructs of clinically relevant dimensions. A 
further modification to these systems can allow for the recycling of used medium 
along with the addition of fresh medium, which allows beneficial proteins such as 
ECM constituents to be maintained in the medium. 
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The use of rotating-wall bioreactors has been a promising approach. The main 
improvement over a direct-perfusion bioreactor is that a low shear environment is 
created without sacrificing the high diffusion in the perfusion systems. 
Essentially, this device consists of two concentric cylinders separated by a space 
containing medium and scaffolds. The rotation rates of the cylinders can be 
modulated so as to create different flow and shear environments within the fluid. 
For example, to produce a low shear force, both cylinders are rotated slowly at 
the same rate or nearly the same rate. This technique has been coupled with 
other parameters, such as in the investigation of the effects of oxygen tension on 
cartilage constructs.118 Since cartilage tissue is avascular and chondrocytes are 
exposed to a low oxygen tension environment in vivo, Saini and Wick118 
investigated the effects of oxygen tension on developing chondrocytes in a 
concentric cylinder bioreactor. They found that 5% oxygen tension led to 
constructs with double the GAG content of constructs cultured in 20% oxygen, 
with no effect on chondrocyte proliferation or collagen production. Interestingly, 
Wang et al.58 found that 5% oxygen tension was also an extremely effective 
inducer of chondrogenesis in hADAS cells, as it led to increased protein, 
collagen, and GAG synthesis, with an inhibition of cell proliferation. This is a 
significant finding, as it may provide additional means of controlling the growth 
and metabolism of undifferentiated progenitor cells. However, culture in a 
rotating-wall bioreactor has not always proven beneficial; a recent TMJ disc 
tissue engineering study found little or no benefit when using a rotating-wall 
bioreactor as compared to static culture.119 
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The use of bioreactors in tissue engineering has yielded exciting results and 
possibilities. Future directions of bioreactor use will likely involve the 
combination of the hydrodynamic flow chambers with other sources of 
mechanical stimulation,120 as well as with growth factor addition in the medium. 
As these technologies improve and the processes of growth factor addition and 
mechanical stimulation are optimized, it may become possible to create a large-
scale cartilage bioreactor for mass production of engineered constructs. 
FUTURE TRENDS AND NEEDS 
Successful tissue engineering approaches that will be used in the clinic likely will 
require optimization of the four parameters of the tissue engineering paradigm. 
Scaffolds will need to exhibit adequate biocompatibility and mechanical 
properties and allow for diffusion of nutrients to the seeded cells, or a "scaffold-
less" approach such as the self-assembling process will need to be employed. 
Stem cells, both adult and embryonic, represent a promising cell source for 
articular cartilage engineering; however, more work needs to be performed to 
understand the developmental processes involved in differentiation so that these 
processes may be further manipulated to optimize in vitro cell expansion while 
maintaining chondrogenic differentiation. Growth factor application also must be 
optimized for tissue engineering, through further characterization of the roles of 
each growth factor and their effects on different cell types, as well as elucidation 
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of the correct dosage frequency and concentrations. Finally, as scaffolds, cell 
sources, growth factor application, and mechanical stimulation are optimized, 
mass production of tissue-engineered constructs may become possible through 
the creation of large-scale bioreactors. 
Current tissue engineering approaches strive to obtain a construct with 
mechanical, biochemical, and histological properties as close as possible to 
native tissue. However, since relatively few constructs have seen clinical use to 
date, it is unclear how closely the properties of the construct must mimic those of 
native tissue in order to prove clinically functional. It is likely that as the 
parameters of the tissue engineering paradigm are optimized to produce 
constructs that approach native tissue properties, constructs with a wide 
spectrum of properties will be produced along the way. Then, implantation 
studies may be performed to determine the optimal properties a construct must 
possess for in vivo use. 
CONCLUSIONS 
When cartilage is damaged, it has a limited ability to heal itself and clinical 
treatment is unable to fully restore tissue function. Therefore, tissue engineering 
is an ideal approach for successful cartilage regeneration, through the interaction 
of the selected scaffold, cell source, growth factors, and mechanical stimulation. 
Although many promising results have been attained thus far, tissue engineering 
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still has to overcome hurdles, as successful regeneration of cartilage cannot be 
realized until the four parameters of the tissue engineering paradigm have been 
optimized. Nonetheless, this is an exciting time as we are rapidly approaching 
widespread clinical use of tissue engineered cartilage constructs for treatment of 
articular cartilage, knee meniscus, and TMJ pathologies. 
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Chapter 2: The Use of Hydrostatic Pressure in 
Articular Cartilage Tissue Engineering 
Benjamin D. Elder and Kyriacos A. Athanasiou 
Chapter submitted as: Elder, BD and Athanasiou, KA. The Use of Hydrostatic 
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ABSTRACT 
Cartilage has a poor intrinsic healing response, and the innate healing response 
as well as current clinical treatments cannot restore its function. Therefore, 
articular cartilage tissue engineering is a promising approach for the regeneration 
of damaged tissue. As cartilage is exposed to mechanical forces during joint 
loading, many tissue engineering strategies utilize exogenous stimuli in order to 
enhance the biochemical or biomechanical properties of the engineered tissue. 
Hydrostatic pressure is emerging as arguably one of the most important 
mechanical stimuli for cartilage. However, no optimal treatment has been 
established across all culture systems. Therefore, this review evaluates prior 
studies on articular cartilage involving the use of hydrostatic pressure to reach a 
consensus on the magnitudes, frequencies, and application times that should be 
pursued further. Additionally, this review addresses hydrostatic pressure 
bioreactor design, chondroprotective effects of hydrostatic pressure, the use of 
hydrostatic pressure for chondrogenic differentiation, the effects of high 
pressures, as well as hydrostatic pressure mechanotransduction. 
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INTRODUCTION 
Injuries to articular cartilage generally result in the formation of mechanically 
inferior fibrocartilage, which will eventually degrade with use.14 Additionally, 
current clinical treatments for articular cartilage injuries generally aim to enhance 
this intrinsic repair response, but may often result in the formation of 
fibrocartilage. Therefore, tissue engineering approaches provide tremendous 
promise for cartilage regeneration. A principal tenet of the cartilage tissue 
engineering approach is the use of exogenous mechanical stimulation to 
simulate joint loading and lead to enhanced chondrocyte metabolic activity and 
extracellular matrix (ECM) production. Hydrostatic pressure (HP) provides a 
robust method for chondrocyte stimulation, as it can be applied to chondrocytes 
in monolayer, 3-D engineered constructs, as well as explants. 
Cartilage is a highly hydrated tissue, comprised of 75-80% water per wet weight. 
The high water content results as water is attracted to the negatively charged 
proteoglycan molecules within the tissue. During joint loading, a uniform 
perpendicular stress (Fig. 4) is imparted to the chondrocytes as the synovial fluid 
imparts a hydrostatic pressure on the fluid phase of the tissue. Additionally, as 
the tissue undergoes a compressive load, the pressurization of the fluid phase 
initially supports the applied load, as water is trapped within the solid matrix of 
the tissue due to its low permeability. Eventually, fluid is expelled from the tissue 
and the frictional force between the fluid and solid phases of the tissue dissipates 
energy from the applied load. In the joint, cartilage is typically exposed to 
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stresses between 3-10 MPa,121 while stress as high as 18 MPa has been 
reported in the hip joint.11 These stresses should be translated to hydrostatic 
pressure due to fluid phase pressurization, as described above. Additionally, the 
human walking cadence generally is up to 1 Hz.104 As such, tissue engineering 
efforts have generally focused on magnitudes and frequencies within these 
physiologic ranges. 
Although prior reviews have addressed the effects of intermittent HP on 
chondrocytes in monolayer,122 and the effects of HP on chondrocyte 
mechanotransduction,123 a comprehensive review discussing the effects of HP in 
articular cartilage tissue engineering studies does not exist. As such, this review 
addresses bioreactor design for the application of HP, different tissue 
engineering strategies involving the application of HP, the chondroprotective 
effects of HP, the use of HP towards chondrogenic differentiation, the effects of 
high pressures on cartilage, as well as the mechanotransduction mechanisms 
that explain the beneficial results from HP application in cartilage tissue 
engineering studies. 
HYDROSTATIC PRESSURE BIOREACTORS 
In general, there are two predominant methods of applying HP to cells, explants, 
or constructs, and they both offer advantages and disadvantages. In the first 
method, HP is applied by compressing a gas phase that transmits load through 
the medium to the cells. However, this method is limited as pressurizing the gas 
46 
phase may alter the gas concentration within the culture medium. For instance, 
Hansen et al.124 observed a 0.36 decrease in the pH of the medium following 10 
h of HP application. However, the advantage of this approach is that it allows for 
the controlled alteration of partial pressures within the medium, such as when 
examining the effects of HP at different oxygen levels.125 Alternatively, a less 
complicated approach involves applying HP by compressing only the fluid phase, 
which limits any changes in gas solubility within the chamber. This method 
generally involves connecting a fluid-filled chamber by hose to a piston attached 
directly to a hydraulic press, controlled by a computer (Fig. 5). This is the 
selected setup in a large number of prior studies, as well as in our own work. 
Both types of bioreactors also include temperature control, generally by placing 
the chamber in a water bath, in order to maintain the culture temperature at 
37 °C. Finally, either type of bioreactor may be altered to allow for 
semicontinuous medium perfusion, as reviewed in detail previously.106 
TISSUE ENGINEERING STRATEGIES WITH HYDROSTATIC 
PRESSURE 
HP has seen extensive use as an agent for increasing the metabolic activity of 
chondrocytes in tissue engineering studies. In general, these studies have 
assessed the effects of HP on chondrocytes cultured in monolayer, cartilage 
explants, as well as chondrocytes in 3-D culture, both with and without a scaffold. 
In tissue engineering studies involving HP application, it is possible to vary the 
magnitude, frequency, and duration of application of HP. Additionally, in studies 
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involving 3-D engineered constructs, it is also possible to vary when HP can be 
applied in construct development. However, little consensus has been reached 
regarding the ideal levels of each of these parameters, particularly when different 
culture conditions are used. 
In general, studies assessing the effects of HP on chondrocytes in monolayer 
have demonstrated beneficial effects of dynamic HP, while static HP has been 
found to have either no effect or a detrimental effect. For instance, Suh et al.126 
cultured young bovine chondrocytes in monolayer, and exposed them to 0.8 
MPa, for 5 min on, 30 min off, 10 times. This treatment resulted in a 40% 
increase in proteoglycan synthesis as well as enhanced aggrecan mRNA. 
However, there was no change in collagen synthesis during pressurization. Also, 
when using juvenile bovine chondrocytes in monolayer, Jortikka et al.127 
demonstrated that HP at 5 MPa, 0.5 Hz, for 20 h, significantly increased sGAG 
incorporation, while 5 MPa static HP for the same application time had no effect 
on sGAG incorporation. 
In addition to these studies using chondrocytes from 1-2 year old animals, 
several studies using adult chondrocytes have been performed, predominantly by 
Smith's group, and have demonstrated similar results. For example, Smith et 
al.128 exposed adult articular chondrocytes in monolayer to 10 MPa HP, static or 
1 Hz, for 4 h. They demonstrated that HP application at 1 Hz increased 
aggrecan and collagen II mRNA immediately after application, while static HP 
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decreased collagen mRNA levels. In a later study, Smith et al.129 cultured normal 
adult bovine chondrocytes in monolayer, and applied HP at 10 MPa, 1 Hz, for up 
to 24 h for just 1 day, or for 4 h/day for 4 days. They found that aggrecan mRNA 
continued to increase up to 24 h of loading, while collagen II mRNA expression 
was increased maximally with 4 and 8 h of HP application. However, they 
demonstrated the importance of examining multiple loading profiles, as changing 
to an application of 4 h/day for 4 days led to even greater increases in both 
aggrecan and collagen II mRNA. Additionally, Ikenoue et al.130 again 
demonstrated the importance of examining multiple application times, as they 
cultured normal adult human chondrocytes in monolayer, and exposed them to 1, 
5, or 10 MPa HP, at 1 Hz, for 4 h/day, for 1 or 4 days. They demonstrated 
enhanced collagen II gene expression only for treatment with 5 and 10 MPa, for 
4 days; also, while enhanced aggrecan expression was observed with all 
treatments, these groups resulted in the greatest enhancement of aggrecan gene 
expression. This study also indicates that magnitude and frequency have 
significant effects on chondrocyte metabolism, and it appears that collagen 
production may be more sensitive to the selected HP regimen. On the other 
hand, a study by Takahashi et al.131 demonstrated beneficial effects when 
applying static HP to chondrocytes in monolayer, although it must be highlighted 
that a chondrosarcoma cell line was used rather than primary chondrocytes. 
They found that 1 and 5 MPa static HP for 2 h resulted in a significant increase in 
sGAG incorporation immediately after HP stimulation, and that 5 MPa static HP 
led to increased expression of TGF-pi mRNA. 
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Studies assessing the effects of HP on chondrocytes in 3-D culture or in explants 
have demonstrated different results, as it has been suggested that chondrocytes 
in monolayer respond differently to HP than tissue, since the cell interaction with 
its ECM is likely involved in the HP response. For instance, Parkkinen et al.132 
observed enhanced sGAG incorporation in explants exposed to HP at 5 MPa, 0.5 
Hz, for 1.5 h, while a significant inhibition of sGAG incorporation was found in 
monolayer cultures exposed to the same regimen. Furthermore, Carver and 
Heath133 observed that adult and juvenile P3 equine chondrocytes in PGA 
meshes respond differently to HP at 0.25 Hz, for 20 min every 4 h for 5 wks. For 
adult cells, 6.87 MPa HP was required to increase GAG and collagen production, 
while for juvenile cells, either magnitude increased GAG production, but only 
6.87 MPa increased collagen production, thus suggesting that collagen 
production may be more sensitive to the applied regimen. In a later study, 
applying HP at 3.44 MPa, 0.25 Hz, 20 min every 4 h for 5 wks to P3 juvenile 
bovine chondrocytes in PGA meshes resulted in significantly increased GAG 
production with no effect on collagen production; however, the results of both 
studies may stem from the use of passaged chondrocytes.134 Finally, in our own 
work,135 exposing immature bovine chondrocytes in scaffoldless constructs to HP 
at 10 MPa, 1 Hz, for 4 h/day, 5 days/wk for up to 8 wks with 10% FBS led to 
increased collagen content relative to control at 4 and 8 wks, and also prevented 
the decreased in GAG/construct observed in the control groups over time. 
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Additionally, contrary to the majority of studies involving chondrocytes in 
monolayer, static HP regimens in the physiologic range have generally 
demonstrated beneficial effects on chondrocytes in 3-D culture or cartilage 
explants. For example, in explants from 2 year old bovines, a 2 h application of 
5-10 MPa static HP enhanced sulfated GAG incorporation while 5-15 MPa static 
HP increased proline incorporation.102 Also, Mizuno et al.136 exposed immature 
bovine chondrocytes in 3-D collagen sponges to static HP, at 2.8 MPa for up to 
15 days, and observed increased GAG production at 5 and 15 days of culture. 
Similarly, Toyoda et al,137 found that exposing immature bovine chondrocytes in 
2% agarose gels to 5 MPa static HP for 4 h resulted in a 4-fold increase in 
aggrecan mRNA as well as a 50% increase in collagen II mRNA. In another 
study using the same constructs and HP regimen, Toyoda et al.138 observed an 
11% increase in GAG production as well as a 4-fold increase in aggrecan mRNA. 
Finally, in our own recent work,139 using scaffoldless articular cartilage constructs 
as described previously,36,14° a full-factorial comparison was made between 3 
magnitudes (1, 5, and 10 MPa) and 3 frequencies (static, 0.1, and 1 Hz) of HP for 
1 h/day, from days 10-14 of construct development. It was determined that static 
HP at 5 or 10 MPa as well as cyclic HP at 10 MPa, 1 Hz, resulted in a significant 
increase in compressive stiffness and GAG production; however, only static HP 
at 5 or 10 MPa resulted in a significant increase in tensile stiffness and collagen 
production. An additional exciting finding of the study was additive and 
synergistic effects when applying HP and growth factors, as the combination of 
10 MPa static HP and TGF-pi resulted in 164% and 231% increases in 
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compressive and tensile stiffness, respectively, as well as 85% and 173% 
increases in GAG and collagen production, respectively. 
Although physiological magnitudes clearly have beneficial effects on chondrocyte 
gene expression, protein production, and biomechanical properties, based on the 
varying results observed in these studies regarding effects of HP regimens, it is 
clear that magnitude, frequency, and application time must all be optimized for 
each system. It is possible that a regimen may yield beneficial effects in a 3-D 
culture system, while simultaneously resulting in little effect or a detrimental 
effect in a monolayer system. Additionally, the cell type used appears to play a 
significant role in the response to HP application, as immature bovine 
chondrocytes appear to have a greater metabolic response to HP stimulation 
than adult human chondrocytes. Finally, performing HP studies on 3-D 
constructs leads to additional issues, as the optimal time to begin applying HP 
during construct development must be determined. Perhaps application of HP 
very early in culture might yield similar results to monolayer studies due to the 
absence of abundant ECM, while studies later in construct development when a 
significant ECM is present may yield substantially different results. 
CHONDROPROTECTIVE EFFECTS OF HYDROSTATIC 
PRESSURE 
HP also appears to be useful in providing chondroprotective effects to 
chondrocytes subjected to an inflammatory stimulus. For instance, the 
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application of HP at 10 MPa, 1 Hz, for 12 or 24 h to human osteoarthritic 
chondrocytes in monolayer resulted in decreased expression of matrix 
metalloproteinase (MMP)-2, interleukin (IL)-6, and monocyte chemoattractant 
protein (MCP)-1.141 Additionally, Lee et al.142 demonstrated chondroprotective 
effects of HP on human osteoarthritic chondrocytes in monolayer. They found 
that applying HP at 10 MPa, 1 Hz, for 4 h, following an 18 h treatment with the 
known inflammatory mediator lipopolysaccharide (LPS), mitigated the damaging 
effects of LPS, as there were decreased nitric oxide and nitric oxide synthase 
levels, which are known to have deleterious effects on ECM production. There 
was also enhanced collagen II and aggrecan mRNA levels relative to 
unpressurized cells treated with LPS. A later study by Lee et al.143 identified 
chondroprotective effects of HP following shear stimulation, as the application of 
HP at 10 MPa, 1 Hz to human osteoarthritic chondrocytes after shear stress 
inhibited nitric oxide release. Additional chondroprotective effects of HP on 
osteoarthritic chondrocytes were observed in work by Fioravanti et al.,144 as 
coupling HP with exogenous application of hyaluronic acid resulted in significant 
chondroprotective effects from IL-ip treatment induced inflammation, as well as a 
significant increase in GAG production. Furthermore, Gavenis et al.145 found that 
applying 40 kPa of HP at 0.0125 Hz to human osteoarthritic chondrocytes 
resulted in a 53.3% increase in GAG content by 14 days; however, the GAG/dry 
weight remained only 0.06%. 
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Finally, chondroprotective effects have also been demonstrated in primary 
chondrocytes, as HP at 5 MPa, 0.5 Hz, 3 h/day, for 3 days led to upregulation of 
TIMP-1 and downregulation of MMP-13 and collagen I gene expression in bovine 
chondrocytes cultured in alginate beads.146 These results appear promising as 
they indicate that HP could possibly be used to delay the onset of osteoarthritis. 
Furthermore, primary osteoarthritic chondrocytes could potentially be used in 
tissue engineering strategies, which is exciting, as they would be somewhat of a 
readily available autologous cell source. However, it must be mentioned that 
Islam et al.147 observed an increase in the number of apoptotic cells when 
applying HP at 5 MPa, 1 Hz, for 4 h to osteoarthritic human chondrocytes in 
monolayer, thus indicating that osteoarthritic chondrocytes may be quite sensitive 
to the selected HP regimen. 
HYDROSTATIC PRESSURE AND DIFFERENTIATION 
In addition to its wide use as an agent for mechanical stimulation in tissue 
engineering, HP has seen tremendous use as a method for differentiating cells 
towards a chondrogenic phenotype. For instance, Angele et al.148 cultured adult 
human bone marrow mesenchymal stem cells (bmMSCs) in aggregate culture, 
and found that HP at 5 MPa, 1 Hz, 4 h/day, for 1 day had no effect, while 7 days 
of treatment resulted in a significant increase in both collagen and GAG content 
as early as 7 days after removal of the HP stimulus, but a maximal increase was 
observed 21 days after removal of the HP stimulus. This study suggests that 
multiple days of HP application are required for an effect, and as seen in our own 
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work with hydrostatic pressure,139 the maximum effects of HP may be delayed 
until several weeks after removal of the stimulus. In a later study, Luo and 
Seedhom149 seeded ovine bmMSCs on polyester scaffolds and demonstrated 
that following 4 wks of culture, HP at 0.1 MPa, 0.25 Hz, for 30 min/day, for 10 
days resulted in both increased GAG and collagen content, while shorter 
timepoints had no effect on collagen content. However, as the constructs were 
assessed immediately after HP application, it is possible that the longer 
application time required to see effects on collagen content may actually just be 
due to the delayed effects of the earlier days of HP application, as discussed 
above. Additionally, Wagner et al.150 seeded human bmMSCs in type I collagen 
sponges, and observed that HP at 1 MPa, 1 Hz, for 4 h/day, for 10 days resulted 
in increased aggrecan, collagen II, and sox9 mRNA and increased histological 
staining for GAGs. However, they also observed an increase in collagen I 
mRNA, which was possibly due to the use of an osteochondrogenic medium, 
which differs from prior work. This hypothesis is further supported as Scherer et 
al.125 found that a chondrogenic medium was required for HP to promote 
chondrogenesis of bovine bmMSCs in high density monolayer. 
As described above in tissue engineering studies, combined treatment with both 
growth factors and HP as agents for chondrogenesis appears promising. For 
example, Miyanishi et al.151 cultured adult human bmMSCs in pellet culture, and 
exposed them to HP at 10 MPa, 1 Hz, 4 h/day, for up to 14 days, with and 
without 10 ng/ml TGF-p3. The combined treatment with HP and TGF-p3 resulted 
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in a significant increase in collagen II, aggrecan, and sox9 mRNA levels, that was 
greater than the increased levels from either treatment alone. In a follow-up 
study, Miyanishi et al.152 created pellet cultures of adult human bmMSCs, and 
applied HP at 0.1, 1, and 10 MPa, 1 Hz, for 4 h/day, for 3, 7, or 14 days, along 
with 10 ng/ml TGF-p3. In this study, all magnitudes significantly increased 
aggrecan and sox9 mRNA, but only 10 MPa significantly increased collagen II 
mRNA. Furthermore, 10 MPa was the only treatment to significantly increase 
both GAG and collagen production, with the maximum effect observed after 14 
days of HP application. Again, this observation may be due to the delayed 
effects of HP as discussed above, and it would be interesting to determine if 
similar results would be obtained if assessment was delayed until 5-10 days after 
removal of the HP stimulus. 
HP has also been used as a method for chondroinduction of other cell types, 
such as fibroblasts and dedifferentiated chondrocytes. For instance, Elder et 
al.153 found that 7200 cycles/day of HP at 5 MPa, 1 Hz, for 3 days, applied to 
murine embryonic fibroblasts in monolayer, resulted in an almost 200% increase 
in GAG production, along with an almost 225% increase in collagen synthesis. 
Additionally, Heyland et al.154 cultured dedifferentiated porcine chondrocytes in 
alginate beads, and observed a 25% increase in GAG production as well as a 
65% increase in collagen II production following HP application at 0.3 MPa, 1 Hz, 
for 6 h/day. Finally, Kawanishi et al.155 grew pellet cultures of dedifferentiated 
bovine chondrocytes (P3), and demonstrated that HP application at 5 MPa, 0.5 
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Hz, for 4 h/day for 4 days led to a 5-fold increase in aggrecan mRNA and a 4-fold 
increase in collagen II mRNA. However, HP had a negligible effect on collagen I 
mRNA levels, as both control and HP treated pellets had similar decreases in 
collagen I mRNA. Based on these results, HP appears to be a promising method 
for differentiating cells to a chondrocytic phenotype, although in the case of 
dedifferentiated chondrocytes, HP may have a greater effect on enhancing 
collagen II production than diminishing collagen I production. 
EFFECTS OF HIGH HYDROSTATIC PRESSURES 
As described above, there has been extensive work demonstrating the beneficial 
effects of physiological magnitudes of hydrostatic pressures on the gene 
expression, biochemical, and biomechanical properties of chondrocytes in 
monolayer, engineered constructs, as well as explants. However, raising 
pressures above these physiological levels has been shown to have either 
limited or even detrimental effects. Also, although static HP has generally been 
shown to have beneficial effects when using physiological magnitudes for 3-D 
tissue engineering studies, it becomes far more detrimental than dynamic loading 
at higher pressures. For example, Hall et al.102 examined the effects of 20-50 
MPa static HP, for 20 s, 5 min, or 2 h on bovine explants, and found that short 
term application times had no effect on GAG and collagen synthesis rates, while 
2 h application resulted in a significant decrease in both GAG and collagen 
synthesis. In another 3-D study, Nakamura et al.156 seeded normal adult rabbit 
chondrocytes in alginate beads and found that 50 MPa static HP for 12 or 24 h 
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resulted in a significant increase in the number of apoptotic cells. Additionally, 
they found that 50 MPa static HP led to a dramatic increase in heat-shock protein 
70 (hsp70) mRNA. In another study, Fioravanti et al.157 studied the effects of 
high HP on normal human chondrocytes in alginate beads, and found that 24 
MPa static HP applied for 3 h decreased mitochondria and golgi body number, 
and altered the actin and tubulin of normal chondrocytes such that they more 
closely resembled osteoarthritic cells in these characteristics. 
Several studies on chondrocytes in monolayer have demonstrated similar 
detrimental results. For instance, Parkkinen et al.109 assessed the effects of high 
pressures on bovine chondrocytes in monolayer, and found that a 2 h application 
of 30 MPa static HP, and to a lesser extent 15 MPa static HP, resulted in a 
microtubule dependent compaction of the golgi apparatus with a concomitant 
decrease in GAG synthesis. However, 15 and 30 MPa HP at either 0.05 or 0.125 
Hz had no effect on the golgi apparatus or GAG synthesis. Similarly, in a later 
study, Parkinnen et al.158 assessed the effects of 2 h of HP stimulation on bovine 
chondrocytes in monolayer, and found that 30 MPa static HP led to a reversible 
complete loss of stress fibers, while 30 MPa HP, at 0.05 or 0.125 Hz, just 
changed the appearance of the stress fibers. It was suggested that the altered 
stress fibers may be the result of very small strains on the cells or microfilaments, 
or possibly due to alterations in the intracellular ion concentrations, as described 
further below. In a similar study using bovine chondrocytes in monolayer, Lammi 
et al.107 found that 30 MPa static HP resulted in a 37% decrease in GAG 
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synthesis accompanied by decreased aggrecan mRNA levels; this treatment also 
resulted in the production of atypically large aggrecan molecules. These results 
are interesting as the altered aggrecan size demonstrates that HP can affect 
production of ECM at the levels of both transcription and translation. 
Detrimental effects of high HP have also been observed in other chondrocyte-like 
cell lines, cultured in monolayer. For example, Sironen et.al.159 assessed the 
effects of 30 MPa HP, static or 1 Hz, for up to 24 h on immortalized human 
chondrocyte cell lines and chondrosarcoma cells, cultured in monolayer. They 
found that static HP resulted in significantly increased hsp70, hsp40, Gadd45 
and Gadd153 gene expression, all of which are genes associated with stress 
responses. Additionally, they demonstrated that static HP had a greater effect on 
the increased gene expression than HP at 1 Hz. In a separate study, Sironen et 
al.160 used a cDNA array to assess the effects of a 6 h treatment with 30 MPa 
static HP on human chondrosarcoma cells. This treatment had negative effects 
on the ECM content, as it led to decreased osteonectin, fibronectin, and 
procollagen levels. Furthermore, Takahashi et al.108 found that in a human 
chondrosarcoma cell line, a 2 h application of 50 MPa static HP significantly 
increased IL-6 and TNF-a mRNA, and also led to decreased expression of 
proteoglycan core protein; these results are indicative of osteoarthritic changes. 
Finally, Kaamiranta et al.161 observed a doubling of hsp70 mRNA after 12 h of 
treatment with 30 MPa static HP, while treatment with 30 MPa, 0.5 Hz did not 
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change the level of hsp70. However, treatment with 4 MPa HP, either static or 
dynamic, did not alter the expression of hsp70. 
Taken together, these results suggest that HP magnitudes outside of the 
physiologic range may result in a stress response, especially when using static 
HP, so tissue engineering strategies should focus on more physiological 
magnitudes. Although these higher pressures likely are not useful for cartilage 
tissue engineering strategies, they indicate that high pressures may play a role in 
the progression of osteoarthritis, as many osteoarthritic changes can be 
observed in chondrocytes exposed to these high pressures. 
HYDROSTATIC PRESSURE MECHANOTRANSDUCTION 
Unlike direct compression and shear mechanical stimulation, hydrostatic 
pressure does not result in macroscopic deformation of cartilage. According to 
the biphasic theory, the solid matrix of cartilage is intrinsically incompressible, 
and no tissue deformation will be observed under an external hydrostatic load, 
even though the tissue may be anisotropic. Bachrach et al.162 tested this 
theoretical prediction on normal bovine cartilage explants, and found that static 
pressures in the physiological range, up to 12 MPa, did not result in measurable 
cartilage deformation. Similarly, Tanck et al.163 found that physiological 
hydrostatic pressure magnitudes on fetal cartilage result only in extremely small 
deformations of approximately 2 (x-strain, as a result of the relative 
incompressibility of the solid matrix of articular cartilage. However, it must be 
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noted that even though there is only a minute tissue strain, this, along with the 
strain imparted by the compressibility of water itself, may be great enough to 
impart strain on the chondrocytes themselves, although it has previously been 
demonstrated that the cells are relatively incompressible at these physiological 
pressures.164 Therefore, as HP generally produces a state of stress with no or 
very little strain, alternative mechanisms have been proposed to explain the 
mechanotransduction pathways of HP application. 
Several studies have indicated that HP likely has direct effects on cell membrane 
ion channels (Fig. 6). Hall165 examined the effects of static HP on isolated bovine 
chondrocytes for 20 s or 10 min, and found that the Na/K pump was substantially 
inhibited when going from 2.5-5 MPa, and this inhibition increased slightly when 
pressure was increased up to 50 MPa. For example, 10 MPa static HP for 10 
min resulted in a 53% decrease in the activity of the Na/K pump, relative to 
control. Additionally, the Na/K/2CI transporter was inhibited by increasing 
pressure up to 50 MPa, and it was found that increasing the magnitude of 10 s of 
static HP application from 7.5-15 MPa resulted in an almost 40% reduction in 
Na/K/2CI transporter activity. An additional study by Browning et al.166 examined 
the effects of static HP, ranging from 2-30 MPa for up to 180s on juvenile bovine 
chondrocytes, in monolayer. They found that both 20 and 30 MPa static HP 
application resulted in a significant increase in the activity of the Na/H pump. 
Furthermore, adding the kinase inhibitor staurosporine prevented the HP-induced 
stimulation of Na/H exchange, thus suggesting that direct activation of the 
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transporter is a phosphorylation-dependent process. In a similar study, 
Mizuno167 assessed the effects of 5 min of static HP at 0.5 MPa on immature 
bovine articular chondrocytes in monolayer, and found that the application of HP 
to middle zone cells resulted in a 2-fold increase in intracellular calcium. It was 
determined that this increase was dependent upon direct effects of HP on 
stretch-activated calcium channels, as well as the release of intracellular calcium. 
Likewise, Browning et al.168 assessed the effects of short term application of 
static HP on isolated juvenile bovine articular chondrocytes. They found that 30 
s of static HP application at 30 MPa resulted in an approximately 3-fold increase 
in intracellular calcium, largely caused by calcium release from intracellular 
stores. Additionally, they found that this intracellular calcium release was 
dependent on IP3 mediation, and that similar induction of IP3-mediated calcium 
release occurred at more physiologic pressure magnitudes, such as 10 MPa. 
As reviewed previously,169 the direct effects of HP on transmembrane ion 
transporter function are likely due to the pressure's effects on the conformations 
of the transmembrane proteins. Although HP does not measurably deform 
cartilage due to the intrinsically incompressible nature of its phases, the 
transporter proteins themselves have void spaces created by their folding 
orientation that can be compressed. As these spaces undergo increased strain 
as pressure rises, the protein will eventually alter its orientation to achieve a 
lower energy folding state. Thus, as described above, a pressure-dependent 
change in intracellular ion concentrations will be observed. It is widely known 
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that alterations in intracellular ion concentrations result in changes in cellular 
gene expression and protein synthesis.170 Thus, it is likely that specific 
pressures result in certain ion concentration changes that lead to the specific 
effects on gene expression, protein production, and eventually biomechanical 
properties, in the tissue engineering studies described previously. 
CONCLUSIONS 
Cartilage regeneration has been an extremely difficult problem due to the poor 
intrinsic healing capacity of the tissue. However, mechanical stimulation with HP 
has provided significant beneficial effects on gene expression and protein 
production of chondrocytes in monolayer, and has led to enhanced biochemical 
and biomechanical properties in engineered constructs. It is apparent that 
physiologic magnitudes, particularly between 5 and 10 MPa have beneficial 
effects on cartilage properties; however, there are substantial differences in the 
effects observed between monolayer and 3-D culture, as static HP regimens 
have little effect or are detrimental to chondrocytes in monolayer, while static HP 
in the physiologic range enhances the functional properties of 3-D engineered 
constructs. Additionally, work involving HP application to osteoarthritic 
chondrocytes demonstrates that osteoarthritic chondrocytes may be used in 
tissue engineering strategies, and that HP could potentially be used as a 
treatment modality to delay osteoarthritic changes. Furthermore, physiologic 
magnitudes of HP, particularly with intermittent loading frequencies can be used 
as a differentiation factor for MSCs, embryonic stem cells, as well as 
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dedifferentiated chondrocytes. Finally, it is clear that high hydrostatic pressures, 
particularly between 30-50 MPa but as low as 15 MPa, have detrimental effects 
on chondrocytes and generally result in a stress response and decreased 
metabolic activity. These detrimental effects are especially apparent with loading 
times exceeding 2 h. 
Although the work performed up to this point appears promising, additional work 
must be performed in each system to optimize the magnitude, frequency, 
duration of application, and application time in construct development. 
Additionally, based on the additive and synergistic effects of HP and growth 
factor application, it is likely that following optimization, HP will need to be used in 
combination with other exogenous stimuli such as growth factors as well as with 
other mechanical stimuli such as direct compression in order to yield a construct 
with biochemical and biomechanical properties approaching those of native 
tissue. 
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ABSTRACT 
During in vivo development, articular cartilage is exposed to several different 
forms of stress. This study examined the effects of radial confinement and 
passive axial compression-induced vertical confinement, on the biomechanical, 
biochemical, and histological properties of self-assembled chondrocyte 
constructs. The self-assembled constructs, engineered without the use of an 
exogenous scaffold, exhibited significant increases in stiffness in the direction 
orthogonal to that of the confinement surface. With radial confinement, the 
significantly increased aggregate modulus was accompanied by increased 
collagen organization in the direction perpendicular to the articular surface, with 
no change in collagen or glycosaminoglycan (GAG) content. Additionally, radial 
confinement was most beneficial when applied before t=2 wks. With passive 
axial compression, the significantly increased Young's modulus and ultimate 
tensile strength were accompanied by a significant increase in collagen 
production. This study is the first to demonstrate the beneficial effects of 
confinement on tissue engineered constructs in the direction orthogonal to that of 
the confinement surface. 
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INTRODUCTION 
Cartilage degeneration, from injury or osteoarthritis, is a tremendous problem in 
current orthopaedic practice. Following injury or osteoarthritis, articular cartilage 
is unable to repair itself, resulting in a permanent defect or the formation of 
mechanically inferior fibrocartilage.14 Therefore, tissue engineering is a 
promising approach for the treatment of articular cartilage injuries, as this 
approach may eventually allow for the production of engineered tissue 
indistinguishable from native cartilage. 
A chondrocyte self-assembling process for tissue engineering articular cartilage 
was recently developed36 that allowed constructs to reach 1/3 the stiffness of 
native cartilage. Additionally, the benefits of hydrostatic pressure stimulation on 
self-assembled constructs have been demonstrated,135 as intermittent hydrostatic 
pressure applied at 10 MPa and 1 Hz, for 4 hrs per day and 5 days per wk was 
shown to increase collagen production. The self-assembling process avoids 
many of the problems associated with scaffold use, namely concerns over stress 
shielding, biocompatibility and biodegradation. 
Articular cartilage is exposed to a variety of forces in vivo including compression, 
shear, and hydrostatic pressure. Additionally, mechanical stimulation is vital for 
maintaining the integrity of the tissue, as articular cartilage demonstrates 
changes representative of a loss of function when immobilized.99,10° Therefore, it 
is likely that some form of mechanical intervention will be required for further 
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refinement of tissue engineering techniques. Although the precise signaling 
pathways involved in mechanotransduction have not been fully elucidated, 
several studies have shown promising results involving the use of mechanical 
stimulation including dynamic compression,111,171_176 shear,174,177 and hydrostatic 
pressure.39,102,178,179 
Although coupling mechanical stimulation with the self-assembling process for 
tissue engineering articular cartilage represents a promising solution for 
treatment of injuries, several questions remain concerning this approach. Aside 
from the studies showing beneficial effects of dynamic compression and 
hydrostatic pressure, studies comparing the effects of passive confinement on 
the anisotropy of articular cartilage are lacking. Additionally, studies involving the 
effects of mechanical intervention at different times are limited.180 
The purpose of this study was to examine the effects of construct confinement in 
different directions and at different times on construct mechanical properties. 
Radial confinement and passive axial compression-induced vertical confinement 
of self-assembled constructs were used. It was hypothesized that the application 
of confinement would enhance the mechanical properties of the constructs in the 
orthogonal direction. It was further hypothesized that confinement at different 
timepoints in construct development would have a significant effect on construct 
properties. To test these hypotheses, three experiments were performed (Fig. 
7). First, self-assembled constructs were radially confined in agarose wells for 1, 
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2, 3, or 4 wks, after which the constructs were cultured unconfined for the 
remainder of the 4-wk study; the effects of confinement on compressive stiffness 
were investigated. Second, the constructs were cultured in the same wells used 
in the first experiment for 2 wks, after which they were transferred to 
incrementally larger wells for the 3rd and 4th wk of culture. Finally, the effects of 
vertical confinement, in the form of passive axial compression, on the tensile 
stiffness were examined. 
METHODS 
Chondrocyte Isolation and Seeding 
Chondrocytes were isolated from the distal femur of wk-old male calves93,118,181 
(Research 87 Inc.) less than 36 hrs after slaughter, with collagenase type 2 
(Worthington) in the culture medium. The medium was DMEM with 4.5 g/L-
glucose and L-glutamine, 100 nM dexamethasone, 1% fungizone, 1% 
Penicillin/Streptomycin, 1% ITS+, 50 |ig/mL ascorbate-2-phosphate, 40 |xg/mL L-
proline, and 100 |xg/mL sodium pyruvate (termed chemically-defined medium). 
Each leg came from a different animal and yielded roughly 150 million 
chondrocytes. To reduce variability among animals, cells from all legs were 
pooled together to yield a mixture of chondrocytes; a mixture of cells from 8 legs 
was used in the 1st study, while a mixture of cells from 6 legs was used in the 2nd 
and 3rd studies (see descriptions below). The pooled cells were counted on a 
hemocytometer, and viability was assessed using a trypan blue exclusion test. 
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Viability was >99% for the pooled cells. Chondrocytes were frozen in culture 
medium supplemented with 20% FBS and 10% DMSO at -80°C for 2 wks to a 
month before use. After thawing, viability remained greater than 75%. A 
polysulfone die consisting of 5 mm dia. x 10 mm long cylindrical prongs was 
constructed to fit into 6 wells of a 48-well plate. Additional polysulfone die 
consisting of 6 mm dia. x 10 mm long cylindrical prongs and 7 mm dia. x 10 mm 
long cylindrical prongs were fabricated. To construct each agarose mold, sterile, 
molten 2% agarose was introduced into a well fitted with the polysulfone die. 
The agarose was allowed to gel at room temperature for 60 min. The agarose 
mold was then separated from the polysulfone die and submerged into two 
exchanges of culture medium to completely saturate the agarose well with 
culture medium by the time of cell seeding. To each agarose well, 5.5 x 106 cells 
were added in 150 fil of culture medium. The cells self-assembled within 24 hrs 
in the agarose wells and were maintained in the same well for a specified amount 
of time; t=0 was defined as 24 hrs after seeding. 
1st Study: Radial Confinement of Self-Assembled Constructs 
At t=1, 2, or 3 wks, self-assembled constructs (n=6) were removed from 
confinement in the 5 mm dia. agarose well, and placed in one well of a 6-well 
culture plate coated with 2% agarose (Fig. 7a). Each agarose-coated well 
contained 3-4 constructs, and 500 nl of medium per construct was changed daily 
(1.5-2 ml per well). At t=4 wks, all samples were tested for morphological, 
histological, biochemical, and biomechanical properties. 
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2nd Study: Maintenance of Radial Confinement of Self-Assembled 
Constructs 
At t=2 wks, self-assembled constructs (n=5) were removed from confinement in 
the 5 mm dia. agarose wells, and transferred to 6 mm dia. agarose wells (Fig. 
7b). At t=3 wks, these constructs were removed from confinement in the 6 mm 
dia. agarose wells, and transferred to 7 mm dia. agarose wells. A control 
consisted of constructs confined in 5 mm dia. agarose wells for 2 wks, and then 
maintained in agarose-coated wells, as described above. Each day, 500 jxl of 
medium was changed. At t=4 wks, all samples were tested for morphological, 
histological, biochemical, and biomechanical properties. 
3rd Study: Passive Axial Compression of Self-Assembled Constructs 
At t=10 days, self-assembled constructs (n=5) were removed from confinement 
in 5 mm dia. agarose wells, and transferred to 6 mm dia. agarose wells. Vertical 
confinement, in the form of passive axial compression with a dead weight, was 
applied by placing a 5 mm dia. x 1 cm long, 1 g, porous, sintered steel cylinder 
on top of each construct in the 6 mm dia. wells (Fig. 7c). The dead weight 
corresponded to a stress of 0.5 kPa. At t=14 days, the porous cylinders were 
removed, and the constructs were transferred to agarose-coated wells for the 
remainder of the study. A control consisted of constructs cultured in 5 mm dia. 
agarose wells, then transferred to 6 mm dia. agarose wells at t=10 days, and 
finally maintained in agarose-coated wells for the remainder of the study. 
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Histology and Immunohistochemistry 
Samples were frozen and sectioned at 14 \m\. Safranin-0 and fast green 
staining were used to examine GAG distribution.182,183 Picrosirius red was used 
for qualitative examination of collagen content. Polarized light microscopy of 
picrosirius red-stained sections was used to examine the collagen organization of 
the constructs. Slides were also processed with immunohistochemistry (IHC) to 
test for the presence of collagen types I (COL1) and II (COL2) on a Biogenex 
(San Ramon, CA) i6000 autostainer. After fixing in chilled acetone, the slides 
were rinsed with IHC buffer (Biogenex), quenched of peroxidase activity with 
hydrogen peroxide/methanol, and blocked with horse serum (Vectastain ABC kit, 
Vector Laboratories, Burlingame, CA). The slides were then incubated with 
either mouse anti-COL1 (Accurate Chemicals (Westbury, NY)) or mouse anti-
COL2 (Chondrex (Redmond, WA) antibodies). The secondary antibody (mouse 
IgG, Vectastain ABC kit) was then applied, and color was developed using the 
Vectastain ABC reagent and DAB (Vector Laboratories). 
Quantitative Biochemistry 
Samples were digested with 10 mg/ml pepsin solution (Sigma) in 0.05 M acetic 
acid with 0.5 M NaCI at 4°C for 72 hrs, followed by 1 mg/ml pancreatic elastic in 
1x TBS at 4°C overnight. Total DNA content was measured by Picogreen® Cell 
Proliferation Assay Kit (Molecular Probes). Total sulfated GAG was then 
quantified using the Blyscan Glycosaminoglycan Assay kit (Biocolor), based on 
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1,9-dimethylmethylene blue binding.184,185 After being hydrolyzed by 2 N NaOH 
for 20 min at 110°C, samples were assayed for total collagen content by a 
chloramine-T hydroxyproline assay.186 
Indentation Testing 
Samples were evaluated with an automated indentation apparatus.187 A step 
mass of 0.7 g (0.007 N) was applied with a 1 mm flat-ended* porous indentertip, 
and the specimens were allowed to creep until equilibrium, as described 
elsewhere.36 Preliminary estimations of the Young's modulus of the samples 
were obtained using the analytical solution for the axisymmetric Boussinesq 
problem with Papkovich potential functions.188, 189 The intrinsic mechanical 
properties of the samples were then determined using the linear biphasic theory.3 
Tensile Testing 
Samples were cut into 500 |xm thickness and tested using a uniaxial materials 
testing machine (Instron 5565), as described elsewhere.190 Samples were cut 
into dog-bone shapes that had approximately 1-mm-long gauge lengths. 
Cyanoacrylate glue was used to attach the samples to paper tabs for gripping, 
outside of the gauge length. A constant strain rate of 0.01 s"1 was used. The 
Young's modulus was equal to the slope of the linear region of the curve, the 
tensile strength equal to the maximum stress, the maximum strain was the strain 
corresponding to the maximum stress, and the energy was equal to the area 
under the curve (trapezoid rule) from zero strain to maximum strain. 
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Statistical Analysis 
All samples were assessed biochemically and biomechanically (n=5 or 6). A 
single factor ANOVA was used to analyze the samples, and Tukey's post hoc 
test was used when warranted. Significance was defined as p < 0.05. 
RESULTS 
Gross Appearance and Histology 
There were no differences in gross morphology between any of the groups. After 
2 wks of culture, all constructs reached a diameter slightly below 6 mm. By 3 
wks of culture, constructs reached a diameter slightly below 7 mm, and by 4 wks 
of culture, constructs reached a diameter approaching 7.5 mm. In the 
confinement study, there were no significant differences in thickness between the 
2-wk confinement group and the 1, 3, or 4-wk confinement groups, with 
thicknesses of 1.05±0.05 mm, 1.02±0.06 mm, 1.07±0.17 mm, and 1.10±0.14 mm 
respectively. Likewise, in the passive axial compression study, there were no 
significant differences in thickness between treatment groups. The compressed 
group had a thickness of 0.73±0.09 mm and the control group had a thickness of 
0.81 ±0.07 mm. Additionally, in the follow-up confinement study, there was no 
significant difference in thickness between the 2-wk confinement group and the 
group confined for 2 wks in 5 mm dia. wells, 1 wk in 6 mm dia. wells, and 1 wk in 
7 mm dia. wells, with values of 0.58±0.09 and 0.51 ±0.04 respectively. At t=4 
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wks, all constructs stained positive for collagen throughout the thickness of the 
construct (Fig. 8b). Additionally, safranin-0 staining for GAG was observed 
throughout the constructs (Fig. 8c). COL2 immunostaining was observed 
throughout the constructs, with no differences in production among the treatment 
groups (Fig. 8d). Based on IHC, there was no COL1 production for any 
constructs (Fig. 8e). 
Polarized Light Microscopy 
Polarized light microscopy was used to assess the collagen organization of the 
constructs in the confinement study. The constructs that were confined in 5 mm 
dia. wells for 2 wks and then unconfined and cultured in agarose-coated wells for 
the remaining 2 wks exhibited small-fiber collagen organization in the direction 
perpendicular to the construct surface as well as larger-fiber collagen 
organization in the direction parallel to the construct surface (Fig. 8a). The 
alignment of the small collagen fibers resembled struts. Small-fiber collagen 
organization was minimally observed in the other treatment groups (Fig. 8a), 
namely confinement in 5 mm dia. wells for 1, 3, or 4 wks. 
The increased collagen organization was not observed in the passive axial 
compression study, as the constructs to which a dead weight was applied did not 
show any small-fiber collagen organization. 
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Quantitative Biochemistry 
There was no significant difference in WW/construct, DNA/construct, GAG/WW, 
and collagen/WW between the 2-wk confinement group and the 1, 3, or 4-wk 
confinement groups. The 2-wk confinement group had a WW of 39±4 mg, while 
the 1-wk, 3-wk, and 4-wk confinement groups had a WW of 44±3 mg, 37±4 mg, 
and 41 ±2 mg respectively. The 2-wk confinement group had a DNA/construct of 
49±2 |j.g, while the 1-wk, 3-wk, and 4-wk confinement groups had a 
DNA/construct of 44±11 ^g, 46±13 ng, and 47±5 |xg respectively. The 2-wk 
confinement group had a GAG/WW of 0.061 ±0.009 mg/mg, while the 1-wk, 3-wk, 
and 4-wk confinement groups had a GAG/WW of 0.067±0.014 mg/mg, 
0.055±0.003 mg/mg, and 0.050±0.004 mg/mg respectively. The 2-wk 
confinement group had a collagen/WW of 0.039±0.006 mg/mg, while the 1-wk, 3-
wk, and 4-wk confinement groups had a collagen/WW of 0.032±0.005 mg/mg, 
0.041 ±0.009 mg/mg, and 0.036±0.008 mg/mg respectively. Additionally, in the 
follow-up confinement study, there was no significant difference in WW/construct, 
DNA/construct, GAG/WW or collagen/WW between the 2-wk confinement group 
and the group confined for 2 wks in 5 mm dia. wells, 1 wk in 6 mm dia. wells, and 
1 wk in 7 mm dia. wells. These groups had WW values of 16±1 mg and 14±2 
mg, DNA/construct values of 31 ±2 ng and 31 ±4 ng, GAG/WW values of 
0.074±0.008 mg/mg and 0.065±0.006 mg/mg, and collagen/WW values of 
0.071 ±0.019 mg/mg and 0.088±0.011 mg/mg respectively. The collagen/WW for 
the passive axial compression group at 0.067±0.009 mg/mg was significantly 
higher than the unloaded control group, which had a collagen/WW of 
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0.044±0.008 mg/rhg. There was no significant difference in GAG/WW between 
the passive axial compression group and the control, with values of 0.070±0.006 
mg/mg and 0.064±0.007 mg/mg respectively. Finally, the passive axial 
compression group had WW values of 20±1 mg and 29±3 mg respectively; there 
was no difference in DNA/construct between the passive axial compression 
group and the control group, with values of 41 ±7 ng and 40±2 jxg respectively. 
Mechanical Evaluation 
The aggregate modulus of the 2-wk confinement group reached 225±32 kPa, 
and was significantly higher than the aggregate moduli of the 1, 3, or 4-wk 
confinement groups, with values of 120±43 kPa, 126±56 kPa, and 94±52 kPa 
respectively (Fig. 9). In the follow-up confinement study, the aggregate modulus 
of the 2-wk confinement group at 214±110 kPa was insignificantly higher than 
that of the group confined for 2 wks in 5 mm dia. wells, 1 wk in 6 mm dia. wells, 
and 1 wk in 7 mm dia. wells, at 177±96 kPa. 
The tensile modulus of the passive axial compression group at 1.4±0.3 MPa was 
significantly higher than the tensile modulus of the control group at 1.0±0.1 MPa 
(Fig. 10a). Additionally, the ultimate tensile strength of the passive axial 
compression group at 339±86 kPa was significantly higher than the ultimate 
tensile strength of the control group at 200±71 kPa (Fig. 10b). However, there 
was no significant difference between the aggregate modulus of the passive axial 
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compression group and control group, with values of 101 ±48 kPa and 111 ±52 
kPa respectively. 
DISCUSSION 
This study was designed to assess the effects of radial confinement and, 
separately, to determine the effects of passive axial compression-induced vertical 
confinement, on the mechanical properties of 3-D self-assembled articular 
cartilage constructs over a 4-wk culture period. Confining constructs for 2 wks in 
5 mm dia. agarose wells led to a significantly increased aggregate modulus. This 
increased compressive stiffness was accompanied by increased collagen 
organization without a change in GAG or collagen content. However, 
confinement in 5 mm dia. wells for 2 wks, followed by confinement in 6 mm dia. 
wells for 1 wk and confinement in 7 mm dia. wells for 1 wk did not enhance the 
compressive properties of the constructs, and trended towards a decrease in 
aggregate modulus. The application of a 0.01 N dead weight to the constructs, 
corresponding to 0.5 kPa of stress, resulted in significant increases in both 
tensile modulus and ultimate tensile strength, as well as total collagen per wet 
weight. These results, discussed further below, support our hypothesis, as 
changes in mechanical properties were identified in a direction orthogonal to the 
confinement surface in tissue-engineered articular chondrocyte constructs. 
Additionally, this study demonstrates further refinement and characterization of 
the self-assembling process. 
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Radial confinement in 5 mm dia. agarose wells for 2 wks led to approximately a 
2-fold increase in aggregate modulus at t=4 wks, relative to confinement for 1, 3, 
or 4 wks. There was no difference in ECM content among the different 
confinement groups; however, increased collagen organization in the direction 
parallel to that of the compression testing and orthogonal to the confinement 
surface was observed only in the group confined for 2 wks. The organized 
collagen fibers appeared to form struts that may help to increase the 
compressive stiffness of the constructs. These results were unexpected as the 
collagen of articular cartilage is typically responsible for the tensile stiffness, 
while the GAG content is responsible for the compressive stiffness. However, 
these results agree with those found in previous studies,191, 192 that have 
demonstrated that total GAG and collagen content may not be an ideal indicator 
of mechanical properties; rather, ECM organization may play a significant role in 
predicting mechanical properties. A possible explanation is that the organization 
of the collagen fibers aids the proteoglycans in resisting compressive forces. 
Confinement during the self-assembly process may lead to radial construct 
compression. We observed that at t=10 days of confinement, the constructs 
reached the wall of the 5 mm dia. wells. At t=2 wks of confinement, constructs 
slightly less than 6 mm dia. were unconfined from the 5 mm dia. wells. 
Therefore, we hypothesized that the constructs confined for 2 wks exhibited a 
higher aggregate modulus and increased collagen organization due to the effects 
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of a low-magnitude radial compression, as well as contact with the agarose well. 
This radial compression would neither be constant strain nor constant stress, 
since the constructs continued to grow radially while confined, thus resulting in 
potentially increasing strain and increasing stress with construct growth. This 
could account for the results observed in the other three confinement groups, as 
the constructs confined for 1 wk did not contact the walls of the well and 
therefore may not have been radially compressed. Additionally, at t=3 wks of 
confinement, constructs slightly less than 7 mm dia. were unconfined from the 5 
mm dia. wells, and at t=4 wks of confinement, constructs approaching 7.5 mm 
dia. were unconfined from the 5 mm dia. wells; therefore, they may have 
experienced higher magnitudes of radial compression, which negated the 
positive effects of the lower-magnitude radial compression. 
Since the aforementioned radial confinement-induced stress could not be 
quantified, it is possible that the constructs merely were radially confined rather 
than radially compressed. Perhaps, confinement may have diminished the 
nutrient supply through the lateral surface, potentially becoming more detrimental 
over periods longer than 2 wks. However, the wells were constructed of 
agarose, with a 98% fluid phase to allow for adequate nutrient diffusion to the 
edges of the constructs. Additionally, confinement did not affect the cellularity of 
the constructs, as there was no difference in histological images and 
DNA/construct between the 2-wk confinement group and the other confinement 
groups. 
80 
In a follow-up to this study, we examined the temporal effects of the radial 
confinement of the 2-wk confinement group, and found that t=10-14 days was the 
most beneficial time for constructs to be confined by the agarose well. To 
maintain radial confinement similar to that experienced by the 2-wk confinement 
group during t=10-14 days for a longer period, constructs were confined in 
incrementally larger agarose wells, to mimic the radial growth of the constructs 
with time and approximately allow the constructs to contact the edge of the wells 
from t=1.5 wks to 4 wks. Constructs only confined for 2 wks in 5 mm dia. wells 
and unconfined for the duration of the study were used as controls. Interestingly, 
maintaining confinement for 4 wks caused the aggregate modulus to trend lower 
than the 2-wk confined control, from 214±110 kPa to 177±96 kPa, although there 
was no significant difference between these values. These results demonstrate 
that the application of radial confinement between 1 and 2 wks was more 
beneficial than the maintenance of a similar level of radial confinement through 
later time-points, which may actually be detrimental to the constructs. However, 
due to the constraints of the experimental setup used for the confinement 
studies, we were unable to apply radial confinement before approximately t=1.5 
wks, so it is possible that applying radial confinement at even earlier timepoints 
may be more beneficial. 
As described above, radial confinement resulted in changes in the compressive 
stiffness of constructs. Therefore, the effects of vertical confinement, in the form 
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of a passive axial stress, on the tensile characteristics of the constructs were 
examined. The application of a dead weight from t=10-14 days increased the 
tensile properties of the constructs. To eliminate the effects of radial 
confinement, the control constructs were placed in incrementally larger agarose 
wells. At t=4 wks, the passive axial compression group demonstrated a 1.4-fold 
increase in Young's modulus, as well as a 1.7-fold increase in ultimate tensile 
strength, relative to the control group, again confirming our hypothesis that the 
application of confinement to self-assembled articular cartilage constructs affects 
the mechanical properties in the direction orthogonal to the confinement surface. 
In this case, the increased tensile strength of the passive axial compression 
group was accounted for by a significantly higher value of collagen/WW for the 
passive axial compression group vs. the control group, with minimal small-fiber 
collagen organization for either group. Interestingly, vertical confinement led to 
different changes in the construct ECM than found in radial confinement. This 
suggests that there may be different mechanotransduction pathways for radial 
confinement and passive axial compression, and future studies should be 
performed to elucidate these potential differences. Finally, the application of a 
dead weight had no effect on the cellularity of the constructs, as there was no 
difference in histological images or DNA/construct between the passive axial 
compression group and the control group. 
To our knowledge, this study is the first to provide evidence of the benefits of 
confinement on mechanical properties in the direction orthogonal to the 
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confinement surface. It shows that an increased construct aggregate modulus 
can be accounted for by increased collagen organization in the direction 
orthogonal to the construct surface. Previous studies have also demonstrated a 
relationship between cartilage mechanical properties and collagen organization, 
as determined by polarized light microscopy. For example, Kiviranta et al.193 
found that in bovine knee osteochondral plugs, there was a significant correlation 
between Poisson's ratio and collagen organization, as assessed by quantitative 
polarized light microscopy. Additionally, Kelly et al.192 found that dynamic 
deformational loading of chondrocyte-seeded agarose hydrogels led to an 
increased bulk Young's modulus with increased collagen organization in the 
radial direction relative to the free-swelling control. Although several other 
studies have examined collagen organization in cartilage explants, to our 
knowledge, this study is the only one to demonstrate a relationship between 
collagen organization and aggregate modulus in tissue engineered constructs. 
Several prior studies have investigated the use of dynamic compression 111'176, 
177
 and/or shear 174,177 on the ECM of tissue-engineered cartilage constructs. 
These studies demonstrated 1.5-2.8-fold increases in GAG, and 1.4-fold 
increases in collagen with mechanical stimulation, which differ from the results of 
the radial confinement study, which demonstrated no change in ECM content, 
and the passive axial compression study, which demonstrated a 1.5-fold increase 
in collagen without an increase in GAG. Since the other studies all involved 
dynamic, rather than passive stimulation, it is possible that simultaneous GAG 
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and collagen increases may only be observed under dynamic mechanical 
stimulation as a result of the increased nutrient diffusion to the construct in 
dynamic stimulation, as noted elsewhere.192 However, Waldman et al.176 found 
that dynamic compression of 5% amplitude at 1 Hz, for 400 cycles every other 
day for 1 wk, resulted in increased collagen with no change in GAG content, 
which matches the results of the passive axial compression study. 
Although many studies have examined the relationship between mechanical 
stimulation and construct mechanical properties, to our knowledge, this is the first 
tissue engineering study to indicate the beneficial effects of passive confinement 
for a short term. This result indicates the possibility of an adaptive response to 
confinement that either results in increased collagen organization as seen in the 
radial confinement experiment, or increased matrix synthesis as seen in the 
passive axial compression experiment. Consistent with this finding, although 
using immature bovine cartilage explants, Boustany et al.194 found that static 
compression of <25% strain for 60 hours increased the biosynthetic rate of GAG 
and collagen production, although the mechanical properties of the explants were 
not examined. 
Additional studies should be performed in the future to track construct 
development using electron microscopy in order to elucidate the mechanism 
leading to strut-like collagen organization, observed only in the 2-wk confined 
constructs. In addition, future studies should investigate the combination of 
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confinement with other modalities of mechanical stimulation such as hydrostatic 
pressure and direct compression, as the combination may result in synergistic 
effects on construct mechanical properties. Finally, future work should examine 
the effects of the addition of growth factors to the culture medium both before 
and after the application of confinement, in order to look for a synergistic effect 
between the growth factors and confinement. 
In summary, this study permitted the examination of the hypothesis that the 
mechanical properties of self-assembled articular cartilage constructs are 
influenced by the application of stress in a direction orthogonal to the 
confinement surface. This study furthers our prior work involving the self-
assembling process, by indicating that the ECM of self-assembled constructs 
may be modulated by both radial and vertical confinement. Also, this study 
provides evidence to support early (<2 wks) application of confinement and 
passive axial compression, and demonstrates the benefit of low-magnitude 
passive stress application. 
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ABSTRACT 
The objective of this study was to determine the effects of temporal hydrostatic 
pressure on the properties of scaffoldless bovine articular cartilage constructs. 
The study was organized in three phases: First, a suitable control for HP 
application was identified. Second, 10 MPa static HP was applied at three 
different timepoints (6-10 days, 10-14 days, and 14-18 days) to identify a window 
in construct development when HP application would be most beneficial. Third, 
the temporal effects of 10-14 days static HP application, as determined in phase 
II, were assessed at 2, 4, and 8 wks. Compressive and tensile mechanical 
properties, GAG and collagen content, histology for GAG and collagen, and 
immunohistochemistry for collagen types I and II were assessed. Using a culture 
control identified in phase I, in phase II HP application from 10-14 days resulted 
in a significant 1.4-fold increase in aggregate modulus, accompanied by an 
increase in GAG content, while HP application at all timepoints enhanced tensile 
properties and collagen content. In phase III, HP had an immediate effect on 
GAG content, collagen content, and compressive stiffness, while there was a 
delayed increase in tensile stiffness. The enhanced tensile stiffness was still 
present at 8 wks. For the first time, this study examined the immediate and long 
term effects of hydrostatic pressure on biomechanical properties, and 
demonstrated that HP has an optimal application time in construct development. 
These findings are exciting as HP stimulation allowed for the formation of robust 
tissue engineered cartilage; for example, 10 MPa static HP resulted in an 
87 
aggregate modulus of 273±123 kPa, a Young's modulus of 1.6±0.4 MPa, a 
GAG/wet weight of 6.1 ±1.4% and a collagen/wet weight of 10.6±2.4% at 4 wks. 
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INTRODUCTION 
Cartilage is an avascular tissue and therefore has a limited intrinsic ability for 
repair following injury or osteoarthritis. Current treatments result in the formation 
of fibrocartilage, which is mechanically inferior to articular cartilage.14 Due to the 
limitations of current therapies, tissue engineering has emerged as a promising 
approach for treating cartilage degeneration, as a result of injury or osteoarthritis. 
Scaffoldless approaches for tissue engineering articular cartilage36"38'195 bypass 
several of the problems associated with scaffold use including stress shielding, 
biocompatibility, and biodegradation. In particular, the self-assembling process 
has allowed for significant increases in construct biochemical and biomechanical 
properties; however, these properties are still lacking in comparison to adult 
native tissue.140 Therefore, the use of mechanical stimulation modalities such as 
hydrostatic pressure (HP) appears to be a promising approach for enhancing the 
biomechanical and biochemical properties of engineered constructs. 
Articular cartilage is exposed to hydrostatic pressure in vivo, and efforts to 
stimulate chondrocytes with HP have focused on the physiological range of 3-18 
M p a 11, 121, 122, 129, 130, 132, 133, 135, 139, 196 | t j s b e | i e v e d t h a t t h e r e arQ significant 
differences in the effects of static and intermittent HP. For example, several 
studies on human articular chondrocytes in monolayer have demonstrated that 
intermittent HP at 10 MPa, 1 Hz, results in increased aggrecan and collagen II 
mRNA,128"130 while static HP was shown to have no effects on mRNA levels.128 
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In contrast, in other work using explants or immature chondrocytes in 3-D culture, 
the beneficial effects of static HP have been demonstrated. Hall et al.102 
demonstrated enhanced GAG production with static pressures in the 
physiological range, while both Hall et al.102 and Lammi et al.107 observed either 
no benefit or detrimental effects with pressures above the physiological range. In 
tissue engineered constructs with immature bovine chondrocytes, Toyoda et 
a l 137,138 anc| M j z u n o e t a|.136 have also observed beneficial effects of static HP 
on GAG synthesis, aggrecan mRNA, and collagen type II mRNA. Finally, a 
recent study by our group compared the effects of 1, 5, and 10 MPa under static, 
0.1 Hz, and 1 Hz conditions, and found that 10 MPa static HP significantly 
increased construct compressive and tensile properties, while 10 MPa, 1 Hz 
treatment only resulted in a significant increase in compressive properties.139 
Based on these results, 10 MPa static HP was selected for this study. 
Additionally, our own prior work has suggested 10-14 days to be a potentially 
suitable timeframe to apply mechanical stimulation,140 while previous work by 
Ikenoue et al.130 demonstrated that 4 days of HP application had a greater effect 
on aggrecan and collagen II mRNA than 1 day of HP application. Based on the 
results of these studies, a comparison among HP application times of 6-10, 10-
14, and 14-18 days was made in this study. 
Although several studies have been performed to assess the effects of HP on 
tissue engineered constructs, no studies have determined the optimal timepoint 
in construct development for the application of HP. Additionally, studies 
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assessing the immediate and delayed effects of HP on construct biomechanical 
properties are lacking. Therefore, the objective of this study was to determine 
when in construct development the biomechanical and biochemical properties 
were maximally sensitive to HP application. Furthermore, this study sought to 
examine the effects of HP on construct biochemical and biomechanical 
properties immediately after HP application, as wellas up to 6 wks following HP 
application, in order to determine how long the beneficial effects of HP would last 
after removal of the stimulus. First, it was hypothesized that the bagging process 
used in applying HP would have no effect on construct properties. As prior 
studies involving mechanical stimulation demonstrated the benefit of application 
from 10-14 days, it was likewise hypothesized that HP would have an optimal 
application timepoint in construct development for the enhancement of construct 
biomechanical and biochemical properties. Finally, due to the slower turnover of 
collagen remodeling relative to GAG in the ECM, it was hypothesized that 
construct compressive properties would be increased immediately following HP 
application, while there would be a delayed increase in tensile properties. To test 
these hypotheses, three experiments were performed. First, 10 MPa static HP 
was applied to self-assembled constructs and compared to two different control 
groups. Second, 10 MPa static HP was applied to the constructs at three 
different times in construct development. Finally, the effects of HP application 
were assessed immediately at 2 wks, as well as at later timepoints of 4 wks and 
8 wks. 
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MATERIALS AND METHODS 
Chondrocyte Isolation and Seeding 
Cartilage was obtained from the distal femur of wk-old male calves93, 118, 181 
(Research 87, Boston, MA) less than 36 hrs after slaughter, and was digested 
with collagenase type 2 (Worthington, Lakewood, NJ) to yield chondrocytes. To 
reduce variability among animals, each leg was obtained from a different animal, 
and cells from all legs were combined together to create a mixture of 
chondrocytes; a mixture of cells from at least 4 legs was used in each study. Cell 
number was assessed on a hemocytometer, and viability remained >90%, as 
determined by a trypan blue exclusion test. Chondrocytes were frozen in culture 
medium supplemented with 20% FBS (Bidwhittaker, Walkersville, MD) and 10% 
DMSO at -80°C for 1-2 wks before use. Following thawing, viability remained 
greater than 85% in each study. A polysulfone mold consisting of 5 mm dia. x 10 
mm long cylindrical prongs fit into 6 wells of a 48-well plate, and to construct 
each agarose well, sterile, molten 2% agarose was added to wells fitted with the 
polysulfone die. The agarose was allowed to gel at room temperature for 60 min, 
after which the mold was separated from the agarose. Culture medium was 
exchanged twice to completely saturate the agarose well with culture medium by 
the time of cell seeding. The medium was DMEM with 4.5 g/L-glucose and L-
glutamine (Biowhittaker), 100 nM dexamethasone (Sigma, St. Louis, MO), 1% 
Fungizone/Penicillin/Streptomycin (Biowhittaker), 1% ITS+ (BD Scientific, 
Franklin Lakes, NJ), 50 )ig/mL ascorbate-2-phosphate, 40 u,g/mL L-prbline, and 
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100 [ig/mL sodium pyruvate (Fisher Scientific, Pittsburgh, PA). To each well, 5.5 
x 106 cells were added in 125 JLLI of culture medium. The cells self-assembled 
within 24 hrs in the agarose wells and were maintained in the same well for a 
specified amount of time; t=0 was defined as 24 hrs after seeding. 
Preparation for Specimen Pressurization 
Both bagged control (BC) and HP constructs were loaded into heat sealable 
bags (Kapak/Ampak Flexibles, Cincinnati, OH) previously sterilized by ethylene 
oxide. To each bag, 40 ml medium was added, and any air bubbles adhering to 
the bottom of the bag were released. The bags were then heat-sealed without 
any bubbles inside. 
Specimen Pressurization 
BC specimens were placed into an opened pressure chamber maintained at 
37°C, while pressure specimens were placed into a pressure chamber (Parr 
Instrument, Moline, IL), filled with water, and sealed underwater without any 
bubbles inside. The pressure chamber used has been described previously.135 
Briefly, for 5 consecutive days, the specimens were pressurized to 10 MPa static 
HP for 1 h. After the execution of the desired regimen, the pressure chamber 
was disassembled, and the pouches were sterilized with 70% ethanol. In a 
sterile culture hood, the pouches were opened with autoclaved scissors and the 
samples were returned to agarose coated wells of 6-well culture plates. 
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Phase I: Selection of HP Control 
At 10 days, self-assembled constructs (n=6/group) were removed from 
confinement in 5 mm dia. agarose wells and exposed to 10 MPa static HP for 1 
h/day, for 5 days. The constructs were then placed in one well of a 6-well culture 
plate coated with 2% agarose for the remainder of the study. A bagged control 
consisted of constructs removed from confinement in 5 mm dia. agarose wells at 
10 days, and placed in the HP chamber for 1 h/day, for 5 days, but 
unpressurized. The constructs were then placed in one well of a 6-well culture 
plate coated with 2% agarose for the remainder of the study. A culture control 
(CC) consisted of constructs removed from confinement in 5 mm dia. agarose 
wells at 10 days, and cultured in one well of a 6-well culture plate coated with 2% 
agarose for the remainder of the study. 500 nl of medium per construct was 
changed daily, and all constructs were assessed at 4 wks. 
Phase II: Temporal Effects of HP Application 
At 6 days, 10 days, or 14 days, self-assembled constructs (n=6/group) were 
removed from confinement in 5 mm dia. agarose wells, and placed in one well of 
a 6-well culture plate coated with 2% agarose. The constructs unconfined at 6 
days were exposed to 10 MPa static HP, 1 h/day, from 6-10 days, and were 
cultured unconfined in the 6-well plate for the remainder of the study. The 6-day 
culture control group (CC 6) remained unconfined in culture from 6 days until the 
conclusion of the study. The constructs unconfined at 10 days were exposed to 
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10 MPa static HP, 1 h/day, from 10-14 days, and were cultured unconfined in the 
6-well plate for the remainder of the study. The 10-day culture control group (CC 
10) remained unconfined in culture from 10 days until the conclusion of the study. 
The constructs unconfined at 14 days were exposed to 10 MPa static HP, 1 
h/day, from 14-18 days, and were cultured unconfined for the remainder of the 
study. The 14-day culture control group (CC 14) remained unconfined in culture 
from 14 days until the conclusion of the study. 500 nl of medium per construct 
was changed daily, and all constructs were assessed at 4 wks. 
Phase III: Short-term and Long-term Effects of HP Application. 
At 10 days, constructs were removed from confinement, and 10 MPa static HP 
was applied for 1 h/day, from 10-14 days. A CC was treated as in phase I. Both 
HP and CC constructs (n=6/group) were assessed at 2 wks, 4 wks, and 8 wks. 
Histology and Immunohistochemistry 
Samples were frozen and sectioned at 14 |im. GAG distribution was examined 
with a safranin-O/fast green stain.182,183 To examine collagen content, picrosirius 
red was used. Slides were also processed with IHC to test for the presence of 
collagen types I and II on a Biogenex (San Ramon, CA) i6000 autostainer. 
Following fixation in chilled acetone, the slides were washed with IHC buffer 
(Biogenex), quenched of peroxidase activity with hydrogen peroxide/methanol, 
and blocked with horse serum (Vectastain ABC kit, Vector Laboratories, 
Burlingame, CA). The slides were then incubated with either mouse anti-
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collagen type I (Accurate Chemicals, Westbury, NY) or rabbit anti-collagen type II 
(Cedarlane Labs, Burlington, NC) antibodies, Secondary antibody (anti-mouse 
or anti-rabbit IgG, Vectastain ABC kit) was applied, and color was developed 
using the Vectastain ABC reagent and DAB (Vectastain kit). 
Quantitative Biochemistry 
Samples were frozen overnight and lyophilized for 72 hrs, followed by re-
suspension in 0.8 mL of 0.05 M acetic acid with 0.5 M NaCI and 0.1 mL of a 10 
mg/mL pepsin solution (Sigma) at 4°C for 72 hrs. Next, 0.1 mL of 10x TBS was 
added along with 0.1 mL pancreatic elastase and mixed at 4°C overnight. From 
this digest, total DNA content was measured by Picogreen® Cell Proliferation 
Assay Kit (Molecular Probes, Eugene, OR). Total sulfated GAG was then 
quantified using the Blyscan Glycosaminoglycan Assay kit (Biocolor), based on 
1,9-dimethylmethylene blue binding.184,185 After being hydrolyzed by 2 N NaOH 
for 20 min at 110°C, samples were assayed for total collagen content by a 
chloramine-T hydroxyproline assay.186 
Indentation Testing 
Samples were evaluated with an automated indentation apparatus.187 A step 
mass of 0.7 g (0.007 N) was applied with a 1 mm flat-ended, porous indenter tip, 
and specimens were allowed to creep until equilibrium, as described 
elsewhere.36 Preliminary estimations of the aggregate modulus of the samples 
were obtained using the analytical solution for the axisymmetric Boussinesq 
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problem with Papkovich potential functions.188, 189 The intrinsic mechanical 
properties of the samples, including aggregate modulus, Poisson's ratio, and 
permeability were then determined using the linear biphasic theory.3 
Tensile Testing 
Tensile tests were performed using a uniaxial materials testing system (Instron 
Model 5565, Canton, MA) with a 50 N load cell as described previously.197 
Briefly, samples were cut into a dog-bone shape with a 1-mm-long gauge length. 
Samples were attached to paper tabs for gripping with cyanoacrylate glue 
outside of the gauge length. The 1-mm-long sections were pulled at a constant 
strain rate of 0.01 s'1. All samples broke within the gauge length. Stress-strain 
curves were created from the load-displacement curve and the cross-sectional 
area of each sample, and Young's modulus was calculated from each stress-
strain curve. 
Statistical Analysis 
All samples were assessed biochemically and biomechanically (n=6). For phase 
I, a single factor ANOVA was used to analyze the samples, and a Fisher LSD 
post hoc test was used when warranted. For phase II, a two-factor ANOVA was 
used to analyze the samples, and a Fisher LSD post hoc test was used when 
warranted. For phase III, a student's t test was used to compare the two groups 
at each timepoint. Significance was defined as p < 0.05. 
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RESULTS 
Gross Appearance and Histology 
In all studies, the construct diameter slightly exceeded 6 mm at 4 wks (Fig. 11a). 
In phase I, there were no differences in thickness among the HP, BC, and CC 
groups, with values of 0.46±0.06, 0.41 ±0.03, and 0.43±0.06 mm respectively 
(Fig. 11b). In phase II, there were no differences in thickness among the 
different groups, with values of 0.5110.03 and 0.50±0.07 mm for the HP 6-10 and 
CC 6 groups, 0.52±0.06 and 0.4810.07 mm for the HP 10-14 and CC 10 groups, 
and 0.5410.06 and 0.5110.09 mm for the HP 14-18 and CC 14 groups, 
respectively. In phase III, there were no differences in thickness among the 
groups, with values of 0.4210.03 and 0.4110.02 at 2 wks, 0.7010.07 and 
0.6710.05 at .4 wks, and 0.9310.14 and 0.8510.16 mm at 8 wks for the CC and 
HP groups, respectively. 
In each phase, all constructs stained positive for collagen throughout their 
thickness (Fig. 11c). Based on Safranin-0 staining, GAG production was 
observed throughout the constructs (Fig. 11d). Based on IHC, collagen II was 
expressed throughout each construct (Fig. 11e), while there was no collagen I 
production (Fig. 11f). 
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Quantitative Biochemistry 
In phase I, there were no differences in WW/construct or DNA/construct among 
the different treatment groups. The HP, BC, and CC groups had WW/construct 
values of 11.6±1.9, 12.2±0.6, and 12.011.9 mg, and DNA/construct values of 
39.9+8.9, 41.0111.0, and 36.9111.4 ng, respectively. The HP group had a 
significantly higher GAG/WW than either the BC or CC groups, with values of 
6.111.4, 4.410.5, and 4.1+0.1%, respectively (Fig. 12c). The HP treated group 
had a significantly higher collagen/WW than either the BC or CC groups, with 
values of 10.612.4, 6.211.9 and 6.710.6%, respectively (Fig. 12d). 
In phase II, there were no differences in WW/construct or DNA/construct among 
the different treatment groups. The WW/construct values were 10.711.3 and 
12.211.5 mg for the HP 6-10 and CC 6 groups, 11.111.2 and 11.011.5 mg for the 
HP 10-14 and CC 10 groups, and 11.911.7 and 11.011.6 mg for the HP 14-18 
and CC 14 groups, respectively. The DNA/construct values were 34.317.5 and 
32.311.4 ng for the HP 6-10 and CC 6 groups, 43.618.6 and 32.717.6 ng for the 
HP 10-14 and CC 10 groups, and 44.6110.5 and 43.6114.2 ng for the HP 14-18 
and CC 14 groups, respectively. HP was a significant factor for GAG/WW and 
collagen/WW. HP application from 6-10, 10-14, and 14-18 days increased 
GAG/WW from 3.911.4 to 4.510.4%, 3.510.9 to 4.810.6%, and 4.310.7 to 
5.110.8%, respectively (Fig. 13c). HP application from 6-10, 10-14, and 14-18 
days increased collagen/WW from 7.4H.7 to 10.411.7%, 8.010.9 to 10.811.2%, 
and 8.511.1 to 9.411.5%, respectively (Fig. 13d). 
99 
In phase III, the WW/construct values were 10.011.2 and 7.7±0.3 mg at 2 wks, 
17.111.7 and 14.412.2 mg at 4 wks, and 28.515.6 and 27.713.9 mg at 8 wks for 
the CC and HP groups, respectively. There were no differences in cellularity at 
each time point with DNA/construct values of 35.714.7 and 34.013.8 |ig at 2 wks, 
37.117.3 and 34.312.0 ng at 4 wks, and 33.513.3 and 30.213.0 HQ at 8 wks for 
the CC and HP groups, respectively. HP significantly increased GAG/WW from 
4.410.9 to 5.711.3% at 2 wks, and from 6.210.3 to 8.110.4% at 4 wks. The 
GAG/WW was 7.810.6 and 8.510.7% for the CC and HP groups at 8 wks (Fig. 
14c). HP significantly increased collagen/WW from 7.412.5 to 12.210.3% at 2 
wks, and from 7.111.8 to 10.811.9% at 4 wks. The collagen/WW was 8.611.6 
and 7.411.5% for the CC and HP groups at 8 wks (Fig. 14d). 
Mechanical Evaluation 
In phase I, the HP treated group had a significantly higher aggregate modulus 
than the BC or CC groups, with values of 2731123, 134145, and 116119 kPa, 
respectively (Fig. 12a). There were no differences among the groups in 
Poisson's ratio or permeability, with ranges of 0.14-0.19 and 3.94x10"14-9.78x10" 
14
, respectively. Additionally, the HP treated group had a significantly higher 
Young's modulus than the BC Or CC groups, with values of 1.610.4,1.010.3, and 
0.910.1 MPa, respectively (Fig. 12b). 
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In phase II, HP was a significant factor for aggregate modulus and Young's 
modulus. HP application from 10-14 days led to a significant increase in 
aggregate modulus from 101 ±32 to 238±131 kPa. HP application from 6-10 
days increased aggregate modulus from 97±24 to 159±52 kPa, and HP 
application from 14-18 days decreased aggregate modulus slightly from 195±64 
to 177±68 kPa (Fig. 13a). HP application did not significantly change Poisson's 
ratio from control for any group, with a range of 0.04-0.22. Additionally, there 
were no differences in permeability among the groups, with a range of 2.83x10" 
15
-2.04x10"13. HP application from 6-10, 10-14, and 14-18 days increased 
Young's modulus from 0.9±0.1 to 1.3±0.1 MPa, 0.9±0.2 to 1.4±0.3 MPa, and 
0.8±0.2 to 1.3±0.2 MPa, respectively (Fig. 13b). 
In phase III, HP significantly increased aggregate modulus from 113±16 to 
158±28 kPa at 2 wks, and from 138±30 to 270±46 kPa at 4 wks. There was no 
difference at 8 wks, with values of 257±51 and 296±68 kPa for the CC and HP 
groups, respectively (Fig. 14a). There were no differences among the groups in 
Poisson's ratio or permeability, with ranges of 0.18-0.26 and 2.26x10"14-6.78x10" 
14
. There was no difference in Young's modulus at 2 wks, with values of 
373±182 and 4761228 kPa for the CC and HP groups, respectively. HP 
significantly increased Young's modulus from 596±185 to 1144±281 kPa at 4 
wks, and from 912±131 to 1404±442 kPa at 8 wks (Fig. 14d). 
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DISCUSSION 
This study utilized a 3-phase approach to choose an appropriate control group 
for HP application, to determine the effects of temporal HP application, and to 
assess the temporal effects following HP application. To the best of our 
knowledge, this study is the first to assess the effects of HP application at 
different timepoints in construct development, and the first to examine short-term 
and long-term changes in construct properties following HP application. 
In phase I, HP application significantly increased construct biomechanical and 
biochemical properties relative to both control groups, and the bagging process 
had no effect on construct properties. The application of 10 MPa static HP for 1 
hr/day, from days 10-14 led to a 120% increase in aggregate modulus and a 60% 
increase in Young's modulus, accompanied by significant increases in GAG and 
collagen content, respectively. Additionally, there were no differences in 
biomechanical, biochemical, histological, or gross morphological properties 
between the BC and CC groups. These results support our hypotheses, as HP 
application led to a significant increase in both compressive and tensile 
properties, and the bagging process inherent to HP application was shown to 
have no effect on construct biomechanical and biochemical properties. A 
comparison between the BC and CC groups was necessary to determine the 
effects of the bagging and handling process requisite for HP stimulation. In our 
setup, it is impossible to apply HP under sterile conditions without handling and 
bagging the constructs. As the handling and bagging is inherent to HP 
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application, we consider HP application to include these inherent steps. 
Therefore, the CC group was selected for use in subsequent phases as it allows 
us to compare HP application in its entirety (including the handling and bagging 
process) to a control. 
In phase II, it was determined that 10-14 days was the optimal time in construct 
development for HP application. HP application at all timepoints led to similar 
increases in tensile properties; however, HP application from 10-14 days had the 
greatest effect on aggregate modulus, a 140% increase. These results support 
our hypothesis, as HP application at a certain timepoint in construct development 
had the most beneficial effect on construct biomechanical properties. A 40% 
increase in GAG/WW accompanied the increased aggregate modulus of the 10-
14 day HP group. On the other hand, HP application at all timepoints led to an 
approximately 0.5-fold increase in Young's modulus, accompanied by increases 
in collagen/WW. These results are interesting as they suggest that there may be 
different mechanisms for the effects of HP on compressive and tensile 
properties. Additionally, these results correlate with a prior study on self-
assembled constructs that suggested that 10-14 days of construct development 
may be an important window for mechanical intervention.140 
In phase III, HP application had immediate and delayed effects on construct 
properties. Application of static HP at 10 MPa for 1 hr/day significantly increased 
compressive properties, GAG/WW, and collagen/WW immediately after the 5 
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days of HP application at 2 wks, but the significant increase in tensile properties 
observed in the prior phases was delayed until 4 wks. These results support our 
hypotheses, as the aggregate modulus was enhanced immediately after 10-14 
days of HP application, while there was a delayed increase in tensile properties. 
This result was expected due to the slower turnover of collagen remodeling 
relative to GAG in the ECM. Since collagen content was quantified with a 
hydroxyproline assay, it is also possible that the measured collagen at 2 wks was 
pro-collagen or immature collagen, which was not fully cross-linked or organized 
in the ECM until the next measurement at 4 wks. Additionally, by 8 wks, 
construct biomechanical and biochemical properties appear to level off, although 
a significant difference in tensile stiffness remains, likely as a result of the initial 
matrix formation present at the 4 wk timepoint. 
The results of these studies correlate with those of previous studies involving the 
use of static HP in physiologic magnitude ranges. For instance, Mizuno et al.136 
found that the application of 2.8 MPa static HP to 3-D collagen sponges seeded 
with bovine articular chondrocytes led to a 3.1-fold increase in [(35)S]-sulfate 
incorporation in GAG. Additionally, Smith et al.128 observed a 32% increase in 
GAG synthesis with 10 MPa static HP application to high density cultures of adult 
bovine articular chondrocytes. Likewise, Toyoda et al.138 found that 5 MPa static 
HP, applied to bovine articular chondrocytes cultured in agarose gels, 
significantly increased GAG synthesis and increased levels of aggrecan mRNA 
4-fold, while in a separate study, a 50% increase in the level of type II collagen 
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mRNA was recorded with this same regimen.137 These results mirror the 
biochemical findings of the currently presented studies, as significant increases 
in both collagen content and GAG content were observed, that presumably led to 
significant increases in both compressive and tensile biomechanical properties. 
Since HP application does not lead to cartilage deformation,162 it is difficult to 
envisage a mechanism to explain the beneficial effects of HP on construct 
biomechanical properties. However, as reviewed elsewhere,169 HP can deform 
the void spaces of cell transmembrane proteins, and at a certain pressure, the 
void space deformation leads to a change in protein conformation. This 
conformation change likely occurs in cell surface ion channels that act as 
"pressure sensors," theoretically occurring over the pressures at which we see 
effects. For example, in chondrocytes, the Na/K pump and Na/K/2CI transporter 
were shown to be sensitive to 10 MPa static HP application.165 Additionally, the 
Na/H pump166 and stretch-activated calcium channels167 in articular chondrocytes 
are affected by HP application. As ion concentration changes have been shown 
to alter protein synthesis,170 different ion channel responses to HP likely stimulate 
signal transduction cascades that eventually lead to upregulation of ECM-specific 
genes. The increased gene expression likely leads to increased ECM protein 
production, eventually resulting in enhanced biomechanical properties as 
observed in this study. Alternatively, although water has a high bulk modulus, it 
is not incompressible. Therefore, it is possible that 10 MPa HP results in 
stimulation of additional mechanotransduction pathways as a result of the 
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compressibility of water, as this may result in small strains on the cells without a 
measurable construct deformation. 
Although several studies have examined the effects of various HP regimens on 
construct gene expression and protein production, to our knowledge, this is the 
first study to assess the effects of temporal HP application, as well as the first to 
examine the immediate and long-term effects of HP on construct biomechanical 
and biochemical properties. Future studies should determine if combining HP 
with other mechanical stimulation, such as direct compression or shear, leads to 
additive or synergistic effects. 
106 
Chapter 5: Systematic Assessment of Growth 
Factor Treatment on Biochemical and 
Biomechanical Properties of Engineered Articular 
Cartilage Constructs 
Benjamin D. Elder and Kyriacos A. Athanasiou 
Chapter accepted as: Elder, BD and Athanasiou, KA. Systematic Assessment of 
Growth Factor Treatment on Biochemical and Biomechanical Properties of 
Engineered Articular Cartilage Constructs. Osteoarthritis and Cartilage. 2008 
107 
ABSTRACT 
The objective of this study was to determine the effects of bone morphogenetic 
protein-2 (BMP-2), insulin-like growth factor (IGF-I), and transforming growth 
factor-pi (TGF-pi) on the biochemical and biomechanical properties of 
engineered articular cartilage constructs under serum free conditions. A 
scaffoldless approach for tissue engineering, the self-assembly process, was 
employed. The study consisted of two phases. In the first phase, the effects of 
BMP-2, IGF-I, and TGF-pi, at two concentrations and two dosage frequencies 
each were assessed on construct biochemical and biomechanical properties. In 
phase II, the effects of growth factor combination treatments were determined. 
Compressive and tensile mechanical properties, glycosaminoglycan (GAG) and 
collagen content, histology for GAG and collagen, and immunohistochemistry 
(IHC) for collagen types I and II were assessed. In phase I, BMP-2 and IGF-I 
treatment resulted in significant, >1 -fold increases in aggregate modulus, 
accompanied by increases in GAG production. Additionally, TGF-pi treatment 
resulted in significant, ~1-fold increases in both aggregate modulus and tensile 
modulus, with corresponding increases in GAG and collagen content. In phase 
II, combined treatment with BMP-2 and IGF-I increased aggregate modulus and 
GAG content further than either growth factor alone, while TGF-pi treatment 
alone remained the only treatment to also enhance tensile properties and 
collagen content. This study determined systematically the effects of multiple 
growth factor treatments under serum-free conditions, and is the first to 
demonstrate significant increases in both compressive and tensile biomechanical 
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properties as a result of growth factor treatment. These findings are exciting as 
coupling growth factor application with the self-assembly process resulted in 
tissue engineered constructs with functional properties approaching native 
cartilage values. 
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INTRODUCTION 
Articular cartilage has a limited ability for self-repair, and injuries to articular 
cartilage result in the formation of mechanically inferior fibrocartilage.14 Since 
current clinical treatments are limited, tissue engineering is a promising strategy 
for articular cartilage regeneration. 
To alleviate some of the potential issues associated with scaffold use, our lab 
has developed and employed a scaffoldless process for tissue engineering, 
called the self-assembly process.36, 135,140 Using this process, the goal is to 
create engineered constructs with biochemical and biomechanical properties 
approaching those of native tissue. Growth factor application appears to be a 
promising approach for enhancing these properties. 
Previous studies74' 198 systematically assessed the effects of several growth 
factors at different concentrations on chondrocyte-seeded PGA scaffolds, and 
indicated that treatment with BMP-2 and IGF-I enhanced GAG production, while 
TGF-p1 enhanced collagen production. However, these studies employed fetal 
bovine serum (FBS) in the medium, potentially confounding the effects of 
exogenous growth factor application. Also, a prior study by Ng et al.199 indicated 
beneficial effects from temporal application of IGF-I and TGF-(31. 
Although many studies have demonstrated beneficial effects of growth factor 
application, no studies have systematically assessed the effects of growth factors 
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alone and in combination under serum-free conditions. Furthermore, no studies 
have examined growth factor effects on both compressive and tensile properties. 
The objective of this study was to determine the effects of growth factor 
application on the biomechanical and biochemical properties of self-assembled 
articular cartilage constructs. This study utilized a 2-phase approach to 
determine the effects of single growth factor treatments followed by the 
determination of the effects of combined growth factor treatments. Based on the 
results of prior studies,74,80,150,198'200 in phase I, it was hypothesized that BMP-2 
and IGF-I treatment would enhance compressive properties by increasing GAG 
production, and TGF-01 treatment would enhance both compressive and tensile 
properties by increasing GAG production and collagen production respectively. It 
was further hypothesized that growth factor concentration and dosage frequency 
would have significant effects on construct biochemical and biomechanical 
properties, based on prior work.201' 202 In phase II, it was hypothesized that 
combined growth factor treatment would have beneficial effects on construct 
properties, by increasing biochemical and biomechanical properties further than 
any growth factor alone. To test these hypotheses, three experiments were 
performed in phase I and one experiment was performed in phase II. In phase I, 
BMP-2, IGF-I, and TGF-p1 were all assessed at two concentrations and two 
dosage frequencies each, with the best treatment for each growth factor selected 
for use in phase II. In phase II, the growth factor treatments selected from phase 
I were assessed in combinations of two and three. 
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METHODS 
Chondrocyte Isolation and Seeding 
Chondrocytes were obtained from the distal femur of wk-old male calves93'118,181 
(Research 87, Boston, MA), and digested with collagenase type 2 (Worthington, 
Lakewood, NJ). Each leg yielded roughly 150 million chondrocytes, and animal 
variability was reduced by pooling cells from five legs of different animals to yield 
a mixture of chondrocytes for each study (see descriptions below). The pooled 
cells were counted on a hemocytometer, and viability >90% was found using a 
trypan blue exclusion test. Chondrocytes were frozen in culture medium 
supplemented with 20% FBS (Biowhittaker) and 10% DMSO at -80°C for 3 days 
before use in phase I, and for 3 wks before use in phase II. After thawing, viability 
remained greater than 85%. A polysulfone die consisting of 5 mm dia. x 10 mm 
long cylindrical prongs was used to construct each agarose mold. Sterile, molten 
2% agarose was introduced into a well fitted with the polysulfone die. The 
agarose was allowed to gel at room temperature for 60 min, and two exchanges 
of culture medium were used to completely saturate the agarose well with culture 
medium by the time of cell seeding. To each well, 5.5 x 106 cells in 100 |il of 
culture medium were added. The cells self-assembled within 24 hrs in the 
agarose wells and were maintained in the same well for t=10 days; t=0 was 
defined as 24 hrs after seeding. The culture medium was DMEM with 4.5 g/L-
glucose and L-glutamine (Biowhittaker/Cambrex, Walkersville, MD), 100 nM 
dexamethasone (Sigma, St. Louis, MO), 1% Fungizone/Penicillin/Streptomycin 
(Biowhittaker), 1% ITS+ (BD Scientific, Franklin Lakes, NJ), 50 ng/mL ascorbate-
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2-phosphate, 40 u.g/mL L-proline, and 100 jig/mL sodium pyruvate (Fisher 
Scientific, Pittsburgh, PA). 
Phase I: Individual Growth Factor Effects 
This phase included three separate studies to assess the individual effects of 
BMP-2, IGF-I and TGF-01 at different concentrations and dosage frequencies. 
All growth factors were obtained from Peprotech Inc. (Rocky Hill, NJ), and were 
applied in the culture medium. For each growth factor, the effects of two 
concentrations (low and high) and two dosage frequencies were assessed, with 
separate no growth factor controls for each study, yielding a total of five 
treatment groups for each growth factor study (Fig. 15). The concentrations used 
were 10 and 100 ng/ml for BMP-2 and IGF-I, and 10 and 30 ng/ml for TGF-01, 
selected from prior studies.74'198 The dosage regimens were 2 wks continuous 
application followed by 2 wks of no growth factor (continuous), or growth factor 
application only during the 1st and 3rd wk of culture (wk rotation), which were 
chosen based on pilot studies and current ongoing work in our group as well as 
adapted from prior studies using intermittent growth factor application by Lieb et 
a l 201,202 
For all studies, at t=lO days, self-assembled constructs (n=6/group) were 
removed from confinement in 5 mm dia. agarose wells and transferred to 
individual 2% agarose coated wells of a 48-well culture plate for the remainder of 
the study. Per construct, 500 i^l of medium was changed daily, and all constructs 
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were assessed at t=4 wks. The "best" treatment for each growth factor was 
selected, using a functionality index as described below, for use in phase II. 
Phase II: Growth Factor Combination Effects 
One treatment for each growth factor was selected from phase I to be compared 
individually, as well as in combinations of two and three in phase II (Fig. 15). The 
specific application treatments selected were 10 ng/ml continuous BMP-2, 10 
ng/ml wk rotation IGF-I, and 30 ng/ml continuous TGF-01. As in phase I, 
constructs were unconfined from agarose wells at t=10 days, and transferred to 
individual 2% agarose coated wells of a 48-well culture plate for the remainder of 
the study. Again, 500 nl of medium per construct was changed daily, and all 
constructs were assessed at t=4 wks. 
Histology and Immunohistochemistry 
Samples were frozen and sectioned at 14 jxm. Safranin-0 and fast green 
staining were used to examine GAG distribution.182,183 Picrosirius red was used 
for qualitative examination of collagen content. A von Kossa stain was used to 
assess for mineralization. Slides were also processed with IHC to test for the 
presence of collagen types I, II, and X. After fixing in chilled acetone, the slides 
were rinsed with IHC buffer (Biogenex), quenched of peroxidase activity with 
hydrogen peroxide/methanol, and blocked with horse serum (Vectastain ABC kit, 
Vector Laboratories, Burlingame, CA). The slides were then incubated with 
either mouse anti-collagen type I (Accurate Chemicals, Westbury, NY), rabbit 
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anti-collagen type II (Cedarlane Labs, Burlington, NC), or rabbit anti-collagen X 
(Abeam Inc., Cambridge, MA) antibodies. The secondary antibody (anti-mouse 
or anti-rabbit IgG, Vectastain ABC kit) was applied, and color was developed 
using the Vectastain ABC reagent and DAB (Vectastain kit). 
Quantitative Biochemistry 
Samples were frozen overnight and lyophilized for 72 hrs, followed by re-
suspension in 0.8 ml_ of 0.05 M acetic acid with 0.5 M NaCI and 0.1 mL of a 10 
mg/mL pepsin solution (Sigma) at 4°C for 72 hrs. Next, 0.1 mL of 10x TBS was 
added along with 0.1 mL pancreatic elastase and mixed at 4°C overnight. From 
this digest, total DNA content was measured by Picogreen® Cell Proliferation 
Assay Kit (Molecular Probes, Eugene, OR). Total sulfated GAG was then 
quantified using the Blyscan Glycosaminoglycan Assay kit (Biocolor), based on 
1,9-dimethylmethylene blue binding.184,185 After being hydrolyzed by 2 N NaOH 
for 20 min at 110°C, samples were assayed for total collagen content by a 
chloramine-T hydroxyproline assay.186 
Indentation Testing 
Samples were evaluated with an indentation apparatus.187 A step mass of 0T7 g 
(0.007 N) was applied with a 1 mm flat-ended, porous indenter tip, and 
specimens were allowed to creep until equilibrium, as described elsewhere.36 
Preliminary estimations of the aggregate modulus of the samples were obtained 
using the analytical solution for the axisymmetric Boussinesq problem with 
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Papkovich potential functions.188,189 The aggregate modulus (HA), permeability, 
and Poisson's ratio of the samples were then determined using the linear 
biphasic theory.3 
Tensile Testing 
Tensile tests were performed using a uniaxial materials testing system (Instron 
Model 5565, Canton, MA) with a 50 N load cell as described previously.197 
Briefly, samples were cut into a dog-bone shape with a 1-mm-long gauge length. 
Samples were attached to paper tabs for gripping with cyanoacrylate glue 
outside of the gauge length. The 1-mm-long sections were pulled at a constant 
strain rate of 0.01 s"1. Stress-strain curves were created from the load-
displacement curve and the cross-sectional area of each sample, and Young's 
modulus (EY) was calculated from the linear region of each stress-strain curve. 
Functionality Index (Fl) 
A functionality index (Eq. 1) was used to determine the "best" treatment condition 
for each growth factor in phase I, for use in phase II. The index was only used as 
a selection tool within each experiment, without making comparisons among 
experiments. It was weighted using normalized collagen and GAG content, 
tensile stiffness, and creep indentation compressive stiffness. The index served 
as a quantified comparison between the properties of the engineered constructs 
and native tissue. In the functionality index, G represents GAG/WW, C 
represents collagen/WW, ET represents tensile modulus, and Ec represents 
116 
compressive stiffness (aggregate modulus). The subscripts nat and sac are 
used to denote native and self-assembled construct values, respectively. Using 
immature bovine cartilage explants, native tissue values were 5% and 15% for 
GAG/WW and collagen/WW respectively, and 213 kPa and 12.1 MPa for Ec and 
ET respectively. Although different weights may be afforded to each component 
of the Fl, they are equally weighted in this study. Since the eventual goal of our 
tissue engineering approach is in vivo construct implantation, as cartilage 
experiences both compressive and tensile loading in the joint, these properties 
are equally weighted. Furthermore, the biochemical characteristics are equally 
important as constructs with biochemical characteristics divergent from native 
tissue may present problems in construct integration with native tissue. 
However, due to the flexibility of the Fl, the exact weights can easily be modified 
based on the results of future studies. 
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Statistical Analysis 
All samples were assessed biochemically and biomechanically (n=6 or 7). In 
each phase, a single factor ANOVA was used to analyze the samples, and a 
Fisher LSD post hoc test was used when warranted. Significance was defined 
as p < 0.05. 
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RESULTS 
Gross Appearance and Histology 
Construct diameter was approximately 6 mm in all studies. In phase I, BMP-2 at 
all concentrations and dosages increased construct wet weight (WW) and 
thickness slightly, as demonstrated in Table I. IGF-I treatment led to a slightly 
decreased construct WW, with no differences in construct thickness, as shown in 
Table II. Finally, treatment with TGF-pi resulted in a concentration dependent 
decrease in construct WW and thickness, as indicated in Table III. In phase II, 
there were no differences in construct WW or thickness among any of the 
treatment groups (Table IV). In all studies, constructs stained positive for 
collagen and GAG throughout their thickness (Fig. 16), and based on IHC, 
collagen II was expressed throughout each construct, with no collagen I 
production. Similar images can be observed in our previous work.140 
Additionally, no constructs demonstrated mineralization and no chondrocyte 
hypertrophy was noted with BMP-2 treatment. 
Quantitative Biochemistry 
In phase I, there were no differences in cells/construct among the different 
treatment groups in the BMP-2 study (Table I). Treatment with 10 ng/ml 
continuous BMP-2 led to the greatest increase in GAG/WW, although all BMP-2 
treatments significantly increased GAG/WW (Fig. 17c). There were no 
differences in collagen/WW among any of the treatment groups (Fig. 17d). In the 
IGF-I study, there were no differences in cells/construct among any of the 
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treatment groups (Table II). All IGF-I treatments significantly increased 
GAG/WW, with the exception of 10 ng/ml continuous treatment (Fig. 18c). There 
were no differences in collagen/WW among any of the treatment groups (Fig. 
18d). In the TGF-pi study, 30 ng/ml treatment led to an approximately 14% 
increase in cells/construct (Table III). Additionally, 30 ng/ml TGF-pi, at either 
continuous or 2 wk rotation dosages, significantly increased both collagen/WW 
and GAG/WW (Figs. 19c and 19d). 
In phase II, there were no differences in cells/construct among any of the 
treatment groups (Table IV). All growth factor treatments significantly increased 
GAG/WW, although combined BMP-2 and IGF-I treatment led to the greatest 
increase in GAG/WW (Fig. 20c). However, both treatment with TGF-pi alone 
and combined application of all three growth factors significantly increased 
collagen/WW (Fig. 20d). 
Mechanical Evaluation 
In phase I, all BMP-2 treatments significantly increased aggregate modulus, 
although BMP-2 at 10 ng/ml continuous application led to the greatest increase 
(Fig. 16a). There were no differences in Poisson's ratio or permeability noted 
among the different groups, with ranges of 0.15-0.28 and 4.1x10"14-1.2x10"13, 
respectively. Furthermore, there were no differences in Young's modulus among 
any of the treatment groups in the BMP-2 study (Fig. 16b). In the IGF-I study, all 
IGF-I treatments except for 10 ng/ml continuous significantly increased 
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aggregate modulus, while application at 10 ng/ml wk rotation led to the greatest 
increase in aggregate modulus (Fig. 17a). There were no differences in 
Poisson's ratio or permeability noted among the different groups, with ranges of 
0.19-0.26 and 8.0x10"14-1.2x10"13, respectively. Additionally, there were no 
differences in Young's modulus among any of the treatment groups in the IGF-I 
study (Fig. 18b). In the TGF-p1 study, only 30 ng/ml continuous treatment 
significantly increased aggregate modulus (Fig. 19a). However, both TGF-pi 
treatments at 30 ng/ml exhibited a significant increase in Young's modulus (Fig. 
19b). There were no differences among the treatment groups for Poisson's ratio 
and permeability, with ranges of 0.09-0.22 and 2.3x10"14-7.2x10"14, respectively. 
In phase II, all three individual growth factor treatments significantly increased 
aggregate modulus (Fig. 20a), replicating the results of phase I. However, 
combined BMP-2 and IGF-I treatment led to the greatest enhancement of 
aggregate modulus. Only individual application of TGF-pi significantly increased 
Young's modulus (Fig. 20b). There were no differences in Poisson's ratio or 
permeability among the treatment groups, with ranges of 0.09-0.26 and 5.1x10" 
14
-1.3x10"13, respectively. 
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DISCUSSION 
The objective of this study was to assess systematically the effects of growth 
factors on the biochemical and biomechanical properties of self-assembled 
articular cartilage constructs. The study utilized a 2-phase approach to 
determine the effects of different growth factors, concentrations, and dosage 
frequencies, as well as to examine the effects of growth factor combination 
treatment. This approach allowed for a methodical growth factor examination 
under serum-free conditions. To the best of our knowledge, this study is the first 
to demonstrate significant increases in both compressive and tensile 
biomechanical properties as a result of growth factor treatment. 
In phase I, all BMP-2 treatments led to significant increases in construct 
compressive stiffness and GAG/WW. The greatest enhancement was observed 
with 2 wk continuous treatment at 10 ng/ml, resulting in a 104% increase in 
compressive stiffness. Despite the increased compressive properties, no 
increases in tensile properties or collagen/WW were noted for any of the 
treatment groups. These results supported our hypothesis that BMP-2 would 
only increase the compressive properties of the constructs by increasing the 
GAG/WW, as increased GAG production without changes in collagen synthesis 
has previously been observed with BMP-2 treatment.198,203 BMP-2 treatment of 
2 wk continuous dosage at 10 ng/ml was selected for use in phase II as it 
demonstrated the greatest increase in the functionality index. 
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Similarly, in phase I, all IGF-I treatments except for 10 ng/ml continuous 
application significantly increased construct compressive stiffness and GAG/WW. 
However, the greatest increase was observed with the wk rotation dosage at 10 
ng/ml, with a 122% increase in compressive stiffness. As with BMP-2 treatment, 
no increases in tensile properties or collagen/WW were observed for any of the 
treatment groups. These results supported our hypothesis that IGF-I would 
increase only the compressive properties of the constructs by increasing the 
GAG/WW, as previous studies demonstrated enhanced GAG production without 
changes in collagen synthesis from IGF-I treatment in both tissue engineered 
constructs and explants.74'204,205 IGF-I treatment of wk rotation dosage at 10 
ng/ml was selected for use in phase II as it demonstrated the greatest increase in 
the functionality index. 
Finally, in phase I, 30 ng/ml TGF-pi treatment, at either dosage frequency, 
significantly increased tensile stiffness and collagen/WW, as well as GAG/WW. 
However, only 30 ng/ml TGF-pi treatment at the 2 wk continuous dosage 
significantly increased compressive stiffness. These results demonstrate that 
the enhancement of compressive properties likely requires a lag period, as 
suggested previously,199 following TGF-pi treatment; both 30 ng/ml treatments 
increased GAG/WW, but only the 2 wk continuous application, with 2 wks 
between cessation of growth factor treatment and construct evaluation, 
demonstrated an increase in compressive stiffness. It is likely that the increased 
lag time is required to incorporate and organize the GAG and collagen into the 
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ECM.199 Based on these results, 2 wk continuous TGF-pi treatment at 30 ng/ml 
was selected for use in phase II as it demonstrated the greatest increase in the 
functionality index, and was the only treatment in phase I that increased both 
compressive and tensile properties. This result supported our hypothesis that 
TGF-pi treatment would increase both compressive and tensile properties by 
increasing both GAG and collagen content, respectively. Additionally this finding 
corresponds with previous work that has demonstrated that TGF-pi treatment 
increases collagen synthesis or gene expression,73' 74' 206, 207 while TGF-pi 
treatment only under serum free conditions increases proteoglycan synthesis.206 
In phase I, the different dosage frequencies had profound effects on the 
biochemical and biomechanical properties of the constructs. For example, 10 
ng/ml IGF-I applied at the 2 wk continuous dosage significantly increased 
compressive stiffness and GAG/WW, while 10 ng/ml IGF-I applied at the wk 
rotation dosage had no effect on compressive stiffness and GAG/WW. 
Additionally, as described above, only 30 ng/ml TGF-pi treatment at the 2 wk 
continuous dosage increased the compressive stiffness. A possible explanation 
is that different dosages may mimic temporal patterns of growth factor 
expression during wound healing208 as well as during chondrogenesis, as 
reviewed by Goldring et al.209 
TGF-p1 and the combination of BMP-2 and IGF-I were identified as the winners 
in terms of construct functionality in this study. These results were primarily 
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obtained in phase II, where BMP-2, IGF-I, and TGF-pi were applied at the 
selected conditions from phase I in combinations of one, two, or three. 
Combined BMP-2 and IGF-I treatment had beneficial effects, demonstrating the 
greatest increase in aggregate modulus (119%), accompanied by the greatest 
increase in GAG/WW (54%). However, as with the use of these growth factors 
individually, there was no difference in tensile properties or collagen/WW. As in 
phase I, only treatment with TGF-pi alone led to a significant increase in tensile 
properties and collagen/WW. There was a disparity in values obtained for the 
individual growth factor treatments between phases I and II, likely as a result of 
different donor tissue from which the cells were isolated. However, although the 
values for the properties of the control constructs vary between the phases, 
similar percent increases in properties are observed for the individual growth 
factors in each phase. 
It is also interesting to note that combining TGF-pi with either of the other growth 
factors did not have additive or synergistic effects, negating the increased 
compressive and tensile stiffness observed with TGF-pi treatment alone. This 
result agrees with prior work by Blunk et al.74 which noted that combined TGF-pi 
and IGF-I treatment decreased GAG and collagen fractions. Additionally, TGF-
pi has been shown to regulate the autocrine/paracrine axis of IGF-I,210 and it is 
likely that combined growth factor treatment may alter these intracellular 
pathways, potentially leading to the reduced effects observed in this study. Prior 
work by Suzuki et al.211 also supports our results, as it was demonstrated that 
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BMP-2 signal transduction was inhibited by application of TGF-pi. However, it is 
possible that there is a concentration-dependence of our results; for example, if 
TGF-pi was applied at much higher or lower concentrations than used in the 
manuscript, IGF-I and BMP-2 may have different responses than what was 
reported in this study. 
It is important to note that our results differ from several prior growth factors 
studies74,198 which have utilized culture medium containing FBS. This medium 
already contains growth factors, potentially confounding the effects of additional 
growth factor application. In this study, we utilized serum-free medium to control 
for any confounding from the presence of FBS in the medium and to enable us to 
look solely at the effects of the growth factor supplementation. The use of 
serum-free medium may explain some of the differences between our results and 
those of prior studies. Additionally, the self-assembly process may modulate 
some of the effects of growth factors differently. For example, Gooch et al.198 
found that treatment with BMP-2 at 100 ng/ml led to the presence of hypertrophic 
chondrocytes; however, we found no differences in chondrocyte morphology nor 
any other histological properties. Furthermore, it has previously been shown that 
growth factor application at higher concentrations significantly increases 
construct WW.74,198 We did not observe this WW increase, and in fact found that 
TGF-pi treatment actually decreased the construct WW. It is possible that these 
responses are due to the combined effects of FBS and supplemental growth 
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factors, and that the use of growth factors in serum-free conditions mitigates the 
hypertrophic response at the concentrations used in the present study. 
Although multiple studies have examined the effects of various growth factors on 
monolayer, explant, and engineered construct gene expression and biochemical 
properties, this study systematically assessed the effects of different growth 
factors, concentrations, dosages, and combinations, leading to construct 
biochemical and biomechanical properties in the range of native tissue values. 
Since most other investigations of engineered cartilage have not achieved the 
biochemical and biomechanical properties found in this study in only 4 wks, the 
results presented here likely are due to the combination of the self-assembling 
process, serum-free media, and the selected growth factor regimens. Only 
treatment with TGF-pi was found to enhance both the compressive and tensile 
properties of engineered constructs, while combined treatment with BMP-2 and 
IGF-I led to adjunctive enhancement of construct compressive stiffness and GAG 
content. As previous studies have demonstrated beneficial effects of combined 
growth factor treatment and direct compression,92,93 future studies should assess 
the effects of these growth factor treatments when combined with mechanical 
stimulation, such as hydrostatic pressure and direct compression. 
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ABSTRACT 
Hydrostatic pressure (HP) is a significant factor in the function of many tissues, 
including cartilage, knee meniscus, temporomandibular joint disc, intervertebral 
disc, bone, bladder, and vasculature. Though studies have been performed in 
assessing the role of HP in tissue biochemistry, to the best of our knowledge, no 
studies have demonstrated enhanced mechanical properties from HP application 
in any tissue. The objective of this study was to determine the effects of 
hydrostatic pressure (HP), with and without growth factors, on the biomechanical 
and biochemical properties of engineered articular cartilage constructs, using a 
two-phased approach. In phase I, a 3 x 3 full-factorial design of HP magnitude 
(1, 5, 10 MPa) and frequency (0, 0.1, 1 Hz) was used, and the best two 
treatments were selected for use in phase II. Static HP at 5 MPa and 10 MPa 
resulted in significant 95% and 96% increases, respectively, in aggregate 
modulus (HA), with corresponding increases in GAG content. These regimens 
also resulted in significant 101% and 92% increases in Young's modulus (EY), 
with corresponding increases in collagen content. Phase II employed a 3 x 3 full-
factorial design of HP (no HP, 5 MPa static, 10 MPa static) and growth factor 
application (no GF, BMP-2 + IGF-I, TGF-p1). The combination of 10 MPa static 
HP and TGF-pi treatment had an additive effect on both HA and Ey, as well as a 
synergistic effect on collagen content. This group demonstrated a 164% 
increase in HA, a 231% increase in EY, an 85% increase in GAG/wet weight 
(WW), and a 173% increase in collagen/WW, relative to control. To our 
knowledge, this is the first study to demonstrate increases in the biomechanical 
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properties of tissue from pure HP application, using a cartilage model. 
Furthermore, it is the only study to demonstrate additive or synergistic effects 
between HP and growth factors on tissue functional properties. These findings 
are exciting as coupling HP stimulation with growth factor application has allowed 
for the formation of tissue engineered constructs with biomechanical and 
biochemical properties spanning native tissue values. 
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INTRODUCTION 
Hydrostatic pressure plays an important role in the mechanoregulation of several 
tissues; including cartilage,102' 122' m 132' 135' 136' 138' 165 knee meniscus,212 
temporomandibular joint disc,178,213 intervertebral disc,213"215 bone,216 bladder,217 
and vasculature.218 In these studies, HP generally led to increased extracellular 
matrix (ECM) production. HP application appears particularly promising as a 
strategy in cartilage tissue engineering, as cartilage degeneration remains a 
tremendous problem.1 Following injury, cartilage has a poor ability to self-repair 
due to its avascularity, and current clinical treatments for articular cartilage 
injuries result in the formation of mechanically inferior fibrocartilage.14 Therefore, 
cartilage regeneration with tissue engineering strategies appears to be a 
promising approach. A scaffoldless approach to tissue engineering, the self-
assembly process, has been developed and utilized by our group to produce 
engineered constructs with biochemical and biomechanical properties 
approaching native tissue values.36,135,140 
Cartilage is typically exposed to pressures in the physiologic range of 3-18 
MPa,11, 121,196 and tissue engineering efforts have generally focused on these 
physiologic pressures. Prior studies have shown complex effects from HP 
application, demonstrating both inhibition and enhancement of ECM protein 
production and gene expression depending on the selected HP regimen and 
culture system. For example, several pioneering studies by Smith et al.128"130,142, 
143
 on monolayers have demonstrated enhanced protein production and gene 
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expression when applying intermittent hydrostatic pressure at 10 MPa, 1 Hz to 
both normal human adult articular chondrocytes as well as to osteoarthritic 
chondrocytes. However, they found detrimental effects on collagen II mRNA 
production when applying 10 MPa static (0 Hz) HP to adult articular chondrocytes 
in monolayer.128 On the other hand, Mizuno et al.136 applied 2.8 MPa static HP to 
3-D bovine chondrocyte seeded collagen sponges and found an increase in GAG 
production. Similarly, Toyoda et al.137,138 observed significantly increased GAG 
production, aggrecan mRNA, and type II collagen mRNA expression when 
applying 5 MPa static HP to bovine articular chondrocyte seeded agarose gels. 
Several prior studies have also demonstrated the benefits of growth factors, 
including BMP-2, IGF-I, and TGF-pi, on construct functional properties.74,80'198 
In recent work (under review, Osteoarthritis and Cartilage), we have 
demonstrated the benefits of combined BMP-2 and IGF-I treatment on construct 
compressive properties and GAG production, as well as the benefit of TGF-pi 
treatment on construct compressive and tensile properties, with corresponding 
enhancement of GAG and collagen production. Furthermore, previous work has 
demonstrated the benefits of combining growth factor application with direct 
compression mechanical stimulation on construct93 and explant92 functional 
properties. 
Though several studies have been performed in assessing the role of HP in 
tissue biochemistry, to the best of our knowledge, no studies have demonstrated 
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enhanced biomechanical properties from HP application in any tissue. 
Furthermore, studies that systematically assess the effects of multiple HP 
magnitudes and frequencies on construct functional properties are lacking. 
Additionally, there is a dearth of studies demonstrating synergistic effects on 
tissue functionality from combining hydrostatic pressure and growth factors. 
Using a scaffoldless cartilage tissue engineering model,36'140 this study sought to 
test the hypotheses that 1) a short-term application of static HP during construct 
development will have the greatest enhancement of construct biochemical and 
biomechanical properties, and that 2) there will be additive or synergistic effects 
when combining growth factors and HP stimulation. These hypotheses were 
assessed and supported using a two-phased approach. In phase I, a 3 x 3 full-
factorial design of HP magnitude (1, 5, and 10 MPa) and frequency (0, 0.1, and 1 
Hz) was used, and the best two treatments were selected for use in phase II. 
Phase II employed a 3 x 3 full-factorial design of HP (no HP, 5 MPa static, 10 
MPa static) and growth factor application (no GF, BMP-2 + IGF-I, TGF-pi) for a 
total of nine treatment groups. 
MATERIALS AND METHODS 
Chondrocyte Isolation and Seeding 
Cartilage from the distal femur of wk-old male calves was obtained93, 118, 181 
(Research 87, Boston, MA) and digested with collagenase type 2 (Worthington, 
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Lakewood, NJ) for 24 hrs, as described in detail previously.140 A polysulfone die 
consisting of 5 mm dia. x 10 mm long cylindrical prongs that fit into 6 wells of a 
48-well plate was used to construct each agarose mold, as described in detail 
previously.140 The culture medium is a chemically defined medium that has been 
described previously.140 To each agarose well, 5.5 x 106 cells were added in 100 
\i\ of culture medium; t=0 was defined as 24 hrs after seeding. 
Phase I: HP Magnitude and Frequency Selection 
At t=10 days, self-assembled constructs (n=6/group) were removed from 
confinement in 5 mm dia. agarose wells and exposed to HP for 1 h/day, for 5 
days. The study employed a 3 x 3 full-factorial design of magnitude (1, 5, 10 
MPa) and frequency (0, 0.1, 1 Hz), for a total of 9 treatment groups. The 
constructs were then placed in individual agarose-coated wells of 48-well culture 
plates for the remainder of the study. A control (CC) consisted of constructs 
removed from confinement in 5 mm dia. agarose wells at 10 days, and cultured 
in individual wells of 48-well culture plates coated with 2% agarose for the 
remainder of the study. Per construct, 500 nl of medium was changed daily, and 
all constructs were assessed at t=4 wks. 
Phase II: Combination of HP and Growth Factors 
This study employed a 3 x 3 full-factorial design of HP (no HP, 5 MPa static, 10 
MPa static) and growth factor application (no GF, BMP-2 + IGF-I, TGF-p1) for a 
total of nine treatment groups. The hydrostatic pressure regimens were selected 
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in phase I (please see results), while the growth factor treatments were selected 
from a prior study by our group (under review, Osteoarthritis and Cartilage). The 
HP regimens were applied as in phase I, for 1 hr/day, from t=10-14 days. The 
specific growth factor treatments were TGF-pi (30 ng/ml) continuously from t=0-
14 days, or a combined treatment of BMP-2 (10 ng/ml) continuously from t=10-14 
days and IGF-I (10 ng/ml) from t=0-7 days and t=14-21 days. All growth factors 
were obtained from Peprotech Inc. (Rocky Hill, NJ), and applied in the culture 
medium. As in phase I, constructs were removed from confinement at t=10 days, 
and cultured in individual wells for the remainder of the study. Per construct, 500 
nl of medium was changed daily, and all constructs were assessed at t=4 wks. 
Specimen Pressurization 
The procedure used has been described previously.135 Briefly, constructs were 
placed into heat sealable bags (Kapak/Ampak Flexibles, Cincinnati, OH) with 35 
ml medium, and the bags were heat-sealed without any bubbles inside. The 
chamber was maintained at 37° C during pressurization. From t=10-14 days, the 
constructs were pressurized at a specific regimen for 1 hr. Following HP 
application, the pouches were opened with autoclaved instruments and the 
samples were returned to individual agarose coated wells. 
Histology and Immunohistochemistry 
Samples were frozen and sectioned at 14 jim. Safranin-0 and fast green 
staining were used to examine GAG distribution.182,183 Picrosirius red was used 
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for qualitative examination of collagen content. A von Kossa stain was used to 
examine mineralization. IHC was used to determine the presence of collagen 
types I and II, as described previously.140 
Quantitative Biochemistry 
Samples were frozen overnight and lyophilized for 72 hrs, followed by re-
suspension in 0.8 mL of 0.05 M acetic acid with 0.5 M NaCI and 0.1 mL of a 10 
mg/mL pepsin solution (Sigma) at 4°C for 72 hrs. Next, 0.1 mL of 10x TBS was 
added along with 0.1 mL pancreatic elastase and mixed at 4°C overnight. From 
this digest, total DNA content was measured by Picogreen® Cell Proliferation 
Assay Kit (Molecular Probes, Eugene, OR). Total sulfated GAG was quantified 
using the Blyscan Glycosaminoglycan Assay kit (Biocolor).184,185 Total collagen 
content was assessed by a chloramine-T hydroxyproline assay.186 
Mechanical Testing 
To obtain salient compressive properties, samples were evaluated under 
conditions of creep indentation,187 which has been described in detail 
previously.140 The aggregate modulus (HA), permeability, and Poisson's ratio of 
the samples were then determined using the linear biphasic theory.3 To obtain 
construct tensile properties, uniaxial tests were run on a materials testing system 
(Instron Model 5565, Canton, MA) with a 50 N load cell, as described 
previously.197 Stress-strain curves were created from the load-displacement 
curve and the cross-sectional area of each sample, and Young's modulus (EY) 
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was calculated from the linear region of each stress-strain curve. Construct 
thickness was measured using digital calipers. 
Statistical Analysis 
Biochemical and biomechanical assessments were performed on all constructs 
(n=6 or 7). In each phase, a single factor ANOVA was used to analyze the 
samples, and a Fisher LSD post hoc test was used when warranted. 
Significance was defined as p<0.05. Additionally, in phase II, the interaction term 
of a two factor ANOVA was used to test for synergism, as described previously 
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, with significance defined as p<0.05. 
RESULTS 
Gross Appearance and Histology 
All constructs reached a diameter of approximately 6 mm at t=4 wks (Fig. 21a). 
In phase I, there were no differences in wet weight (WW) or thickness among the 
treatment groups, as demonstrated in Table V. However, as shown in Table VI, 
in phase II, there was a decrease in construct WW and thickness in all groups 
treated with TGF-pi. 
In both studies, positive staining for collagen (Fig. 21b) and GAG (Fig. 21 e) was 
observed throughout the construct thickness. Additionally, based on IHC, 
collagen II was expressed throughout each construct (Fig. 21c), with no collagen 
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I production (Fig, 21 f). Finally, in phase II, there was no mineralization or 
chondrocyte hypertrophy observed with BMP-2 + IGF-I treatment. 
Quantitative Biochemistry 
In phase I, all values of cells/construct, GAG/WW, and collagen/WW are found in 
Table V. There were no differences in cells/construct among the different 
treatment groups. Several treatments resulted in significant increases in 
GAG/WW, but the greatest increases in GAG/WW were observed with the 5 MPa 
static, 10 MPa static, and 10 MPa, 1 Hz regimens (Fig. 22c), with GAG/WW 
values of 8.1 ±0.6, 8.1 ±0.4, and 9.1 ±0.8%, respectively. However, only 5 MPa 
static and 10 MPa static HP application significantly increased collagen/WW (Fig. 
22d), with values of 9.4±2.5 and 10.8±1.9%, respectively. 
In phase II, all values of cells/construct, GAG/WW, and collagen/WW are found 
in Table VI. There were no differences in cells/construct among the different 
treatment groups. All treatments exhibited a significant increase in GAG/WW 
(Fig. 23c); additionally, there was an adjunctive effect between 10 MPa static HP 
and TGF-pi, as their combination resulted in a greater GAG/WW, of 9.6±0.4%, 
than either treatment alone. Treatment with either HP regimen or with TGF-pi 
significantly increased the collagen/WW (Fig. 22d). Furthermore, combined 
treatment with 10 MPa static HP and TGF-pi led to a synergistic increase in 
collagen/WW to 15.3±2.9%; the increase in collagen/WW was statistically greater 
than the sum of either treatment alone. 
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Mechanical Evaluation 
In phase I, all values of HA and EY are found in Table V. The 1, 5, and 10 MPa 
static HP groups, as well as the 10 MPa, 1 Hz group all demonstrated a 
significant increase in HA relative to the control group (Fig. 22a), with values of 
268145, 269±44, 270±46, and 287±82 kPa, respectively. However, only the 5 
MPa static HP group exhibited significant increases in EY to 1196±271 kPa (Fig. 
22b); a similar increase in Ey to 1144±281 kPa was observed for the 10 MPa 
static HP group. 
In phase II, all values of HA and Ey are found in Table VI. All treatments 
exhibited a significant increase in HA (Fig. 23a), with the 10 MPa + TGF-pi 
treatment group displaying the greatest increase, to 248±37 kPa. This increase 
indicated an additive effect between 10 MPa static HP and TGF-p1, as the effect 
of their combined use on HA was equal to the sum of the effects of either 
treatment alone. Treatment with either HP regimen alone or with TGF-pi 
significantly increased the Ey; furthermore, combined treatment of 10 MPa static 
HP and TGF-p1 led to an additive increase in EY to 20481266 kPa (Fig. 23b). 
DISCUSSION 
This study employed a 2-phased approach to choose an optimal HP loading 
regimen, as well as to determine the effects of combined growth factor and HP 
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application. To the best of our knowledge, this study is the first to 1) demonstrate 
increases in the biomechanical properties of tissue from pure HP application, 
using a cartilage model, 2) demonstrate additive or synergistic effects between 
HP and growth factors on tissue functional properties, and 3) systematically 
assess the effects of varying physiologic magnitudes and frequencies of HP on 
tissue functional properties. 
In phase I, 5 MPa and 10 MPa static HP were the only regimens that increased 
both HA and Ey with parallel increases in GAG and collagen content. These 
results support our hypothesis, as static hydrostatic pressure was found to have 
the greatest effect on construct biochemical and biomechanical properties. Since 
5 MPa and 10 MPa static HP were the only regimens to significantly increase the 
Compressive and tensile stiffness as well as GAG/WW and collagen/WW, these 
two regimens were selected for use in phase II. 
In phase II, the combination of 10 MPa static HP and TGF-pi treatment had 
significant effects on construct biomechanical and biochemical properties, thus 
supporting the hypothesis that combined HP and growth factor treatment would 
have additive and synergistic effects on construct functional properties. The 
combined treatment of 10 MPa static HP and TGF-pi had an additive effect on 
both HA and Ey, as the increases in compressive and tensile stiffness for the 
combined treatment were equal to the sum of the effects of the two individual 
treatments. Additionally, the combined treatment exhibited a synergistic increase 
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in collagen/WW, as the effect of the combined treatment was statistically greater 
than the sum of the effects of each individual treatment. Excitingly, the 
collagen/WW of this group, at 15.3%, spanned reported values for native articular 
cartilage.4 
However, although 5 MPa and 10 MPa static HP have similar effects on 
construct properties when applied alone, 5 MPa static HP did not exhibit the 
same additive and synergistic effects when combined with TGF-pi treatment. 
This result suggests that there are different cellular responses to varying HP 
magnitudes; for example, it can be speculated that increasing HP from 5 MPa to 
10 MPa in the presence of TGF-pi may activate additional intracellular pathways 
that lead to enhanced production of ECM proteins and increased biomechanical 
properties. Interestingly, a similar effect has been observed previously in work 
on chondrogenic differentiation of human mesenchymal stem cells (MSCs).151 It 
was found that collagen II mRNA expression of MSCs cultured with TGF-P3 
responded maximally to 10 MPa HP application. 
It is also interesting to note that combining BMP-2 + IGF-I treatment with either of 
the HP treatments did not lead to further enhancement of construct properties, 
and actually negated the beneficial effects of HP alone on construct properties. It 
has previously been shown that HP modulates the level of TGF-p mRNA.131 
Additionally, combined treatment with TGF-pi and IGF-I has detrimental effects 
on GAG and collagen content shown by Blunk et al.74 and our own work (under 
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review, Osteoarthritis and Cartilage). Based on these prior studies, one can 
speculate that HP application may lead to the production of TGF-pi, which, when 
combined with the effects of exogenously applied IGF-I may have detrimental 
effects, as seen previously, although it is possible that enhanced TGF-pi mRNA 
expression may not correspond to increased TGF-pi production due to the 
extensive post-transcriptional and post-translational regulation of TGF-pi, as 
reviewed previously.220 In future studies, it would be exciting to elucidate the 
pathways involved in HP signal transduction, and how they coincide with the 
growth factor signal transduction cascades. Since the exact pathways for HP 
signal transduction have not been elucidated, we can only speculate that the 
pathways leading to increased matrix synthesis are either further enhanced, 
when combining HP and TGF-pi, or perhaps inhibited, when combining HP and 
the BMP-2 + IGF-I combination. 
By demonstrating the beneficial effects of static HP over cyclic HP application on 
construct biomechanical and biochemical properties, this study contradicts 
several prior studies that have shown positive effects from cyclic HP.122,128130' 142> 
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 Though when comparing these studies, it is important to note that HP was 
applied to chondrocytes in monolayer rather than 3-D constructs. Furthermore, 
these studies utilized adult or osteoarthritic chondrocytes which behave 
substantially differently than the immature bovine chondrocytes used in this 
study.41 On the other hand, the results of this study agree with the conclusions of 
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several other studies that applied static HP to 3-D constructs and found 
beneficial effects on construct biochemical properties.136"138 
When assessing the effects of combined HP and growth factor treatment on 
cartilage properties, the results presented here agree with prior studies that have 
combined these treatments as differentiation agents for mesenchymal stem 
cells.151,152 For example, Miyanishi et al.151 found that combined HP application 
with TGF-p3 increased SOX9, collagen II, and aggrecan mRNA levels 1.9, 3.3, 
and 1.6-fold, respectively, more than treatment with TGF-03 alone. It is also 
known that another form of mechanical stimulation, namely direct compression, 
exhibits synergistic effects when combined with growth factor treatment on 
articular cartilage constructs93 and explants92. Specifically, Mauck et al.93 found 
that combined treatment with dynamic compression and TGF-p1 resulted in a 
277% increase in equilibrium aggregate modulus, while Bonassar et al.92 
observed a 290% increase in proteoglycan synthesis with combined dynamic 
compression and IGF-I treatment. 
Physiologic HP does not deform cartilage;162 therefore, the enhanced construct 
biomechanical properties observed in this study must be accounted for by other 
mechanisms. As reviewed elsewhere,169 on the microscopic level, HP can 
compress void spaces within and around proteins on the cell surface. At a 
certain pressure, the compression of void spaces becomes great enough that the 
protein can achieve a lower energy state by changing its conformation. Cell 
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surface ion channels may serve as "pressure sensors," altering their 
conformations and thus changing the intracellular ion concentrations depending 
on the applied pressure. For example, Hall165 found that in chondrocytes, the 
activity of the Na/K pump was suppressed substantially with 10 MPa static HP 
application for 10 min, while the Na/K/2CI transporter was more sensitive to HP 
application. Also, Browning et al.166 observed activation of the Na/H pump in 
bovine articular chondrocytes with HP application at approximately 10 MPa. 
Additionally, Mizuno167 found that HP increases intracellular calcium through the 
activation of stretch-activated channels. Since protein synthesis is affected by 
intracellular ion concentrations,170 it is envisioned that different ion channel 
responses to varying HP magnitudes alters the intracellular ion flux and 
stimulates signal transduction cascades for upregulation of ECM-specific genes, 
enhanced ECM protein production, and increased biomechanical properties as 
observed in this study. Growth factors may serve as an adjunctive method for 
stimulating similar downstream pathways, thus leading to additive and synergistic 
effects, as observed in this study. 
The beneficial effects of HP on tissue biochemical properties are not confined 
merely to cartilage, and it is possible that the approach of this study, namely 
combining optimized HP and growth factor treatments, may be applicable to 
several other tissues. For example, Stover et al.217 found that applying cyclic HP 
to bladder smooth muscle cells resulted in a proliferative response suggestive of 
tissue remodeling. Also, Reza and Nicoll214 observed increased production of 
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collagen II in intervertebral disc cells from the outer annulus exposed to 5 MPa 
HP. Additionally, Almarza and Athanasiou178 demonstrated increased collagen I 
gene expression and protein production when applying 10 MPa static HP to 
temporomandibular joint disc cells. Finally, Suzuki et al.212 applied 4 MPa static 
HP to knee meniscal cells, and found a significant increase in collagen I mRNA 
and a significant decrease in matrix metalloproteinase - 1 , and -13. Although 
none of these studies assessed the effects of HP on biomechanical properties, it 
can be speculated that coupling these HP regimens with the application of 
exogenous bioactive agents specific to these tissues, may also result in additive 
and synergistic effects on the functional properties. 
Multiple studies have assessed the effects of both static and intermittent HP 
regimens on gene expression and protein production. This study, which 
investigated the effects of multiple HP magnitudes and frequencies on construct 
functional properties, demonstrated enhanced biomechanical and biochemical 
tissue properties. Additionally, it systematically assessed the effects of 
combining HP and growth factors on construct functional properties, and 
indicated synergistic and additive effects. Future studies should determine the 
effects of temporal HP application during construct development, as well as 
examine the immediate and long-term effects of HP application on construct 
properties. 
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Chapter 7: Evaluating Five Extraction Techniques 
for the Decellularization of Scaffoldless Tissue 
Engineered Articular Cartilage Constructs 
Benjamin D. Elder and Kyriacos A. Athanasiou 
Chapter to be submitted as: Elder, BD and Athanasiou, KA. Evaluating Five 
Extraction Techniques for the Decellularization of Scaffoldless Tissue 
Engineered Articular Cartilage Constructs. 
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ABSTRACT 
Several prior studies have been performed to determine the feasibility of tissue 
decellularization to create a non-immunogenic xenogenic tissue replacement for 
bladder, vasculature, heart valves, knee meniscus, temporomandibular joint disc, 
ligament, and tendon. However, to the best of our knowledge, no studies have 
examined the decellularization of either scaffoldless engineered constructs or 
articular cartilage tissue. The objective of this study was to assess the effects of 
5 different decellularization treatments, for 1 h or 8 h, on scaffoldless tissue 
engineered articular cartilage constructs after 4 wks of culture. The specific 
treatments used were 1 ) 1 % SDS, 2) 2% SDS, 3) 2% Tributyl phosphate, 4) 2% 
Triton X-100, and 5) Hypotonic followed by hypertonic solution, followed by a 3 h 
wash in PBS. Following this wash, the constructs were assessed histologically, 
biochemically for cellularity, GAG, and collagen content, and biomechanically for 
compressive and tensile properties. Treatment with 2% SDS for 1 h eliminated 
33% of DNA, while maintaining or increasing biochemical and biomechanical 
properties. On the other hand, treatment for 8 h resulted in the elimination of 
46% of DNA, although GAG content and compressive properties were 
significantly decreased. As all other treatments either did not result in significant 
decellularization, or else significantly compromised construct functional 
properties, 2% SDS appeared to be the most effective agent for cartilage 
decellularization. The results of this study are exciting as they indicate the 
feasibility of creating engineered cartilage that will be non-immunogenic as a 
replacement tissue. 
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INTRODUCTION 
Injuries to articular cartilage, whether traumatic or from degeneration, generally 
result in the formation of mechanically inferior fibrocartilage, due to the tissue's 
poor intrinsic healing response.14 As such, tissue engineering strategies have 
focused on developing replacement tissue in vitro for eventual in vivo 
implantation. 
Although engineered articular cartilage tissue has recently been created with 
biochemical and biomechanical properties in the range of native tissue values,139 
there are currently two significant limitations to cartilage tissue engineering. 
First, human cells are scarce in number and difficult to procure, and passage of 
these cells leads to dedifferentiation. These issues make the use of autologous 
cells for cartilage repair extremely difficult. Additionally, the majority of cartilage 
tissue engineering approaches have employed bovine or other animal cells, and 
tissues grown from these cells are xenogenic and may result in a severe immune 
response following implantation that would preclude their use, though this has 
not been fully elucidated. 
It is believed that a decellularized xenogenic tissue may be a viable option as a 
replacement tissue, as the antigenic cellular material will be removed while 
preserving the relatively non-immunogenic extracellular matrix (ECM), as 
described in an earlier review.221 Ideally, this will also preserve the 
biomechanical properties of the tissue. For instance, an acellular dermal 
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matrix222 has seen successful use clinically as the FDA approved Alloderm 
product. Additionally, acellular xenogenic tissues have been created for many 
musculoskeletal applications, including replacements for the knee meniscus,223 
temporomandibular joint disc,224 tendon,225 and ACL,226 as well as in other 
tissues including heart valves,227"233 bladder,234 artery,235 and small intestinal 
submucosal36, 237 However, studies demonstrating the effects of tissue 
decellularization on cartilage as well as on musculoskeletal tissue engineered 
constructs are lacking. 
Therefore, the objective of this study was to determine the effects of multiple 
decellularization treatments on construct cellularity, biochemical, and 
biomechanical properties. It was hypothesized that cells could be removed from 
self-assembled constructs while preserving the biochemical and biomechanical 
properties. To test this hypothesis, self-assembled articular cartilage constructs 
were cultured for 4 wks, and then treated with 1% SDS, 2% SDS, 2% Tributyl 
Phosphate (TnBP), 2% Triton X-100, or a hypotonic/hypertonic solution, for either 
1 or 8 h. The effects of the decellularization treatments were assessed on 
construct cellularity and functional properties. 
MATERIALS AND METHODS 
Chondrocyte Isolation and Seeding 
Cartilage was harvested from the distal femur of wk-old male calves93, 118, 181 
(Research 87, Boston, MA) shortly after slaughter, and chondrocytes were 
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isolated following digestion with collagenase type 2 (Worthington, Lakewood, 
NJ). To normalize variability among animals, each leg came from a different 
animal, and cells from all legs were combined together to create a mixture of 
chondrocytes; a mixture of cells from five legs was used in the study. Cell 
number was determined on a hemocytometer, and a trypan blue exclusion test 
indicated that viability remained >90%. Chondrocytes were frozen in culture 
medium supplemented with 20% FBS (Biowhittaker, Walkersville, MD) and 10% 
DMSO at -80°C for 1 day prior to use. After thawing, viability was greater than 
90%. A stainless steel mold consisting of 5 mm dia. x 10 mm long cylindrical 
prongs was placed into a row of a 48-well plate. To construct each agarose well, 
sterile, molten 2% agarose was added to wells fitted with the die. The agarose 
solidified at room temperature for 60 min, after which the mold was removed from 
the agarose. Two changes of culture medium were used to completely saturate 
the agarose well by the time of cell seeding. The medium was DMEM with 4.5 
g/L-glucose and L-glutamine (Biowhittaker), 100 nM dexamethasone (Sigma, St. 
Louis, MO), 1% Fungizone/Penicillin/Streptomycin (Biowhittaker), 1% ITS+ (BD 
Scientific, Franklin Lakes, NJ), 50 |ig/mL ascorbate-2-phosphate, 40 |ig/mL L-
proline, and 100 |i,g/mL sodium pyruvate (Fisher Scientific, Pittsburgh, PA). To 
seed each construct, 5.5 x 106 cells were added in 100 JLL! of culture medium. 
Constructs formed within 24 h in the agarose wells and were cultured in the 
same well until t=10 days, after which they were unconfined for the remainder of 
the study, as described previously;2581=0 was defined as 24 h after seeding. 
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Decellularization Treatments 
At t=4 wks, self-assembled constructs (n=6/group) were removed from culture 
and exposed to one of five decellularization treatments, for either 1 h or 8 h. The 
decellularization treatments included: 
1) 1%SDS 
2) 2%SDS 
3) 2% Tributyl Phosphate (TnBP) 
4) Triton X-100 
5) Hypotonic/Hypertonic Solution (half-time of each) 
a. Hypotonic: 10 mM Tris HCI, 5 mM EDTA, 1 ^ M PMSF 
b. Hypertonic: 50 mM Tris HCI, 1 M NaCI, 10 mM EDTA, 1 yM PMSF 
All treatments included 0.5 mg/ml DNase Type I, 50 ng/ml RNase, 0.02% EDTA, 
and 1 % P/S/F, in PBS. Both 1 h control and 8 h control groups were exposed to 
this same solution without detergent treatments. These treatments were applied 
at 37°C with agitation. Following the 1 h or 8 h treatment, the constructs were 
washed for 3 h in PBS at 37°C with agitation. Additionally, an untreated control 
was assessed immediately following removal from culture, without the treatment 
or wash steps. 
Histology and Immunohistochemistry 
After freezing, samples were sectioned at 14 (xm. To determine construct 
cellularity, a hematoxylin & eosin (H&E) stain was used. A Safranin-O/fast green 
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stain was used to examine GAG distribution.182'183 To assess collagen content, 
picrosirius-red was employed. Immunohistochemistry was utilized to test for the 
presence of collagen types I and II on a Biogenex (San Ramon, CA) i6000 
autostainer. Following fixation in chilled acetone, the slides were washed with 
IHC buffer (Biogenex), quenched of peroxidase activity with hydrogen 
peroxide/methanol, and blocked with horse serum (Vectastain ABC kit, Vector 
Laboratories, Burlingame, CA). The slides were then incubated with either 
mouse anti-collagen type I (Accurate Chemicals, Westbury, NY) or rabbit anti-
collagen type II (Cedarlane Labs, Burlington, NC) antibodies. Secondary 
antibody (anti-mouse or anti-rabbit IgG, Vectastain ABC kit) was applied, and 
color was developed using the Vectastain ABC reagent and DAB (Vectastain kit). 
Quantitative Biochemistry 
Samples were frozen overnight and lyophilized for 48 h, followed by re-
suspension in 0.8 mL of 0.05 M acetic acid with 0.5 M NaCI and 0.1 mL of a 10 
mg/mL pepsin solution (Sigma) at 4°C for 72 h. Next, 0.1 mL of 10x TBS was 
added along with 0.1 mL pancreatic elastase and mixed at 4°C overnight. A 
Picogreen® Cell Proliferation Assay Kit (Molecular Probes, Eugene, OR) was 
used to assess total DNA content. GAG content was quantified using the 
Blyscan Glycosaminoglycan Assay kit (Biocolor), based on 1,9-
dimethylmethylene blue binding.184,185 After hydrolysis with 2 N NaOH for 20 min 
at 110°C, total collagen content was determined using a chloramine-T 
hydroxyproline assay.186 
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Indentation Testing 
Samples were assessed with an automated indentation apparatus, as described 
previously.187 A 0.7 g (0.007 N) mass was applied with a 1 mm flat-ended, 
porous indenter tip, and specimens crept until equilibrium, as described 
elsewhere.36 Preliminary estimations of the aggregate modulus of the samples 
were obtained using the analytical solution for the axisymmetric Boussinesq 
problem with Papkovich potential functions.188, 189 The sample biomechanical 
properties, including aggregate modulus, Poisson's ratio, and permeability were 
then calculated using the linear biphasic theory.3 
Tensile Testing 
A uniaxial materials testing system (Instron Model 5565, Canton, MA) was 
employed to determine tensile properties with a 50 N load cell, as described 
previously.197 Briefly, samples were cut into a dog-bone shape with a 1-mm-long 
gauge length. Samples were glued to paper tabs with cyanoacrylate glue outside 
of the gauge length. The 1 -mm-long sections were pulled at a 1% constant strain 
rate. All samples broke within the gauge length. Stress-strain curves were 
created from the load-displacement curve and the cross-sectional area of each 
sample, and Young's modulus was calculated from each stress-strain curve. 
Statistical Analysis 
All samples were assessed biochemically and biomechanically (n=6). First, the 
three control groups were compared using a single factor ANOVA. As no 
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difference was noted, only the culture control was used in the final analysis. To 
compare treatment groups, a single factor ANOVA was used, and a Tukey HSD 
post hoc test was used when warranted. Significance was defined as p< 0.05. 
RESULTS 
Gross Appearance and Histology 
In all groups, the construct diameter was approximately 6 mm at 4 wks. 
Treatment for 8 h with either 1% SDS or the hypotonic/hypertonic solution 
resulted in a significant decrease in construct thickness (Table VII). Additionally, 
treatment for 8 h with 1% SDS, 2% SDS, 2% Triton X-100, or the 
hypotonic/hypertonic solution resulted in a significant decrease in construct wet 
weight (Table VII). 
Figure 24 displays the histological results of the study. Extensive staining for cell 
nuclei was observed in the H&E staining of the control group. 1% SDS treatment 
for 1 h reduced the number of cell nuclei, while treatment for 8 h eliminated all 
nuclei from the construct. The 2% SDS treatment had similar results. However, 
treatment with 2% TnBP or 2% Triton X-100, for either timepoint, had no effect 
on the number of nuclei. Both hypotonic/hypertonic treatments resulted in a 
slight reduction in number of cell nuclei. All decellularization treatments for 8 h 
resulted in a significant reduction or complete elimination of staining for GAGs. 
Additionally, 1 h treatment with the hypotonic/hypertonic solution reduced the 
GAG content. However, there were no apparent differences in GAG staining 
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among the 1 h treatments with 1% SDS, 2% SDS, 2% TnBP, 2% Triton X-100, 
and the control. Finally, all constructs demonstrated extensive staining for 
collagen, although the 8h decellularization treatments resulted in slight 
alterations in construct morphology. 
Quantitative Biochemistry 
Several decellularization treatments resulted in a significant reduction in 
construct DNA (Fig. 25). Treatment for 1 h with 2% SDS or the 
hypotonic/hypertonic solution, as well as 8 h treatment with 1 or 2% SDS or the 
hypotonic/hypertonic solution all resulted in a significant reduction of the DNA in 
the constructs. However, treatment with 2% TnBP or 2% Triton X-100 for either 
amount of time had no effect on construct DNA. 
The effects of the decellularization agents on construct GAG content are found in 
Fig. 26. Treatment with 1% or 2% SDS for 1 h had no effect on GAG content, 
while all other treatments significantly reduced the GAG content of the 
constructs. Additionally, all 8 h treatments resulted in complete or nearly 
complete removal of GAG from the constructs. Finally, there were no significant 
changes in total collagen content following treatment with the decellularization 
agents (Fig. 27). 
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Biomechanical Evaluation 
The effects of the various decellularization treatments on construct aggregate 
modulus are displayed in Fig. 28. Treatment for 1 h with 1% or 2% SDS as well 
as with 2% TnBP maintained the compressive stiffness. However, treatment for 
8 h with 1% SDS, 2% TnBP, and 2% Triton X-100 significantly reduced the 
aggregate modulus. The groups treated for 8 h with either 2% SDS or the 
hypotonic/hypertonic solutions were too weak to be mechanically tested with 
creep indentation. Additionally, the effects of the various decellularization 
treatments on Poisson's ratio and permeability are displayed in Table VIII. A 
significant decrease in Poisson's ratio was noted for the groups treated for 8 h 
with 1% SDS, 2% TnBP, and 2% Triton X-100. Finally, only treatment for 8 h 
with 1% SDS resulted in a significantly decreased permeability. 
Figure 29 indicates the tensile properties of the constructs treated with the 
various agents. Treatment for 1 h with 1% SDS, 2% TnBP, or 2% Triton X-100 
maintained the tensile stiffness. A 1 h treatment with 2% SDS actually increased 
the Young's modulus. However, 8 h treatments with 2% SDS, 2% TnBP, and 2% 
Triton X-100 significantly decreased the Young's modulus. Similar trends are 
noted for the Ultimate Tensile Strength data, although a significant decrease was 
only noted for the hypotonic/hypertonic treatment. 
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DISCUSSION 
To the best of our knowledge, this is the first study to decellularize articular 
cartilage tissue, in this case engineered cartilage. The objective of this study 
was to assess the effectiveness of multiple different decellularization protocols on 
self-assembled articular cartilage constructs. The study utilized a two-factor 
approach, in which five different treatments were examined at two application 
times each. 
The results of this study indicated that SDS, at concentrations of either 1% or 
2%, is an effective treatment for tissue decellularization, thus confirming our 
hypothesis that cells could be eliminated from engineered constructs while 
maintaining the biomechanical properties. An ionic detergent, SDS typically is 
able to solubilize the nuclear and cytoplasmic cell membranes. Although all SDS 
treatments led to cell removal, treatment with 2% SDS appeared the most 
promising, although application time also had significant effects. For instance, 
treatment with 2% SDS for 1 h resulted in a 33% decrease in cellularity, while 
maintaining both GAG and collagen content, as well as maintaining compressive 
stiffness. This treatment even resulted in an increase in tensile stiffness; a 
similar increase in tensile properties was observed in a study of ACL 
decellularization.226 On the other hand, treatment with 2% SDS for 8 h led to 
complete histological decellularization, as well as a 46% decrease in DNA 
content. However, this treatment also resulted in loss of all GAG and 
compressive stiffness, as well as a decrease in tensile stiffness. Treatment with 
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2% SDS for 8 h also resulted in a significant decrease in construct WW, 
presumably as a result of the GAG loss, which would also decrease the tissue 
hydration. 
As described above, it must be noted that although treatment with 2% SDS 
resulted in complete histological decellularization, it did not result in complete 
elimination of DNA. It appeared that SDS treatment was effective at achieving 
complete lysis of cell membranes and nuclear membranes, as an H&E stain did 
not reveal any indication of the presence of cell nuclei, while the DNAse 
treatment was not completely effective in degrading the DNA following 
membrane lysis. It is possible that a higher DNAse concentration is required to 
achieve more complete elimination of DNA. Additionally, as nucleases were only 
added during detergent treatment, it is possible that adding a nuclease during the 
3 h wash step would enable the nucleases to more effectively destroy the 
remaining DNA. 
However, the exact level of tissue decellularization requisite to eliminate an 
immune response, as well as the proper assessment of decellularization, is 
currently unclear. As it is believed that the joint space is relatively immune 
privileged, as reviewed previously,239 it is possible that complete decellularization 
of the tissue is not required. Additionally, it is unclear if decellularization should 
be assessed histologically merely as elimination of cell nuclei, or if a more 
complete assessment involves quantifying the tissue's DNA content, as prior 
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studies have utilized differing approaches. For example, Lumpkins et al.224 found 
that 1% SDS treatment for 24 h resulted in complete removal of cell nuclei, 
although they did not assess the DNA content of the tissue. On the other hand, 
Dahl et al.235 examined the effects of a hypotonic/hypertonic treatment and found 
that there was complete removal of cell nuclei, but no decrease in DNA content. 
To study this issue further, in vivo studies are warranted to determine if there is 
threshold of decellularization at which an immune response is eliminated. 
Although it was less effective than the 2% concentration, 1% SDS displayed 
similar effects. For example, treatment for 1 h resulted in a 15% decrease in 
DNA content, while maintaining GAG and collagen content as well as maintaining 
biomechanical properties. Additionally, treatment for 8 h resulted in a 37% 
decrease in DNA content, loss of all GAG and compressive stiffness, as well as a 
decrease in tensile stiffness. 
On the other hand, treatment with Triton X-100 and TnBP did not appear 
promising, as they had a minimal effect on tissue decellularization, and resulted 
in a slight decrease in GAG content. Several prior studies have indicated the 
ineffectiveness of Triton X-100, although it was used in this study as it is believed 
to have minimal effects on protein-protein interactions.221 For example, Dahl et 
al.235 examined the effects of 1% Triton X-100 on porcine carotid arteries, and 
found that this treatment resulted in similar cellularity to control and no decrease 
in DNA content. In another study on tendon decellularization, Cartmell and 
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Dunn225 examined the effect of 1% Triton X-100 for 24 h, and found that cell 
density remained similar to control. Contrary to our results, this study 
demonstrated complete decellularization with 1% TnBP, although a 48 h 
treatment was required. Therefore, it is possible that TnBP treatment may result 
in decellularization of self-assembled constructs at longer application times, 
although the GAG loss after as little as 8 h prevents the use of longer application 
times. 
Finally, although a hypotonic/hypertonic treatment has been an effective 
decellularization agent in this study as well as prior studies,226' 235 it did not 
appear to be a viable treatment for self-assembled cartilage constructs, as it had 
severely detrimental effects on construct functional properties. For instance, 
treatment for as little as 1 h resulted in nearly complete loss of compressive and 
tensile stiffness, while constructs treated for 8 h were untestable mechanically. 
Additionally, treatment at both application times resulted in nearly complete 
elimination of GAG content. 
Based on these results, treatment with 2% SDS appears to be the most 
promising, and should be examined further in future studies. For example, it is 
possible that treatment with 2% SDS for an application time between 1 h and 8 h 
may result in the best compromise between decellularization and maintaining the 
GAG content and compressive properties. It would therefore be interesting to 
examine the effects of 2% SDS at varying timepoints between 1 and 8 h. 
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Additionally, it is possible that a more effective protocol would involve multiple 
rounds of 1 h SDS treatment followed by a 1 h wash step, as this would re-
establish concentration gradients for the detergent and wash solution at the 
beginning of each step. Finally, although the majority of prior decellularization 
studies have been performed in PBS, it is possible that the constructs could 
maintain their GAG content during a longer detergent treatment if in media, as 
this would maintain an isomolar environment, and potentially eliminate the GAG 
loss down a concentration gradient. Although the results of this study did not 
result in a completely decellularized construct with maintenance of biochemical 
and biomechanical properties, the results are promising and indicate the potential 
of a decellularized articular cartilage construct that could be used to treat 
damaged cartilage tissue without eliciting an immune response. 
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Conclusions 
This thesis demonstrates work towards enhancing the functional properties of 
tissue engineered articular cartilage constructs. Exogenous stimuli, including 
radial and vertical confinement, hydrostatic pressure, and growth factor 
application, as well as their combined use, resulted in constructs with 
biochemical and biomechanical properties in the range of native tissue values, 
thus enhancing the in vivo translatability of the self-assembling process. 
Additional translatability of our laboratory's scaffoldless approach to tissue 
engineering articular cartilage was illustrated, as it was possible to remove cells 
from the constructs without compromising the integrity of the constructs, thus 
paving the way for implantation of a xenogenic tissue engineered replacement 
tissue. 
The global hypotheses of this thesis were that 1) the self-assembling process 
could be enhanced by identifying suitable growth factors and mechanical forces, 
and 2) the effects of these exogenous factors individually or in combination would 
allow for the formation of constructs in vitro resembling native tissue. Prior work 
in our laboratory has generally focused on characterizing the biochemical and 
biomechanical properties of native articular cartilage tissue in order to develop 
design criteria for tissue engineered constructs. Additionally, several prior 
studies have focused on developing and modulating the scaffoldless approach 
utilized in this thesis. However, in these prior tissue engineering studies, the 
functional tissue properties were significantly lacking when compared to native 
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tissue. Therefore, this thesis concentrates on enhancing the functional 
properties of self-assembled articular cartilage constructs such that they 
approach native tissue values. 
Chapter 1 presented an overview of the paradigms of tissue engineering, 
focusing on its application to articular cartilage regeneration. Many prior studies 
have focused on modulating the four parameters of the cartilage tissue 
engineering paradigm, specifically scaffolds, cell sources, bioactive agents, and 
bioreactors. Both natural and synthetic materials have been utilized as scaffolds 
with promising results; however, several issues must be overcome when dealing 
with scaffolds. For instance, the scaffold degradation kinetics must be 
coordinated with the deposition of new tissue, and there is concern over scaffold 
toxicity or the toxicity of byproducts during degradation. Therefore, scaffoldless 
approaches such as the self-assembling process developed by our laboratory 
have demonstrated increased promise in recent studies. Additionally, this 
chapter addressed the inherent advantages and disadvantages to the use of 
different cell sources, and indicated that primary chondrocytes generally result in 
constructs with the most robust functional properties. Furthermore, the effects of 
growth factors on chondrocyte metabolism were reviewed, and it was determined 
that TGF-pi, BMP-2, and IGF-I all have beneficial effects on the biochemical and 
biomechanical properties of tissue engineered constructs. Finally, the effects of 
different mechanical stimulation modalities were assessed, including direct 
compression, hydrostatic pressure, and shear, and it was concluded that these 
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modalities showed promise as agents for enhancing construct functionality. 
However, despite the promise of prior results in the literature as well as in work 
performed in our own laboratory, successful tissue engineering strategies would 
need to optimize all parameters to generate constructs with properties 
approaching those of native tissue. 
Chapter 2 delivered a more comprehensive overview of the use of hydrostatic 
pressure in tissue engineering strategies. This chapter indicated that hydrostatic 
pressure provides a promising method for enhancing the ECM production of 
chondrocytes in monolayer, in 3-D engineered constructs, as well as in tissue 
explants. It was apparent that pressure magnitudes within the physiologic range, 
generally between 3 and 10 MPa, had the most beneficial effects. Additionally, 
chondrocytes in monolayer seemed to respond maximally to regimens using 
dynamic frequencies, generally <1 Hz, while chondrocytes in explants and 3-D 
constructs typically responded favorably to an application of static pressure. 
Furthermore, this chapter demonstrated the potential use of hydrostatic pressure 
as a chondroprotective agent, thus suggesting its potential use as a treatment to 
delay the onset of osteoarthritis, as well as implying that hydrostatic pressure 
could enable the use of osteoarthritic chondrocytes in future tissue engineering 
studies. Also, hydrostatic pressure was found to be effective as a differentiation 
agent, for stem cells as well as dedifferentiated articular chondrocytes. 
Additionally, many studies have examined the use of hydrostatic pressures 
above the physiologic range, and have generally demonstrated detrimental 
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effects at these high magnitudes, particularly between 30 and 50 MPa, but also 
as low as 15 MPa. This indicated that tissue engineering studies should remain 
focused on utilizing pressures in the physiologic range for the enhancement of 
functional properties. Finally, as hydrostatic pressure does not result in 
macroscopic deformation of cartilage, it was postulated that hydrostatic pressure 
has a direct effect on cell transmembrane ion transporters, thus altering their 
activity and changing intracellular ion gradients. An altered intracellular ion 
concentration could activate signal transduction cascades and lead to 
upregulation of ECM-specific genes, and the eventually increased biochemical 
properties, as observed previously. 
The temporal and directional effects of confinement on construct biomechanical 
properties were examined in Chapter 3. This was necessary as it would aid in 
identifying more optimal construct culture conditions. It was found that constructs 
confined radially for 2 wks demonstrated a significantly higher aggregate 
modulus than the other treatment groups, accompanied by extensive 
organization of collagen fibrils, forming struts in the direction perpendicular to the 
articular surface. Additionally, when maintaining radial confinement for a longer 
period, it was determined that the increased confinement time resulted in a slight 
decrease in aggregate modulus, thus indicating the importance of early (<2 wks) 
application of confinement, and possibly other forms of mechanical stimulation. 
Finally, passive axial compression during early construct growth resulted in 
increased tensile properties, accompanied by a significant increase in collagen 
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content. These studies indicated that mechanical stimulation, as evidenced by 
radial and vertical confinement, had significant effects on construct properties, as 
the biomechanical properties were influenced by an application of stress in the 
orthogonal direction. 
Although construct confinement for 2 wks demonstrated beneficial results on 
compressive properties in Chapter 3, as this effect was highly dependent on 
construct growth rates, which were variable among different studies, all 
remaining studies involved construct confinement for only 10 days, thus 
controlling for the effects of confinement. However, the effects of mechanical 
stimulation, in the form of hydrostatic pressure, were assessed at similar 
timepoints to the windows observed in the confinement studies. As no prior 
studies had demonstrated the effects of hydrostatic pressure on construct 
biomechanical properties, the temporal effects of hydrostatic pressure on 
construct biomechanical and biochemical properties were examined in Chapter 
4. This study consisted of two phases. In the first phase, a bagged control, 
consisting of constructs placed in an unpressurized HP chamber, was compared 
to a culture control, which remained in culture for the remainder of the study. It 
was determined that there was no difference between the controls, so the culture 
control was used in all subsequent HP studies in this thesis. In the next phase, 
the effects of 10 MPa static HP application were compared at three different 
times in construct development, from 6-10, 10-14, and 14-18 days. It was found 
that 10 MPa static HP enhanced both aggregate modulus and Young's modulus, 
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with parallel increases in GAG and collagen content, respectively. Additionally, it 
was determined that HP application from 10-14 days had the greatest effect on 
construct biomechanical and biochemical properties, so this application time was 
chosen for future HP studies in Chapter 6. Finally, in the third phase, the 
immediate and delayed effects of HP were assessed on construct properties, and 
an immediate increase in GAG production and aggregate modulus were 
demonstrated. However, there was an immediate increase in collagen content, 
but a delayed increase in tensile properties, likely as a result of the slower 
turnover of collagen relative to GAG production. 
Although HP was shown to have significant effects on construct functional 
properties, they still lagged behind those of native tissue. Therefore, additional 
exogenous stimulation modalities, namely growth factor application, were 
examined in Chapter 5, as the effects of multiple growth factor treatments under 
serum-free conditions were assessed. Three growth factors, BMP-2, IGF-I, and 
TGF-pi were examined alone and in combination, on the properties of 
engineered cartilage constructs. All growth factors were assessed at two 
concentrations each, low and high, and two dosage frequencies, in the media for 
the first 2 wks of culture or in the media during the first and third wks of culture. 
From these groups, the best treatment, in terms of construct functional properties 
was determined for each individual growth factor. It was determined that BMP-2, 
at a concentration of 10 ng/ml and the 2-wk continuous dosage, had the greatest 
effects on construct properties, leading to a significant increase in compressive 
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stiffness and GAG production. Treatment with IGF-I, at 10 ng/ml and the 2-wk 
rotation dosage, had a similar effect on construct properties, also leading to 
significant enhancement of construct compressive stiffness and GAG production. 
On the other hand, 30 ng/ml TGF-pi, at the 2-wk continuous dosage, led to a 
significant increase in compressive stiffness and GAG production, as well as a 
significant increase in tensile properties, accompanied by a significant increase in 
collagen production. These three individual treatments were then studied 
individually and in combinations of two and three. It was determined that the 
combination of BMP-2 and IGF-I resulted in the greatest increases in 
compressive stiffness and GAG content, while TGF-pi alone was the only 
treatment that resulted in a significant increase in both compressive and tensile 
properties. Therefore, these two treatments were used for subsequent study, in 
combination with HP, in Chapter 6. These findings were exciting, as this was the 
only study to show increases in both compressive and tensile biomechanical 
properties as a result of growth factor treatment. In addition to combination with 
HP, future studies should assess the effects of combining these growth factor 
regimens with other mechanical stimulation modalities such as direct 
compression. 
As no prior studies systematically assessed the effects of multiple physiologic 
regimens of HP on engineered cartilage constructs, a full-factorial study of three 
magnitudes, 1, 5, and 10 MPa, and three frequencies, static, 0.1, and 1 Hz, was 
conducted and described in Chapter 6. HP duration and application time were 
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selected in Chapter 4. HP application at 10 MPa, 1 Hz resulted in a significant 
increase in compressive stiffness and GAG content, while only static HP at 5 and 
10 MPa resulted in significant increases in compressive and tensile stiffness, as 
well as GAG and collagen content. Therefore, these treatments were combined 
with the optimized growth factor treatments described in Chapter 5. It was 
determined that the combination of 10 MPa HP and TGF-01 had additive and 
synergistic effects on tissue functional properties, with a 164% increase in 
compressive stiffness, a 231% in tensile stiffness, an 85% increase in GAG 
content, and a 173% increase in collagen content. Additionally, the collagen/WW 
of this group, at 15.3% was on par with native tissue. The findings of this study 
were extremely exciting, as engineered cartilage was produced for the first time 
with biochemical and biomechanical properties spanning native tissue values. 
Finally, although the aforementioned results of this thesis appear very promising, 
all of the studies involved the use of bovine chondrocytes, which would lead to a 
xenogenic implant for treating articular cartilage injuries. Therefore, Chapter 7 
assessed the feasibility of decellularizing self-assembled articular cartilage 
constructs, to create a non-immunogenic xenogenic tissue for in vivo 
implantation. The control constructs utilized in Chapters 4-6 were selected for 
use in this study. It was found that treatment with 2% SDS for 1 h resulted in a 
33% decrease in DNA content, while maintaining GAG content, collagen content, 
and compressive stiffness, and even increasing tensile stiffness. On the other 
hand, 2% SDS treatment for 8 h led to complete histological decellularization, 
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with a 46% decrease in DNA content. However, there was loss of all GAG and 
compressive stiffness. Although complete tissue decellularization with 
maintenance of functional properties was not achieved in this study, the results 
indicate that this may be feasible with additional study. 
Current tissue engineering approaches strive to obtain a construct with 
biomechanical, biochemical, and histological properties as close as possible to 
native tissue. The results described in this thesis have tremendous clinical 
implications. For example, the results of the growth factor and hydrostatic 
pressure studies outline an exogenous treatment protocol that could potentially 
be applied to any chondrogenically differentiated cell sources such as embryonic 
or mesenchymal stem cells for the creation of implantable cartilage constructs, 
potentially from a patient's own cells. This approach would alleviate the current 
issues involving the scarcity of primary chondrocytes for tissue engineering 
cartilage. Additionally, it is believed that this approach could be applied to 
enhance passaged autologous chondrocytes such as in the FDA approved 
autologous chondrocyte implantation procedures. Moreover, it is likely that self-
assembled constructs created with bovine cells can be decellularized while 
maintaining their biomechanical properties, enabling the use of a xenogenic 
implant. To fully assess this possibility, in vivo studies will be performed shortly 
to determine the effectiveness of self-assembled constructs following 
implantation in a joint defect. 
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Figure 2: Tissue engineering paradigm. 
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Figure 3: (A) Hydrostatic pressure chamber. (B) Direct compression 
device. 
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Figure 4: Illustration of a chondrocyte exposed to HP. 
The cell experiences a uniform stress, without any measurable tissue strain. 
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Figure 5: Representative HP bioreactor design. 
(a) Computer controls Instron, which compresses piston and generates pressure 
within chamber. Chamber is placed in water bath to maintain temperature at 
37°C. (b) HP chamber, with pressure sensor to verify pressures applied within 
the chamber. 
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Figure 6: HP mechanotransduction. 
Pressurization inhibits Na/K and Na/K/2CI channels, while it activates Na/H and 
stretch-activated Ca channels, and triggers release of intracellular Ca stores. 
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Figure 7: The experimental design. 
(a) 1st study: Radial confinement of self-assembled constructs; (b) 2nd study: 
Maintenance of radial confinement of self-assembled constructs; (c) 3rd study: 
Passive axial compression of self-assembled constructs. 
199 
2 wk confinement 4 wk confinement 
Figure 8: Histology of 2-wk and 4-wk confined constructs at 4 wks. 
Original magnification, 10x. (a) Polarized light microscopy images with the 
construct surface at the top. Two-wk confined group demonstrated organization 
of collagen fibrils perpendicular to the surface, (b) Picrosirius-red. (c) Safranin-
O. (d) Collagen IIIHC. (e) Collagen IIHC. 
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Figure 9: Mechanical properties of constructs in radial confinement study. 
Constructs confined for 2 wks demonstrated significantly higher aggregate 
modulus than the other groups. Means and standard deviations. 
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Figure 10: Mechanical properties of constructs in passive axial 
compression study. 
(a) Passive axial compression group exhibited significantly higher Young's 
modulus than control group, (b) Passive axial compression group exhibited 
significantly higher ultimate tensile strength than control group. Means and 
standard deviations. 
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Figure 11: Histological and immunohistochemical images representative of 
all self-assembled constrcuts at 2,4, and 8 wks. 
10x original magnification, scale bar marks are 10 urn. (a) Gross morphology, 
(b) Gross morphology profile, (c) Picrosirius-red stained sections, (d) Safranin-
O/Fast green stained sections, (e) Collagen II IHC sections, (f) Collagen I IHC 
sections. 
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Figure 12: Biomechanical and biochemical properties of self-assembled 
constructs in phase I. 
The HP treated group exhibited a significantly higher (a) aggregate modulus, (b) 
Young's modulus, (c) GAG/WW and (d) collagen/WW than BC or CC groups. 
Columns and error bars represent means and standard deviations. Groups 
denoted by different letters are significantly different (p<0.05). 
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Figure 13: Biomechanical and biochemical properties of self-assembled 
constructs in phase II. 
HP treatment was a significant factor for (a) aggregate modulus, (b) Young's 
modulus, (c) GAG/WW and (d) collagen/WW. Columns and error bars represent 
means and standard deviations. Groups denoted by different letters are 
significantly different (p<0.05) in the two-factor ANOVA (HP and application 
times). (*) indicates significant difference from control (p<0.05), based on the 
post-hoc analysis comparing each individual group. 
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Figure 14: Biomechanical and biochemical properties of self-assembled 
constructs in phase III. 
(a) Aggregate modulus was significantly increased by HP at 2 wks and 4 wks. 
(b) Young's modulus was significantly increased by HP at 4 wks and 8 wks. (c) 
GAG/WW and (d) collagen/WW were significantly increased at 2 wks and 4 wks 
by HP application. Columns and error bars represent means and standard 
deviations. (*) indicates significant difference from control (p<0.05). 
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Figure 15: Schematic diagram indicating experimental designs of phases I 
and II. 
The experimental design depicted in phase I was carried out for each individual 
growth factor separately (blocked by growth factor). The best treatment for each 
growth factor was selected for phase II. Phase II assessed the effects of each 
growth factor individually and in all combinations of two and three. 
207 
Control BMP-2 + IGF-I TGF-pi 
Picrosirius red 
Safranin-O/ 
Fast green 
Figure 16: Photomicrographs of collagen and GAG staining. 
No growth factor control constructs, BMP-2 + IGF-I constructs, and TGF-pi 
treated constructs. 10x original magnification. 
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Figure 17: Biomechanical and biochemical properties of BMP-2 treated 
constructs in phase I. 
All BMP-2 treatments significantly increased (a) aggregate modulus with no 
effects on (b) Young's modulus. Likewise, all BMP-2 treatments significantly 
increased (c) GAG/WW with no effect on (d) collagen/WW. Columns and error 
bars represent means and standard deviations. Groups denoted by different 
letters are significantly different (p<0.05). 
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Figure 18: Biomechanical and biochemical properties of IGF-I treated 
constructs in phase I. 
All IGF-I treatments, except 10 ng/ml continuous, significantly increased (a) 
aggregate modulus with no effect on (b) Young's modulus. Likewise, all IGF-I 
treatments, except 10 ng/ml continuous, significantly increased (c) GAG/WW with 
no effect on (d) collagen/WW. Columns and error bars represent means and 
standard deviations. Groups denoted by different letters are significantly different 
(p<0.05). 
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Figure 19: Biomechanical and biochemical properties of TGF-pi treated 
constructs in phase I. 
TGF-p1 treatment at 30 ng/ml and 2-wk continuous dosage significantly 
increased (a) aggregate modulus and (b) Young's modulus, with corresponding 
increases in (c) GAG/WW and (d) collagen/WW. Columns and error bars 
represent means and standard deviations. Groups denoted by different letters 
are significantly different (p<0.05). 
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Figure 20: Biomechanical and biochemical properties of constructs in 
phase II. 
Combined treatment with BMP-2 and IGF-I led to the greatest enhancement of 
aggregate modulus and GAG/WW, while TGF-p1 alone was the only treatment to 
enhance both compressive and tensile stiffness, (a) aggregate modulus, (b) 
Young's modulus, (c) GAG/WW and (d) collagen/WW. Columns and error bars 
represent means and standard deviations. Groups denoted by different letters 
are significantly different (p<0.05). 
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Figure 21: Histological and immunohistochemical images representative of 
all self-assembled constructs. 
10x original magnification, (a) Gross morphology, (b) Picrosirius-red stained 
sections, (c) Collagen II IHC sections, (d) Gross morphology profile, (e) 
Safranin-O/fast green stained sections, (f) Collagen I IHC sections. 
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Figure 22: Biomechanical and biochemical properties of self-assembled 
constructs in phase I, normalized to control values. 
HP application at 5 or 10 MPa, 0 Hz, resulted in a significantly higher (a) 
aggregate modulus, (b) Young's modulus, (c) GAG/WW and (d) collagen/WW 
than control. Columns and error bars represent means and standard deviations. 
Groups denoted by different letters are significantly different (p<0.05). 
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Figure 23: Biomechanical and biochemical properties of self-assembled 
constructs in phase II, normalized to control values. 
(a) aggregate modulus, (b) Young's modulus, (c) GAG/WW and (d) 
collagen/WW. Combined treatment with 10 MPa static HP and TGF-p1 led to 
additive increases in aggregate modulus and Young's modulus, and a synergistic 
increase in collagen/WW. Columns and error bars represent means and 
standard deviations. Groups denoted by different letters are significantly different 
(p<0.05). 
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Figure 24. Photomicrographs demonstrating construct cellularity, GAG 
content, and collagen content for various treatment groups. 
10x original magnification. Treatment with 2% SDS for 1 h decreased cellularity 
while preserving GAG content, while treatment for 8 h eliminated all nuclei, but 
also eliminated all GAG. 
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Figure 25. Cellularity (DNA content) of constructs following 
decellularization treatment. 
Treatment with 2% SDS or the hypotonic/hypertonic solutions at either 
application time significantly decreased construct cellularity. Columns and error 
bars represent means and standard deviations. Groups denoted by different 
letters are significantly different (p<0.05). 
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Figure 26. Construct GAG content following decellularization. 
All 8 h treatments resulted in nearly complete GAG removal, while both 1% and 
2% SDS for 1 h maintained GAG content. Columns and error bars represent 
means and standard deviations. Groups denoted by different letters are 
significantly different (p<0.05). 
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Figure 27. Construct collagen content following decellularization. 
Treatment with SDS or TnBP maintained collagen content, while treatment with 
Triton X-100 or the hypotonic/hypertonic combination significantly reduced total 
collagen content. Columns and error bars represent means and standard 
deviations. Groups denoted by different letters are significantly different 
(p<0.05). 
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Figure 28. Construct compressive properties following decellularization. 
All 8 h treatments either significantly reduced compressive stiffness, or were 
untestable. However, treatment for 1 h with 1% or 2% SDS, or 2% TnBP 
maintained compressive stiffness. Columns and error bars represent means and 
standard deviations. Groups denoted by different letters are significantly different 
(p<0.05). 
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Figure 29. Construct tensile properties following decellularization. 
(a) Treatment with 1% SDS for 1 h maintained tensile stiffness, while treatment 
with 2% SDS for 1 h increased tensile stiffness. The 8 h detergent treatments 
resulted in a slight decrease in tensile stiffness, (b) Similar trends were observed 
for ultimate tensile strength. Columns and error bars represent means and 
standard deviations. Groups denoted by different letters are significantly different 
(p<0.05). 
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Appendix B: Tables 
Chapter 5: Tables l-IV 
Chapter 6: Tables V-VI 
Chapter 7: Tables VII-VIII 
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Table I: Properties of constructs treated with BMP-2 in phase I. 
Group 
Control 
100ng/ml 
Continuous 
100 ng/ml 
Wk Rotat. 
10 ng/ml 
Continuous 
10 ng/ml 
Wk Rotat. 
WW 
(mg) 
21.8±2.4 
23.7±1.8 
22.6±1.9 
23.3±2.0 
23.8±1.3 
Thickness 
(mm) 
0.67±0.04 
0.71 ±0.07 
0.71 ±0.04 
0.73±0.07 
0.72±0.04 
Total 
Cells 
(x106) 
4.6±0.5 
5.3±0.3 
4.8±0.9 
4.4±1.0 
4.8±0.3 
Fl 
0.75±0.18 
0.94±0.06a 
0.96±0.08a 
0.97±0.10a 
0.92±0.06a 
Significantly different from control 
Wk Rotat., 2-wk rotation dosage 
Table II: Properties of constructs treated with IGF-I in phase I. 
Group 
Control 
100ng/ml 
Continuous 
100ng/ml 
Wk Rotat. 
10 ng/ml 
Continuous 
10 ng/ml 
Wk Rotat. 
WW 
(mg) 
25.7±1.0 
24.5±1.4 
22.7±1.6a 
23.2±1.7a 
24.111.9 
Thickness 
(mm) 
0.74±0.06 
0.65±0.08 
0.71 ±0.09 
0.75±0.10 
0.75±0.12 
Total Cells 
(x106) 
5.2±0.6 
5.3±0.7 
5.0±0.4 
4.6±0.6 
5.0±0.3 
Fl 
0.59±0.19 
0.93±0.12a 
0.92±0.14a 
0.78±0.19a 
0.96±0.08a 
aSignificantly different from control 
Wk Rotat., 2-wk rotation dosage 
Table III: Properties of constructs treated with TGF-pi in phase I. 
Group 
Control 
30 ng/ml 
Continuous 
30 ng/ml 
Wk Rotat. 
10 ng/ml 
Continuous 
10 ng/ml 
Wk Rotat. 
WW 
(mg) 
24.9±2.8 
12.6±0.7a 
13.9±0.6a 
17.8±1.3a 
17.9±4.6a 
Thickness 
(mm) 
0.88±0.14 
0.57±0.06a 
0.57±0.02a 
0.64±0.09a 
0.76±0.17 
Total Cells 
(X106) 
5.7±0.3 
6.6±0.4a 
6.5±0.8a 
5.7±0.4 
5.8±0.8 
Fl 
0.60±0.08 
0.82±0.07a 
0.81 ±0.14a 
0.6210.07 
0.55±0.06 
Significantly different from control 
Wk Rotat., 2-wk rotation dosage 
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Table IV: Phase II construct properties. 
Group 
Control 
BMP-2 
IGF-I 
TGF-P1 
BMP-2 + IGF-I 
BMP-2 + TGF-
P1 
IGF-I + TGF-
P1 
BMP-2 + IGF-I 
+ TGF-p! 
WW 
(mg) 
13.3±1.3 
15.0±1.6 
13.313.1 
14.5±1.6 
16.7±1.3a 
14.9±1.4 
14.2±1.4 
13.0±1.3 
Thickness 
(mm) 
0.45±0.09 
0.55±0.06 
0.5510.05 
0.5810.05 
0.5910.05 
0.5710.04 
0.5710.06 
0.5310.08 
Total Cells 
(x106) 
5.610.5 
5.210.4 
5.710.9 
5.510.3 
5.910.4 
5.810.6 
5.510.3 
6.110.4 
Fl 
0.5310.06 
0.76l0.07a 
0.7310.12a 
0.72i0.04a 
0.80i0.08a 
0.66i0.02a 
0.5910.04 
0.7010.05 
aSignificantly different from control 
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Table V: Phase I construct properties. 
Group 
No HP, No GF 
No HP, BMP-2+IGF-I 
No HP, TGF-P1 
5 MPa, No GF 
5 MPa, BMP-2+IGF-I 
5 MPa, TGF-B1 
10 MPa, No GF 
10 MPa, BMP-2+IGF-I 
10 MPa, TGF-B1 
WW(m9 ) 
32.1 40.7 
33.0±1.8 
16.2+1.1 
29.0-1.7 
32.0+2.5 
15.4+1.0 
27.8+0.8 
31.4+1.3 
14.8±0.4 
Thickness (mm) 
0.98±0.09 
1.09±0.11 
0.6940.06 
1.01+0.15 
1.03+0.14 
0.65+0.06 
0.94+0.13 
1.06±0.09 
0.69+0.08 
HA (kPa) 
94±24 
160±29 
176*38 
173+87 
165+37 
189±46 
161±19 
187±45 
248+.37 
EY (kPa) 
619473 
596±70 
1460+182 
1424+465 
862±293 
1545+235 
1268*404 
776+260 
2048±266 
GAG/WW (%) 
5.240.5 
6.9+1.3 
7.340.3 
7.8+0.6 
7.440.8 
8.1 +0.2 
8.540.6 
7.540.4 
9.640.4 
COI./WW (%) 
S.641.5 
5.441.4 
9.242.0 
7.5+0.5 
5.8+0.4 
12.6+2.4 
7.841 .5 
5.641.2 
15.342.9 
Total Cells 
(x10s) 
5.040.5 
5.1+1.5 
5.044.5 
5.7+0.3 
5.240.5 
5.1 ±0.4 
5.640.4 
5.640.1 
5.540.4 
Col., total collagen 
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Table VI: Phase II construct properties. 
Group 
No HP, No GF 
No HP, BMP-2+IGF-I 
No HP, TGF-pi 
S MPa, No GF 
5 MPa, BMP-2+IGF-I 
5 MPa, TGF-pi 
10 MPa, No GF 
10 MPa, BMP-2+IGF-I 
10 MPa, TGF-pi 
WW(mg) 
32.1 ±0 7 
33.0±1.8 
16.211.1 
29.0 ±1.7 
32.0 :r 2.5 
15.4±1.0 
27.840.8 
31.4±1.3 
14.8+.0.4 
Thickness (mm) 
0.98+0.09 
1.09+0.11 
0.69±0.06 
1.01+0.15 
1.03+0.14 
0.65 ±0.06 
0.94+0.13 
1.06 ±0.09 
0.69±0.08 
HA (kPa) 
94+24 
160+29 
176=: 38 
173+87 
165+37 
189146 
161+19 
187±45 
248+37 
Ev (kPa) 
619+73 
596±70 
1460+182 
1424+465 
862±293 
1545+235 
1268+404 
776±260 
2048+266 
GAG/WW (%) 
5.2±0.5 
6.9 ±1.3 
7.3+0.3 
7.8 ±0.6 
7.4+0.8 
8.1±0.2 
85+0.6 
7.5+0.4 
9.6+0.4 
COI./WW (%) 
5.6+1.5 
5.4+1.4 
9.2+2.0 
7.5+0.5 
5.8+0.4 
12.6+2.4 
7.8±1.5 
5.6 ±1.2 
153±2.9 
Total Cells 
(x10«) 
5.0±0.5 
5.1+1.5 
5.0+4.5 
5.7+0.3 
5.2+0.5 
5.1+0.4 
5.6+0.4 
5.6 ±0.1 
5.5 ±0.4 
Col., total collagen 
Table VII: Phase II construct properties. 
Treatment Group 
Control 
1%SDS, 1h 
1%SDS,8h 
2% SDS, 1 h 
2%SDS,8h 
2% TnBP, 1 h 
2% TnBP, 8 h 
2% Triton X-100,1 h 
2%TritonX-100,8h 
Hypo/Hyper 1 h 
Hypo/Hyper 8 h 
Construct Wet Weight 
14.8±1.1 
14.3±1.0 
8.8±1.2a 
12.3±1.1 
9.3±2.6a 
15.2±1.1 
12.2±1.2 
13.7±1.2 
11.2±1.7a 
15.0±3.0 
7.0±1.3a 
Thickness 
0.49±0.03 
0.50±0.02 
0.38±0.04a 
0.43±0.05 
0.47±0.08 
0.53±0.06 
0.49±0.04 
0.47±0.05 
0.47±0.08 
0.4010.09 
0.35±0.04a 
aSignificantly lower than control (p<0.05) 
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Table VIII: Phase II construct properties. 
Treatment Group 
Control 
1%SDS, 1h 
1%SDS,8h 
2% SDS, 1 h 
2% SDS, 8 h 
2% TnBP, 1 h 
2%TnBP,8h 
2% Triton X-100,1 h 
2%TritonX-100,8h 
Hypo/Hyper 1 h 
Hypo/Hyper 8 h 
Poisson Ratio 
0.30±0.07 
0.26±0.04 
0.07±0.09a 
0.26±0.10 
Not testable 
0.24±0.13 
0.04±0.03a 
0.16±0.11 
0.04±0.04a 
0.14±0.14 
Not testable 
Permeability 
14.3±3.9 
15.618.0 
2.0±1.6a 
12.616.3 
Not testable 
5.513.1 
7.317.5 
4.312.6 
5.1+4.7 
14.916.6 
Not testable 
Significantly lower than control (p<0.05) 
